Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567037 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 26.2" "Cell type enhanced" "Detected in many" "dendritic cells: 79.4;Hepatocytes: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 18.3;MAIT T-cell: 6.6;NK-cell: 10.8;plasmacytoid DC: 23.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 19.2 3.8 3.6 6.2 4.0 8.2 10.6 3.8 3.3 4.6 3.8 7.3 11.2 4.5 3.3 4.7 4.7 5.2 4.9 3.1 4.1 8.9 26.2 6.0 9.1 4.9 4.2 2.9 8.1 7.9 9.1 4.5 4.7 4.7 6.5 1.6 5.1 3.8 2.6 4.6 11.2 4.0 4.2 9.9 8.3 1.8 4.3 4.6 5.8 3.8 8.1 5.6 4.6 4.9 5.8 22.1 2.7 7.7 29.0 12.6 11.3 7.8 8.6 7.6 6.9 5.1 2.9 8.6 5.6 8.4 13.4 15.6 9.7 3.3 4.2 26.5 7.3 3.5 11.0 6.5 8.8 9.0 15.4 9.4 8.9 7.3 1.4 5.6 5.6 5.0 4.6 8.0 4.1 7.8 8.5 10.4 0.6 19.5 6.5 19.7 10.5 20.0 13.7 8.8 1.9 3.1 11.7 5.2 3.1 2.9 13.2 20.5 6.9 4.4 5.5 11.1 7.0 13.3 9.6 4.4 8.8 5.6 9.6 18.3 0.6 2.8 2.6 0.3 6.6 1.4 1.4 2.2 1.5 2.5 0.4 1.3 0.6 10.8 0.2 23.6 1.2 1.1 3.6 4.0 3.8 3.3 3.1 4.1 4.9 4.2 4.7 4.2 4.3 4.9 2.4 3.2 4.1 2.6 11.7 1.3 1.1 2.5 2.2 0.1 3.8 2.4 3.0 2.8 4.3 7.3 0.0 1.5 79.4 12.0 0.0 3.0 0.3 4.7 3.1 2.9 7.2 7.0 0.3 7.6 1.4 4.0 2.0 5.1 2.5 2.9 4.2 30.2 7.2 1.7 0.5 6.1 2.0 6.7 8.4 0.7 4.7 9.5 5.4 2.8 5.6 1.1 15.5 0.5 1.2 5.6 2.5 4.5 5.2 1.5 17.7 5.6 5.2 0.9 0.0 3.5 1.9 0.8 0.6 2.0 2.4 0.3 11.8 4.5 7.4 1.2 AKAP13 "AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB" ENSG00000170776 "A-kinase anchoring protein 13" Q12802 15 85380571-85749358 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 161.8" "Low region specificity" "Detected in all" HPA019773 Approved Supported Cytosol NA NA 14000 "Cluster 2: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA019773: AB_1844686" "unprognostic (4.61e-2)" "unprognostic (1.16e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (5.33e-2)" "unprognostic (7.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (3.99e-2)" "unprognostic (3.92e-1)" "unprognostic (6.69e-2)" "unprognostic (4.88e-2)" "unprognostic (4.80e-2)" "unprognostic (1.46e-1)" "unprognostic (3.81e-3)" 37.7 18.9 10.0 38.7 9.2 56.1 32.1 1.7 9.3 28.5 66.1 25.9 16.7 83.0 20.7 25.6 22.7 44.6 66.6 11.0 17.7 14.4 22.2 54.1 47.6 16.7 17.6 26.7 54.5 11.8 18.5 26.0 13.9 20.3 21.3 8.3 23.9 23.5 83.9 24.7 32.5 40.3 9.7 38.3 34.4 20.0 15.0 46.3 32.7 60.3 46.5 32.9 26.7 16.3 13.2 29.0 20.8 7.8 31.3 34.6 11.2 10.6 23.5 9.4 9.0 11.3 11.0 62.0 14.6 19.2 23.8 26.5 23.9 9.9 9.0 45.2 11.0 83.8 20.0 8.6 17.3 17.2 161.8 25.6 25.5 11.6 39.8 10.6 25.2 22.4 5.5 29.6 14.7 6.3 24.7 12.8 13.5 22.8 11.5 16.7 20.6 23.5 15.3 27.0 13.1 23.4 27.9 8.3 14.5 22.7 6.0 14.3 30.2 11.4 7.8 6.7 10.7 46.1 30.1 48.9 6.8 55.2 9.0 282.9 66.0 181.4 122.2 54.9 68.3 74.9 81.6 93.3 38.8 68.8 68.2 75.5 104.3 108.2 77.5 100.6 73.2 48.0 10.0 9.2 1.7 9.3 11.0 17.7 16.7 17.6 13.9 9.7 15.0 16.3 110.5 125.0 431.2 88.2 186.8 75.7 105.2 29.1 57.5 18.6 50.2 39.9 215.2 91.5 71.6 40.5 41.7 36.7 336.8 143.3 5.9 83.4 258.9 155.6 327.0 121.5 63.5 37.0 51.2 69.6 27.6 119.6 170.2 323.6 279.5 65.6 75.7 53.7 79.2 13.5 13.0 57.8 36.7 147.1 276.3 166.3 77.6 257.9 99.6 290.4 197.3 45.8 252.4 123.6 13.2 101.2 118.7 63.6 205.8 77.0 68.6 10.5 60.1 17.9 85.5 139.6 117.4 23.3 37.2 77.6 79.0 23.4 269.7 30.5 61.7 179.6 ANKRD11 "LZ16, T13" ENSG00000167522 "Ankyrin repeat domain 11" Q6UB99 16 89267630-89490561 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019288, HPA041593, HPA049470" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780" "unprognostic (7.31e-2)" "unprognostic (6.35e-2)" "unprognostic (1.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.81e-1)" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.67e-4)" "unprognostic (1.56e-3)" "unprognostic (1.79e-1)" "unprognostic (7.93e-2)" "unprognostic (5.78e-3)" "unprognostic (2.16e-1)" 24.2 21.1 33.1 26.0 29.3 53.9 14.5 23.2 39.1 18.0 18.7 17.6 21.4 22.0 12.8 22.5 18.4 18.6 22.3 36.8 22.1 15.7 12.2 18.9 26.3 29.8 25.7 29.2 26.6 24.7 24.1 17.9 25.3 16.1 13.6 14.1 20.1 17.0 24.8 35.0 21.0 14.5 19.2 26.6 21.7 18.4 26.7 24.9 19.4 15.0 19.0 19.3 16.5 28.8 55.5 67.9 66.8 51.5 40.3 41.4 64.5 61.7 41.1 36.5 25.8 79.7 57.8 51.0 41.6 44.9 41.1 54.6 46.0 56.8 41.2 25.5 55.3 40.3 49.3 64.7 60.8 30.0 44.0 46.4 56.4 47.9 61.5 52.8 44.4 84.1 88.4 39.6 46.5 52.5 50.1 75.2 58.8 28.7 61.9 101.6 77.0 43.3 38.0 45.7 39.1 47.9 89.0 18.5 65.1 33.9 43.3 46.6 83.2 76.4 71.4 42.9 68.7 71.5 27.1 62.9 61.6 48.6 42.2 7.6 2.9 3.0 2.7 3.1 3.1 2.6 3.1 3.3 1.6 3.0 2.7 2.4 8.5 7.1 5.1 5.4 3.3 1.5 33.1 29.3 23.2 39.1 36.8 22.1 29.8 25.7 25.3 19.2 26.7 28.8 133.0 131.4 103.0 94.7 136.3 116.5 150.3 49.5 91.6 181.3 57.4 65.8 233.3 84.4 52.5 71.7 158.4 42.7 203.7 109.7 31.3 80.1 118.5 200.9 162.6 135.4 106.9 58.5 122.1 72.7 36.3 118.2 96.8 312.8 55.7 164.5 80.7 69.4 48.4 156.5 97.7 89.8 30.5 63.5 117.9 39.5 103.8 112.0 48.0 119.0 110.9 83.1 146.2 117.1 110.0 122.4 66.9 106.1 143.3 147.6 64.6 35.1 45.6 112.9 39.5 148.3 126.3 92.2 98.9 102.6 122.2 38.7 133.8 137.4 87.3 179.0 ARMH1 "C1orf228, MGC33556, NCRNA00082, p40" ENSG00000198520 "Armadillo like helical domain containing 1" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 8.2;testis: 11.7" "Cell type enhanced" "Detected in some" "B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.4 1.1 1.7 0.2 2.2 2.2 0.7 1.1 2.6 0.8 4.5 0.5 0.2 1.7 3.5 0.5 8.2 0.7 0.2 2.3 1.3 0.9 4.2 1.0 0.6 2.6 4.0 2.6 0.5 1.9 3.3 0.3 2.1 0.8 0.3 4.2 0.7 0.6 0.1 0.8 0.3 0.3 1.8 0.3 0.7 11.7 1.9 0.4 0.6 0.0 0.3 0.3 0.3 2.2 0.2 0.3 1.8 0.1 0.5 2.1 0.5 0.0 0.2 0.5 0.3 0.4 3.8 0.2 0.2 0.8 0.9 0.5 0.0 0.0 0.0 1.0 0.2 0.9 2.6 0.6 0.2 6.9 4.1 1.7 0.2 0.7 0.0 1.3 0.2 0.3 0.1 0.7 0.2 0.0 4.9 7.5 0.1 0.5 0.0 2.7 0.1 2.2 0.7 0.0 1.2 0.8 0.0 1.2 0.9 1.2 0.3 3.6 0.0 0.3 0.3 0.3 0.0 0.3 0.1 0.2 0.3 9.9 0.4 8.7 2.1 6.1 0.2 0.7 0.1 0.6 1.1 0.8 1.0 0.9 1.6 1.5 1.0 0.4 0.0 4.8 0.0 1.4 1.7 2.2 1.1 2.6 2.3 1.3 2.6 4.0 2.1 1.8 1.9 2.2 0.5 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 0.0 0.0 3.7 0.0 0.4 1.3 0.0 1.9 0.7 0.0 13.1 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.7 0.0 6.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 5.2 0.9 0.0 0.0 ASIP "AGTIL, ASP" ENSG00000101440 "Agouti signaling protein" P42127 20 34194569-34269344 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 14.8;heart muscle: 28.0;ovary: 41.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 27.4;dendritic cells: 44.1;Hofbauer cells: 15.1;Leydig cells: 12.5;Peritubular cells: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 356 "plasmacytoid DC: 134.8" "Lineage enriched" "Detected in single" 356 "dendritic cells: 134.8" "Cell line enhanced" "Detected in some" "CACO-2: 3.2;HSkMC: 2.4;SK-MEL-30: 1.9;U-698: 1.9" "Not detected" "Not detected" HPA048636 Uncertain Supported Vesicles "Secreted to blood" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA048636: AB_2680471" "unprognostic (4.81e-2)" "unprognostic (7.46e-2)" "unprognostic (1.97e-3)" "unprognostic (3.26e-2)" "unprognostic (2.24e-1)" "unprognostic (3.07e-2)" "unprognostic (5.13e-2)" "unprognostic (4.57e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (5.53e-6)" "unprognostic (1.02e-1)" "unprognostic (3.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" 1.4 0.6 0.2 0.0 0.5 0.3 2.4 0.1 0.4 4.2 0.0 0.5 0.0 2.0 14.8 0.1 4.0 0.1 28.0 0.1 0.1 0.9 1.3 0.3 0.4 0.2 0.1 41.7 0.1 0.0 0.6 0.2 0.6 1.5 0.0 0.3 0.7 0.2 0.9 5.7 0.8 0.0 0.0 0.3 0.3 1.5 0.2 0.2 0.3 1.2 0.5 0.5 1.1 0.3 0.0 1.1 0.4 0.4 0.2 0.7 0.1 0.1 0.0 0.0 0.0 3.2 0.0 1.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 1.7 0.3 0.5 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.1 0.0 0.7 0.6 0.9 0.0 0.3 0.2 1.7 0.0 0.1 0.6 0.3 0.3 1.4 0.0 0.1 0.2 0.2 0.0 0.2 1.9 0.5 0.3 0.2 0.3 0.5 0.5 0.0 0.3 0.4 0.4 1.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 134.8 0.0 0.6 0.2 0.5 0.1 0.4 0.1 0.1 0.2 0.1 0.6 0.0 0.2 0.3 0.4 0.0 0.6 1.3 0.8 2.5 0.0 0.0 0.0 0.0 0.3 0.5 27.4 0.0 0.0 0.0 0.0 0.2 44.1 0.0 1.9 0.0 1.1 0.3 9.2 1.2 0.0 0.0 2.1 0.0 0.2 5.6 0.0 0.4 0.0 0.2 2.5 5.8 15.1 0.0 1.8 0.0 0.0 0.8 7.0 1.7 12.5 2.1 1.8 1.0 0.3 0.0 0.0 2.5 2.5 0.1 0.0 10.5 0.0 0.1 0.0 8.3 0.0 0.0 6.6 0.1 0.6 1.7 1.9 0.2 3.1 0.8 0.6 1.0 0.0 0.1 BANP "BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1" ENSG00000172530 "BTG3 associated nuclear protein" Q8N9N5 16 87949244-88077318 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047164 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "HPA047164: AB_2679964" "unprognostic (1.82e-1)" "unprognostic (7.84e-3)" "unprognostic (4.73e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.35e-2)" "unprognostic (4.95e-2)" "unprognostic (1.47e-1)" "unprognostic (1.19e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.68e-3)" "unprognostic (4.98e-2)" "unprognostic (2.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (5.89e-2)" 8.8 9.3 8.1 9.5 8.8 12.1 7.8 16.0 9.5 10.2 11.3 8.8 5.1 9.6 3.3 7.5 9.6 4.9 8.0 9.1 8.9 9.0 13.9 7.4 9.6 10.6 9.0 12.3 8.7 6.2 9.9 7.7 9.8 8.1 3.6 6.4 7.9 5.1 10.2 8.0 8.7 4.3 7.3 12.1 7.5 11.0 10.3 10.4 8.0 5.1 6.4 9.3 8.3 12.1 12.5 19.7 9.6 14.4 8.4 10.1 32.2 14.8 7.4 14.3 9.7 21.6 17.0 16.8 19.6 3.5 13.0 14.2 14.4 6.7 5.2 13.1 15.5 10.5 12.9 18.0 7.1 11.2 8.3 3.0 10.7 8.8 6.3 12.9 8.9 10.9 17.9 9.3 8.8 14.5 15.5 14.6 16.5 9.7 23.6 16.4 11.1 12.4 8.5 5.9 14.2 11.7 18.8 11.0 13.8 14.1 13.5 14.3 11.0 15.4 10.7 9.1 14.8 7.6 13.9 25.7 9.2 17.2 15.1 22.9 19.9 40.7 22.2 18.2 18.7 25.1 23.5 19.9 24.7 21.5 24.9 22.3 64.5 24.5 22.5 29.7 23.0 19.5 8.1 8.8 16.0 9.5 9.1 8.9 10.6 9.0 9.8 7.3 10.3 12.1 12.0 9.6 8.3 15.0 28.6 14.9 11.8 7.4 6.2 14.2 14.1 13.2 5.8 10.0 5.1 16.5 4.2 19.4 42.2 9.2 3.9 12.5 5.8 10.7 9.7 13.6 12.1 4.4 32.7 8.0 27.3 16.3 4.1 13.4 8.2 17.9 5.3 10.3 12.4 26.9 28.3 8.9 2.0 11.1 48.3 8.2 10.8 22.6 19.6 20.6 16.0 11.6 22.6 23.1 28.6 11.0 8.6 10.9 21.2 16.2 10.0 7.8 6.3 17.2 13.1 10.8 22.7 33.7 22.7 6.2 21.3 56.6 19.1 10.2 8.9 17.2 BCL11A "BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856" ENSG00000119866 "BAF chromatin remodeling complex subunit BCL11A" Q9H165 2 60450520-60554467 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.8;lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" "B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0" "Group enriched" "Detected in all" 15 "B-cells: 415.7;dendritic cells: 899.0" "Cell line enhanced" "Detected in many" "Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7" "CAB014891, HPA029003, HPA075941" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "CAB014891: , HPA029003: AB_2672863, HPA075941: " "unprognostic (4.10e-3)" "unprognostic (6.72e-2)" "unprognostic (4.50e-2)" "unprognostic (9.41e-3)" "unprognostic (2.37e-1)" "unprognostic (4.47e-3)" "unprognostic (2.53e-2)" "unprognostic (1.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.45e-1)" "unprognostic (4.27e-4)" "unprognostic (1.23e-2)" "unprognostic (2.35e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-1)" "unprognostic (4.40e-2)" "unprognostic (2.99e-2)" 0.7 2.1 31.4 11.3 34.7 25.3 7.1 10.5 47.8 5.2 9.7 18.4 9.7 2.1 1.4 18.4 5.7 2.5 8.0 38.7 15.5 1.0 0.5 2.1 29.2 31.6 15.3 0.6 10.8 1.7 3.0 0.9 31.0 7.8 6.1 1.7 13.8 1.9 1.7 33.2 13.9 3.4 15.9 19.6 4.8 2.0 15.9 33.9 2.3 0.2 40.9 3.3 11.5 38.7 0.6 0.0 4.2 0.1 0.8 0.8 0.3 1.5 0.0 0.1 0.0 0.0 0.2 51.1 0.2 0.2 0.0 10.5 15.4 7.4 0.2 0.9 15.2 0.1 0.6 0.2 0.0 18.7 0.1 1.7 4.1 0.0 2.5 4.0 2.6 17.1 0.8 0.3 0.1 0.1 49.0 19.9 28.6 7.7 0.2 48.3 1.3 19.7 0.0 0.9 20.1 4.8 0.3 0.4 0.3 8.0 0.3 9.1 1.0 0.3 11.6 0.3 0.1 0.8 0.2 106.7 0.1 34.0 1.6 4.5 23.8 5.1 0.5 44.1 1.1 312.7 0.5 0.5 89.9 415.7 1.3 1.1 11.0 8.4 33.7 899.0 1.1 11.4 31.4 34.7 10.5 47.8 38.7 15.5 31.6 15.3 31.0 15.9 15.9 38.7 0.6 0.0 7.4 3.6 149.0 46.3 16.0 34.0 118.4 2.5 31.6 28.6 18.2 4.3 11.7 1.8 0.0 0.6 140.3 7.5 5.9 9.5 12.0 3.9 2.0 1.4 19.8 69.6 180.8 6.4 0.5 3.6 5.1 4.8 10.1 67.4 0.7 0.1 43.2 52.2 153.2 13.6 6.1 7.0 86.1 5.0 0.3 20.5 16.0 11.2 16.0 0.3 0.0 3.5 4.6 4.7 12.5 0.0 6.0 11.7 16.2 0.5 5.5 0.3 0.0 0.2 2.0 2.9 6.9 120.3 69.9 0.8 4.6 1.0 28.9 5.8 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168445 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 118.3;Plasma cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 91.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026332, CAB079899" Approved Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Mitochondria "CAB026332: AB_566386, CAB079899: AB_10981505" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 8.1 7.4 4.2 16.4 5.0 38.8 12.5 3.7 3.7 7.2 4.6 11.0 7.2 6.5 4.9 9.8 7.0 8.8 5.7 3.0 3.9 10.7 14.3 8.5 24.2 4.3 4.0 10.3 10.3 18.8 9.4 6.0 4.5 7.8 11.9 12.1 10.1 7.1 12.3 5.8 11.7 4.8 3.9 16.3 7.0 8.1 4.4 18.9 16.6 7.3 23.0 8.9 8.2 6.7 8.0 2.4 10.8 10.4 9.1 4.7 29.1 1.2 2.3 3.3 3.3 6.6 24.9 32.0 6.5 1.2 18.9 9.5 10.0 3.9 2.0 24.9 18.2 39.7 8.1 10.5 3.9 14.6 8.8 4.8 10.5 3.7 3.8 7.0 4.6 14.2 20.8 46.6 0.7 5.2 15.3 14.7 13.2 6.3 7.5 19.5 10.3 40.7 4.5 13.0 9.3 24.0 11.0 14.5 8.3 7.1 5.0 31.2 1.9 1.7 11.4 3.7 4.3 91.2 19.5 45.3 2.7 10.1 1.5 5.2 3.7 1.8 1.7 2.6 1.8 3.3 2.3 1.9 1.9 1.9 1.5 1.5 5.2 1.7 5.7 0.4 5.9 1.5 4.2 5.0 3.7 3.7 3.0 3.9 4.3 4.0 4.5 3.9 4.4 6.7 33.9 3.2 9.9 2.9 61.3 17.5 18.2 7.0 34.7 7.4 19.5 29.2 19.3 12.8 10.3 9.2 10.4 4.6 43.9 37.6 13.7 9.7 118.3 36.6 10.8 18.0 21.5 26.5 2.2 6.5 7.8 11.6 8.6 54.7 11.4 5.9 14.6 11.3 10.9 0.0 4.8 15.2 12.2 26.8 52.6 39.2 5.9 34.8 23.2 6.5 41.0 12.1 5.2 3.0 5.3 8.8 16.4 3.8 137.9 15.9 16.6 6.4 15.2 21.1 0.0 11.8 11.9 7.3 17.7 66.1 10.9 5.7 41.0 2.5 12.3 16.0 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1 RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 10.5 11.4 19.7 5.5 22.2 6.5 10.5 23.1 23.6 12.5 12.9 11.1 7.6 12.1 4.2 10.4 12.8 6.0 12.2 17.1 19.2 11.6 13.1 8.4 8.1 31.8 24.9 13.0 15.1 10.3 20.4 6.0 29.7 12.0 4.2 7.5 10.1 6.3 17.7 11.2 10.3 4.6 18.7 12.6 11.2 14.6 25.4 7.3 10.5 9.6 5.8 11.5 9.9 37.4 12.6 28.0 11.8 25.3 10.3 11.4 11.9 17.4 11.2 15.4 12.2 20.2 18.8 9.4 16.9 12.0 7.5 24.2 14.4 11.7 8.4 25.2 14.2 11.5 15.1 9.9 11.5 13.7 24.3 11.3 10.1 9.3 11.5 7.8 11.3 19.7 13.1 7.5 7.6 40.9 16.2 17.1 8.6 20.7 27.7 28.2 8.1 9.6 7.6 29.9 37.5 27.8 18.4 14.0 16.0 5.4 33.4 18.9 16.8 12.1 9.6 22.7 14.2 13.8 11.5 8.9 14.5 11.3 16.9 0.4 1.2 2.0 1.6 1.0 1.1 1.5 1.1 1.6 1.2 1.4 1.4 1.3 0.5 2.5 4.0 3.1 1.6 1.6 19.7 22.2 23.1 23.6 17.1 19.2 31.8 24.9 29.7 18.7 25.4 37.4 11.5 3.2 5.9 17.6 11.4 7.5 7.1 4.5 8.6 18.8 10.7 9.0 8.5 2.8 6.3 3.7 16.7 11.4 15.5 16.2 3.9 5.8 2.3 26.5 10.9 9.5 9.6 6.3 18.3 7.1 8.9 7.7 14.8 16.5 2.5 16.0 8.9 11.3 7.2 30.3 20.8 11.7 4.1 6.7 10.3 1.4 6.5 7.8 8.8 10.3 5.3 7.1 4.1 15.1 34.2 4.8 6.5 4.5 13.4 7.7 8.9 6.1 12.4 20.0 0.0 9.6 8.2 9.2 12.7 7.7 8.8 9.3 11.6 13.2 12.5 5.1 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986316-105074197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 462.1" "Lineage enriched" "Detected in all" 13 "dendritic cells: 462.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 11.9 8.5 11.8 10.5 12.0 12.2 10.5 15.8 21.0 12.0 6.9 9.7 10.1 8.3 5.9 10.3 7.4 4.3 9.5 10.8 9.1 9.0 14.6 7.2 11.1 7.0 6.7 8.9 24.7 2.4 7.8 4.4 8.4 9.7 7.5 4.5 14.7 4.2 7.5 10.5 7.8 6.4 4.4 11.4 15.1 6.4 10.9 9.2 11.0 2.1 11.0 9.5 10.3 13.3 23.3 32.4 15.3 39.2 12.7 13.0 70.9 20.6 5.2 12.2 6.8 32.8 11.4 44.2 20.1 9.3 30.5 15.2 12.9 31.1 13.5 12.6 22.9 29.5 14.9 45.4 18.4 44.4 22.1 19.1 12.9 18.5 19.7 20.4 20.0 36.4 24.7 11.1 12.0 38.5 29.2 75.3 29.9 34.6 46.2 39.0 18.6 99.9 16.9 29.9 19.5 14.2 20.0 41.9 32.7 27.8 34.8 17.8 9.9 30.2 20.1 26.3 31.6 23.2 28.5 47.5 14.1 30.7 29.2 8.3 34.0 0.6 13.6 30.7 17.1 34.6 18.1 17.3 106.0 25.4 18.6 17.9 3.3 27.8 17.2 462.1 32.9 21.0 11.8 12.0 15.8 21.0 10.8 9.1 7.0 6.7 8.4 4.4 10.9 13.3 15.7 6.4 33.4 1.3 30.4 39.0 44.2 52.8 23.3 11.5 23.4 31.8 37.9 20.0 39.9 33.1 25.0 34.7 66.9 15.8 27.4 27.2 20.8 33.8 25.0 18.0 12.5 12.4 3.8 55.3 63.7 23.0 15.8 40.7 20.3 17.5 11.0 48.2 37.7 3.3 4.2 20.5 30.5 24.2 69.6 10.6 15.2 37.8 39.2 1.0 42.0 18.9 9.2 2.5 4.0 39.0 14.5 10.1 65.8 39.2 12.8 43.7 25.9 11.9 0.0 22.3 24.9 15.9 31.3 19.2 32.7 22.0 23.4 18.1 28.4 39.3 CBFA2T3 "ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4" ENSG00000129993 "CBFA2/RUNX1 partner transcriptional co-repressor 3" O75081 16 88874858-88977207 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8;lymphoid tissue: 29.5" "Cell type enhanced" "Detected in many" "Adipocytes: 24.8;B-cells: 26.2;dendritic cells: 25.7;Erythroid cells: 21.0;Intestinal goblet cells: 19.2;Langerhans cells: 23.3;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 35.8" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 64.2;K-562: 114.9;MCF7: 52.3;MOLT-4: 58.0;NB-4: 70.1;REH: 113.6;T-47d: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059931, HPA062423, HPA065890" Approved Enhanced Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575" "unprognostic (2.47e-1)" "unprognostic (2.03e-2)" "unprognostic (9.24e-3)" "unprognostic (2.62e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.13e-3)" "unprognostic (1.69e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.30e-3)" "unprognostic (2.38e-1)" "unprognostic (7.04e-5)" "unprognostic (2.18e-1)" "unprognostic (4.08e-2)" "unprognostic (4.62e-2)" "unprognostic (9.35e-3)" 9.2 2.3 3.6 6.8 4.7 7.7 7.7 35.8 8.4 3.9 0.0 4.9 3.2 5.0 0.7 2.4 3.7 1.7 17.0 5.7 0.0 1.2 4.3 11.3 8.8 0.6 0.9 1.0 27.3 0.7 4.2 3.1 1.7 6.4 1.0 0.8 4.8 0.8 14.0 3.5 10.8 1.1 0.0 18.5 3.7 4.6 0.0 29.5 3.9 3.2 5.1 3.5 3.8 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.3 3.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.1 64.2 0.0 0.0 0.1 17.2 30.6 0.0 0.0 0.0 0.0 0.1 0.0 30.2 114.9 0.5 0.0 52.3 58.0 70.1 1.2 0.0 0.0 113.6 0.8 11.4 0.0 0.0 21.3 4.8 2.5 0.5 0.4 0.3 50.1 17.9 0.4 0.0 0.4 0.3 0.0 0.4 0.5 37.9 0.0 19.8 0.0 1.0 2.5 2.7 0.0 2.8 0.0 3.1 0.0 0.0 6.6 1.7 0.0 0.0 3.4 0.0 4.8 10.6 0.0 1.8 3.6 4.7 35.8 8.4 5.7 0.0 0.6 0.9 1.7 0.0 0.0 0.8 24.8 0.0 1.1 0.3 26.2 2.5 6.2 1.9 0.6 10.8 1.1 0.9 3.3 1.5 2.4 0.0 0.0 0.1 25.7 0.8 0.0 0.3 0.0 0.6 0.6 9.1 3.6 21.0 5.9 2.9 0.2 2.7 2.0 0.5 6.3 0.1 2.2 10.8 3.0 0.0 2.1 19.2 0.0 5.0 23.3 0.3 2.1 9.8 0.0 9.4 14.8 0.2 0.0 2.0 0.6 0.9 0.5 0.7 14.4 2.9 1.7 0.6 0.5 1.4 19.7 10.8 15.6 0.2 4.8 1.7 2.3 0.3 1.3 3.3 1.0 3.8 CCDC50 "C3orf6, DFNA44, Ymer" ENSG00000152492 "Coiled-coil domain containing 50" Q8IVM0 3 191329085-191398659 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 363.7;Oligodendrocyte precursor cells: 365.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 630.7" "Lineage enriched" "Detected in all" 5 "dendritic cells: 630.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001336 Approved Supported Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA001336: AB_1078421" "unprognostic (5.01e-2)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "unprognostic (8.77e-3)" "unprognostic (1.73e-2)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.03e-2)" "unprognostic (2.51e-2)" "unprognostic (4.48e-2)" "unprognostic (3.17e-3)" "unprognostic (2.05e-2)" "unprognostic (7.79e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-2)" "unprognostic (7.57e-2)" "unprognostic (4.19e-1)" 63.2 28.3 19.6 34.3 20.7 10.3 30.6 21.5 19.1 24.1 18.8 26.9 24.2 33.0 24.8 27.9 24.3 34.8 39.7 17.6 23.3 32.4 56.5 31.6 42.2 24.1 22.0 46.2 35.1 27.6 13.5 34.9 24.1 26.2 25.4 11.8 23.7 33.3 19.0 18.4 25.8 48.1 23.2 45.0 24.3 29.6 21.3 17.7 27.4 26.1 41.0 36.7 18.6 24.7 74.9 24.5 93.6 24.7 82.3 72.1 32.3 135.4 135.2 95.4 95.0 52.6 28.9 14.6 163.0 76.8 70.6 83.6 75.6 60.5 141.9 109.0 37.8 10.0 31.7 60.3 120.8 36.8 37.8 58.2 79.3 75.6 169.7 82.2 148.7 0.0 33.9 77.3 85.4 26.0 0.2 23.1 33.2 7.6 103.0 56.3 51.9 73.1 104.3 31.9 21.8 33.2 48.2 51.6 95.8 67.3 35.6 32.9 153.3 93.4 78.4 68.4 176.3 118.6 54.9 0.9 50.5 0.1 76.9 0.1 22.1 2.1 5.9 20.8 2.4 128.5 6.1 3.9 44.3 76.5 1.3 1.5 2.2 24.0 12.1 630.7 22.1 18.0 19.6 20.7 21.5 19.1 17.6 23.3 24.1 22.0 24.1 23.2 21.3 24.7 143.5 25.6 54.5 40.5 134.5 46.9 52.5 30.7 30.7 27.2 32.5 37.5 48.4 58.6 34.7 51.5 27.1 28.1 363.7 44.1 31.3 120.4 183.0 97.3 58.1 134.0 22.8 11.2 15.8 78.5 36.3 66.6 41.8 79.0 2.5 58.5 175.6 79.5 84.4 25.2 41.3 33.8 38.7 59.4 78.3 92.1 69.3 61.4 53.4 98.4 101.4 32.1 5.2 365.4 28.9 174.7 33.9 75.6 102.7 69.8 37.6 71.8 26.3 14.4 59.2 74.1 65.7 73.2 26.6 24.0 32.5 33.5 22.4 49.5 33.7 62.4 CCDC69 "DKFZP434C171, FLJ13705" ENSG00000198624 "Coiled-coil domain containing 69" A6NI79 5 151181052-151224093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 351.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 124.5;dendritic cells: 106.9;Granulosa cells: 138.2;NK-cells: 197.8;Plasma cells: 133.6;Theca cells: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 129.2;Daudi: 199.9;U-266/70: 120.5;U-698: 119.1" "Region enhanced" "Detected in some" "cerebellum: 4.8" "Low region specificity" "Detected in all" "HPA043648, HPA052896" Uncertain Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane" "Golgi apparatus, Actin filaments" "HPA043648: AB_10795877, HPA052896: AB_2681983" "prognostic favorable (3.21e-4)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (5.62e-2)" "unprognostic (8.63e-3)" "unprognostic (3.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.00e-1)" "unprognostic (9.29e-2)" "unprognostic (3.85e-2)" "unprognostic (1.55e-2)" "unprognostic (3.67e-1)" "unprognostic (4.31e-2)" "unprognostic (3.69e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 108.9 89.6 6.7 45.8 8.4 46.3 60.5 12.2 7.9 15.2 13.4 138.5 19.6 32.9 13.3 54.1 37.1 19.3 96.9 5.9 8.9 10.7 24.0 39.0 70.4 13.3 13.8 27.1 47.5 32.1 8.5 14.8 13.6 23.0 20.5 1.8 14.4 29.4 351.9 13.3 44.7 45.6 11.3 55.4 37.0 13.2 9.2 37.8 11.6 163.8 66.8 87.7 21.9 7.2 8.0 1.6 0.4 6.4 129.2 13.1 4.2 1.5 13.1 2.6 2.4 2.1 1.1 199.9 6.3 0.5 3.3 1.0 3.0 2.8 0.9 0.1 2.7 27.0 0.0 17.5 21.1 9.9 34.4 33.0 0.2 1.0 0.0 2.5 13.1 0.0 23.7 44.0 0.1 0.6 43.8 23.3 7.5 0.1 15.2 36.0 1.0 12.1 0.5 5.9 0.2 0.8 2.4 3.2 1.7 3.2 2.0 24.0 32.0 1.0 6.1 0.6 1.5 120.5 60.1 119.1 1.4 22.2 0.0 30.9 12.4 13.5 11.3 10.9 10.3 5.4 8.8 10.8 10.0 10.4 6.1 6.6 9.6 14.3 10.3 19.3 8.5 11.5 6.7 8.4 12.2 7.9 5.9 8.9 13.3 13.8 13.6 11.3 9.2 7.2 51.0 12.8 78.4 0.7 68.8 2.5 3.0 3.5 1.2 0.4 4.8 2.4 124.5 1.5 13.5 1.8 0.0 7.3 106.9 0.2 0.0 2.9 0.5 26.8 2.7 58.9 1.8 32.2 1.8 20.0 9.6 18.4 7.1 1.3 34.8 138.2 28.2 39.7 7.3 6.7 2.7 0.0 4.1 64.0 12.2 2.4 5.6 46.5 10.6 11.2 73.5 4.9 197.8 1.0 0.6 8.8 0.1 7.9 133.6 3.6 4.5 3.2 51.3 1.4 13.1 4.7 14.8 1.2 1.0 0.7 1.3 35.4 65.7 132.1 0.9 23.5 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790792 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 44.6 60.8 44.3 23.7 43.7 47.0 40.3 40.8 53.8 55.5 35.4 49.3 19.7 49.3 21.1 35.4 65.6 23.7 40.4 50.8 42.0 44.5 65.1 47.2 35.1 44.7 44.1 88.5 44.4 19.2 67.0 18.7 41.1 44.1 12.2 11.1 29.7 23.3 28.3 38.7 40.9 19.1 42.7 65.6 37.4 44.3 42.1 31.9 42.1 17.1 20.9 38.9 40.5 44.4 22.5 40.5 24.9 27.6 27.6 21.4 32.1 22.9 33.3 23.4 20.9 30.3 25.0 39.5 25.7 26.0 32.1 44.2 16.5 37.3 8.9 34.8 19.0 37.1 45.2 25.3 40.2 36.3 56.5 37.9 44.5 24.8 27.7 30.0 48.5 34.8 32.6 51.7 21.2 60.1 39.5 54.5 55.0 34.3 41.9 112.2 21.2 57.0 34.2 24.9 24.5 29.2 34.5 35.8 20.9 19.3 45.0 33.9 56.4 27.8 30.9 24.1 22.3 92.5 76.4 34.7 26.1 24.4 25.9 4.1 3.7 5.8 10.3 5.1 10.1 3.6 5.7 8.3 4.8 6.6 6.3 7.9 5.4 22.4 7.5 9.9 4.4 3.6 44.3 43.7 40.8 53.8 50.8 42.0 44.7 44.1 41.1 42.7 42.1 44.4 43.1 12.8 12.4 39.8 27.1 24.1 27.6 15.8 18.8 13.9 17.9 10.9 14.1 20.0 10.8 11.0 2.1 22.5 28.5 17.1 15.6 31.3 4.4 26.4 22.7 35.6 19.2 15.4 18.1 37.2 22.3 23.0 24.5 25.3 25.3 18.1 33.5 26.4 23.3 25.2 17.0 12.7 8.2 18.8 23.4 6.2 19.6 24.2 16.0 22.5 44.7 17.5 33.0 12.5 16.8 32.9 13.7 31.2 22.2 28.9 14.5 16.7 20.4 7.9 0.0 21.6 22.1 8.9 22.9 19.9 22.0 51.3 24.7 54.5 13.7 31.4 CDYL "CDYL1, DKFZP586C1622" ENSG00000153046 "Chromodomain Y like" Q9Y232 6 4706159-4955551 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Lyase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035578 Enhanced Supported "Nuclear speckles" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 52: Non-specific - Ribosome" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear speckles" "HPA035578: AB_2674685" "unprognostic (1.25e-1)" "unprognostic (8.99e-2)" "unprognostic (6.03e-2)" "unprognostic (2.38e-3)" "prognostic favorable (1.53e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.62e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.09e-1)" "unprognostic (5.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (3.94e-1)" 14.0 6.0 6.9 10.2 6.8 20.0 11.5 5.0 6.7 15.0 4.9 13.0 7.0 15.2 10.5 16.8 10.6 8.4 10.4 6.0 6.4 7.2 5.6 8.9 12.1 6.6 6.2 9.9 7.5 12.4 5.1 18.2 6.0 7.6 13.2 6.7 9.0 11.9 19.5 17.8 9.0 14.5 5.6 9.6 9.2 9.0 6.7 9.3 9.7 12.7 12.9 15.6 13.0 6.9 23.7 22.1 30.1 25.5 23.3 15.9 34.4 23.1 17.9 21.3 22.9 18.0 17.2 5.3 22.1 17.6 33.3 19.8 24.2 28.2 24.9 16.4 20.2 20.9 21.0 16.4 28.5 27.9 21.7 12.5 49.8 25.0 37.5 12.9 20.6 19.2 37.9 16.2 10.8 22.9 14.8 25.9 32.6 17.9 21.3 19.0 26.2 43.7 14.7 20.5 25.5 15.4 28.5 24.9 36.9 86.5 15.0 26.3 28.1 25.2 21.6 18.5 26.8 33.7 57.8 18.4 8.3 17.7 28.1 5.3 1.3 0.6 1.5 0.6 1.1 1.0 1.1 1.2 1.6 1.1 0.7 1.1 0.4 1.6 0.8 6.8 0.1 1.3 6.9 6.8 5.0 6.7 6.0 6.4 6.6 6.2 6.0 5.6 6.7 6.9 32.7 19.2 9.4 28.7 18.4 37.3 23.9 11.9 10.8 16.7 31.2 35.8 18.8 14.3 12.0 14.7 22.9 12.9 64.5 44.7 15.6 10.8 62.8 26.9 43.2 22.9 32.3 41.5 52.3 10.4 22.0 18.7 6.1 60.3 5.7 24.3 18.9 11.7 10.5 45.4 41.5 26.6 6.1 17.3 57.9 74.9 5.9 28.1 8.8 101.2 22.7 25.4 19.6 54.3 64.1 16.8 41.8 8.2 22.3 30.1 4.6 10.7 12.1 25.7 6.6 29.7 20.9 10.4 25.3 9.8 41.9 63.8 17.5 10.9 22.6 56.9 CHML REP-2 ENSG00000203668 "CHM like Rab escort protein" P26374 1 241628851-241640369 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029627, HPA029628, HPA062967" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 9: U-2 OS - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA029627: AB_2756314, HPA029628: AB_10603784, HPA062967: AB_2797269" "unprognostic (1.63e-1)" "unprognostic (6.84e-2)" "unprognostic (3.57e-1)" "unprognostic (8.00e-2)" "unprognostic (2.46e-1)" "unprognostic (5.66e-2)" "prognostic unfavorable (9.23e-5)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (8.01e-3)" "unprognostic (3.02e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.03e-3)" "unprognostic (1.09e-1)" 2.7 1.8 0.7 3.5 1.5 7.5 3.6 0.0 3.6 3.1 0.0 3.0 2.2 4.2 2.7 3.3 2.8 3.2 3.0 1.5 0.2 2.9 2.4 3.8 3.7 0.1 1.0 7.4 2.0 4.1 1.5 11.4 0.0 1.9 3.4 3.3 2.3 1.5 2.6 3.2 2.8 3.2 0.0 3.9 3.1 6.1 1.7 6.4 4.4 3.4 3.0 2.1 2.3 1.5 31.3 9.5 14.6 11.7 4.3 12.8 28.4 12.1 6.0 10.3 7.0 17.5 5.6 8.6 18.1 8.1 8.4 6.3 20.6 13.1 19.0 16.5 19.2 11.3 39.4 12.3 8.7 27.2 14.0 10.7 5.8 13.6 14.0 7.2 8.2 22.7 31.0 10.2 12.3 12.2 18.1 18.1 19.4 11.8 30.6 27.3 18.0 28.8 10.4 19.2 18.6 30.6 15.2 11.5 13.3 14.2 13.5 17.4 16.7 20.9 40.8 10.6 23.3 11.9 31.2 9.0 20.3 16.0 33.0 1.1 0.2 0.1 0.1 0.3 0.1 0.3 0.0 0.0 0.2 0.3 0.3 0.2 0.0 0.1 0.2 0.7 0.0 0.0 0.7 1.5 0.0 3.6 1.5 0.2 0.1 1.0 0.0 0.0 1.7 1.5 14.0 48.1 7.0 0.0 17.2 8.5 6.1 3.8 3.4 3.6 9.9 11.7 19.6 4.3 7.9 0.0 0.0 23.5 26.4 6.2 5.9 14.8 12.3 14.4 15.1 8.1 6.7 10.3 0.0 21.3 26.7 6.5 6.6 34.8 3.8 21.3 4.2 2.1 7.1 5.0 0.0 4.2 6.1 17.6 31.0 30.9 10.5 34.7 17.8 0.0 18.6 3.1 4.1 0.0 0.0 22.5 4.3 18.0 5.8 3.9 4.3 2.2 2.0 4.7 13.1 11.4 20.7 9.0 12.6 7.6 7.2 20.1 5.8 9.9 5.0 4.3 CLEC4C "BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL" ENSG00000198178 "C-type lectin domain family 4 member C" Q8WTT0 12 7729383-7751605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.5" "Cell type enriched" "Detected in some" 21 "dendritic cells: 107.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 16 "plasmacytoid DC: 468.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 468.0" "Cell line enriched" "Detected in single" 5 "HDLM-2: 2.1" HPA029432 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA029432: AB_10601259" "unprognostic (3.55e-3)" "unprognostic (3.01e-2)" "unprognostic (1.03e-1)" "unprognostic (3.70e-2)" "unprognostic (7.37e-5)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-2)" "unprognostic (6.98e-2)" "unprognostic (1.39e-1)" "unprognostic (1.88e-3)" "unprognostic (2.82e-2)" "unprognostic (3.18e-3)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" 0.3 0.1 0.0 1.4 0.1 1.6 1.4 0.4 0.2 0.1 0.7 0.1 0.0 0.1 0.0 0.2 0.1 1.2 0.0 0.1 0.0 0.1 0.2 0.6 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 3.8 0.2 0.9 0.0 2.1 0.1 0.0 5.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 5.3 0.7 30.0 0.1 0.1 0.1 0.6 0.1 0.1 4.1 2.6 0.1 0.0 14.7 2.9 0.0 468.0 0.2 3.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 107.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.0 0.1 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 4.9 0.0 0.3 0.0 0.8 0.0 0.0 0.0 CLN8 "C8orf61, EPMR, FLJ39417, TLCD6" ENSG00000182372 "CLN8 transmembrane ER and ERGIC protein" Q9UBY8 8 1755778-1801711 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 136.8;Syncytiotrophoblasts: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 76.7" "Lineage enriched" "Detected in all" 5 "dendritic cells: 76.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (5.86e-2)" "unprognostic (1.95e-2)" "unprognostic (6.40e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (4.05e-3)" "unprognostic (1.21e-1)" "unprognostic (3.45e-1)" "unprognostic (3.03e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-3)" "unprognostic (1.83e-1)" "prognostic favorable (4.36e-8)" "unprognostic (1.36e-1)" "unprognostic (1.70e-1)" "unprognostic (6.24e-2)" "unprognostic (8.38e-2)" 5.4 5.2 11.4 3.7 15.7 9.1 4.3 14.6 12.4 4.7 6.6 4.9 5.0 3.2 11.2 9.8 3.3 7.5 6.2 10.6 11.3 6.2 8.9 8.9 6.5 18.2 15.2 2.5 10.1 8.0 3.5 6.0 18.5 3.8 4.4 3.8 5.1 3.6 5.9 13.2 6.3 4.0 16.9 7.9 6.8 5.9 15.1 3.2 5.1 3.3 7.2 4.4 5.8 24.3 3.6 8.5 6.2 6.5 8.3 8.4 14.8 8.3 5.1 4.2 5.2 8.6 10.0 4.4 2.3 8.2 5.6 13.7 4.9 15.6 8.6 3.3 3.6 4.4 3.2 4.9 4.7 3.7 19.1 8.4 12.2 5.8 4.1 10.1 9.2 3.2 6.0 2.6 13.1 9.0 6.0 3.2 6.1 14.0 7.3 4.2 4.3 3.4 7.8 15.4 3.2 3.9 3.5 8.1 4.6 12.7 16.2 4.2 17.3 11.3 3.2 0.9 5.2 1.5 5.4 5.0 11.4 7.3 16.9 7.4 10.6 4.7 6.4 13.6 7.1 10.3 6.9 4.5 10.6 14.0 6.7 4.4 3.7 5.1 12.5 76.7 8.0 6.4 11.4 15.7 14.6 12.4 10.6 11.3 18.2 15.2 18.5 16.9 15.1 24.3 18.3 9.6 17.5 6.2 30.1 54.7 71.6 38.6 26.7 27.6 23.4 13.2 7.7 20.0 37.2 31.3 31.3 38.0 115.3 28.5 15.6 27.2 5.4 20.5 6.9 34.7 19.7 40.8 7.4 19.0 18.0 32.7 13.7 37.2 27.3 17.1 27.8 28.5 44.1 40.4 7.6 17.5 50.8 54.6 136.8 5.9 8.1 69.8 21.4 8.4 22.3 13.9 23.7 10.1 27.1 19.3 20.7 12.0 9.1 76.5 19.5 10.6 27.1 26.1 13.1 22.5 16.8 34.4 23.5 20.1 63.5 131.6 22.0 16.1 15.4 61.2 COPA HEP-COP ENSG00000122218 "COPI coat complex subunit alpha" P53621 1 160288594-160343273 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA NA 150000 "Cluster 18: Basophils - Vesicular transport" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 47.7 43.1 46.6 38.5 48.9 30.0 42.0 57.2 57.1 52.9 67.4 42.3 53.7 46.7 55.1 38.3 41.2 38.6 55.1 48.6 53.7 48.6 55.0 47.0 36.1 57.9 51.0 46.9 49.9 51.8 59.8 48.3 60.0 43.5 47.9 26.2 57.6 39.4 59.1 40.0 49.0 50.0 53.9 42.7 43.5 24.4 51.1 37.6 60.1 38.2 38.9 41.3 37.9 66.4 91.0 68.5 70.1 66.9 164.9 154.7 78.6 116.5 144.3 103.1 138.7 72.0 60.5 64.4 73.3 194.0 57.7 86.0 92.0 81.3 126.5 68.6 64.3 76.8 95.2 79.0 115.1 94.1 74.5 134.8 49.1 140.0 128.9 126.3 126.4 64.4 71.9 69.7 124.4 43.6 49.3 53.3 80.1 97.3 79.0 49.2 89.2 118.9 94.3 94.7 62.1 84.3 157.3 109.2 148.0 115.0 140.4 133.9 162.8 84.3 54.1 108.2 80.2 106.8 76.3 106.6 104.2 51.3 122.8 48.1 39.0 25.4 18.6 36.7 25.5 17.8 16.7 21.3 40.4 14.2 14.3 17.9 10.9 26.7 36.2 17.8 22.9 35.5 46.6 48.9 57.2 57.1 48.6 53.7 57.9 51.0 60.0 53.9 51.1 66.4 53.6 76.9 54.7 44.7 66.4 28.2 35.5 41.6 29.6 52.4 53.0 41.3 51.8 42.9 49.7 40.5 81.3 41.0 83.2 66.8 13.7 49.9 14.7 50.7 68.1 50.4 55.3 37.0 77.6 49.6 63.3 66.2 65.2 64.3 45.6 63.0 52.8 71.1 51.2 45.4 73.8 83.8 30.5 93.7 58.0 6.4 71.1 84.3 26.6 67.5 75.0 41.0 38.1 65.9 178.9 55.5 48.1 56.8 115.9 52.9 98.9 41.4 66.2 53.7 39.5 57.6 52.4 37.6 25.7 35.8 31.8 69.2 58.3 58.1 66.6 61.2 CORO1C "coronin-3, HCRNN4" ENSG00000110880 "Coronin 1C" Q9ULV4 12 108645109-108731526 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041737 Approved NA NA 13000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA041737: AB_10804115" "unprognostic (2.86e-1)" "unprognostic (2.82e-2)" "unprognostic (2.83e-1)" "unprognostic (3.96e-1)" "unprognostic (6.50e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.59e-5)" "unprognostic (2.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.41e-1)" "unprognostic (1.07e-2)" "unprognostic (3.96e-1)" "unprognostic (1.67e-3)" "unprognostic (2.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.39e-3)" "unprognostic (4.90e-3)" 68.5 30.6 36.1 49.7 36.1 52.5 36.6 28.1 36.8 49.9 22.1 116.6 28.9 96.1 24.1 67.7 55.9 54.4 33.7 41.3 39.1 25.8 49.1 76.4 31.6 43.9 37.1 30.4 13.0 36.4 22.0 48.2 39.0 35.8 53.3 10.5 24.6 67.3 30.0 52.1 42.9 142.9 38.3 26.1 45.0 22.5 40.8 47.4 14.2 23.6 33.6 71.5 44.7 53.4 188.2 207.2 274.3 140.8 137.3 186.5 117.3 347.8 372.0 443.2 353.6 245.8 81.5 10.6 88.8 547.9 173.2 85.4 153.3 255.1 558.1 82.8 71.4 313.8 95.3 192.7 123.8 76.6 154.1 173.7 120.3 501.0 376.9 262.3 234.1 51.8 157.0 101.0 473.6 68.4 34.7 90.5 70.5 68.7 197.9 53.3 158.6 121.9 176.0 122.5 75.0 66.3 115.6 16.0 156.6 173.0 83.0 58.0 263.7 316.1 165.1 297.7 296.8 99.4 245.7 232.8 246.3 64.0 215.5 42.3 70.7 32.0 7.4 78.1 3.5 24.6 2.9 4.5 75.7 19.1 1.0 3.3 81.9 12.6 75.2 75.9 7.5 44.7 36.1 36.1 28.1 36.8 41.3 39.1 43.9 37.1 39.0 38.3 40.8 53.4 24.5 54.5 20.7 18.3 27.8 138.0 168.2 47.7 66.0 7.1 18.2 14.1 19.0 18.6 34.6 12.9 2.1 28.4 39.1 41.3 3.9 59.7 58.9 33.6 47.2 51.9 30.9 25.5 32.8 22.7 125.3 38.4 20.4 39.1 41.8 43.3 17.2 49.8 122.2 15.2 39.7 23.4 16.2 71.0 181.4 56.4 22.4 108.8 90.7 37.5 81.7 6.7 8.2 46.3 42.6 76.9 29.8 58.6 31.6 92.8 19.0 30.1 10.5 5.3 13.1 42.8 53.2 26.8 22.9 60.6 167.8 46.8 12.0 9.9 30.7 93.2 CORO7 FLJ22021 ENSG00000262246 "Coronin 7" P57737 16 4354542-4425705 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 69.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 75.3;RPMI-8226: 142.8" "HPA041657, HPA053586" Uncertain NA NA 50000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA041657: AB_10796351, HPA053586: AB_2682201" "unprognostic (4.75e-3)" "prognostic favorable (8.68e-4)" "unprognostic (2.18e-1)" "prognostic favorable (4.25e-4)" "unprognostic (3.80e-2)" "unprognostic (1.05e-1)" "unprognostic (7.54e-4)" "unprognostic (3.32e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-3)" "unprognostic (1.20e-2)" "unprognostic (6.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.04e-1)" "unprognostic (9.55e-2)" "unprognostic (4.06e-3)" 15.5 15.8 10.8 16.8 16.4 69.5 13.4 12.1 15.5 12.7 5.0 20.4 15.3 13.8 1.8 10.9 16.7 9.0 11.6 12.6 10.9 15.5 8.8 27.5 24.2 16.5 13.5 8.1 10.8 4.5 13.5 9.7 15.5 17.0 4.7 1.4 13.4 5.6 6.5 11.6 31.0 5.5 10.3 56.5 15.3 27.4 15.2 10.9 14.4 1.6 7.9 14.6 11.6 24.1 8.8 12.0 8.0 8.7 1.6 1.1 13.3 5.0 4.4 7.5 6.8 6.8 20.3 18.0 5.0 5.2 5.9 12.2 6.1 9.1 2.5 6.1 29.9 6.1 15.0 6.2 7.0 20.6 48.3 6.3 2.3 4.5 1.9 2.3 13.6 15.0 18.7 75.3 3.8 30.8 15.2 58.1 10.0 6.5 3.1 47.2 24.9 142.8 4.7 13.3 14.9 5.5 6.4 5.7 14.6 3.3 4.8 32.9 16.9 6.5 10.3 16.7 6.7 35.9 20.3 48.7 4.9 29.2 6.6 17.1 16.8 30.8 14.5 23.5 16.4 8.6 13.1 16.8 14.0 3.6 6.5 9.7 17.3 9.1 20.3 7.3 15.5 15.9 10.8 16.4 12.1 15.5 12.6 10.9 16.5 13.5 15.5 10.3 15.2 24.1 10.3 3.2 10.8 0.0 21.2 9.4 6.4 4.8 2.2 13.6 6.4 3.8 2.7 7.2 6.2 5.5 43.8 11.3 41.2 16.6 3.9 12.1 6.6 9.5 4.0 11.9 7.8 2.1 0.0 16.3 12.3 6.3 8.6 8.0 12.0 3.8 21.0 2.4 37.9 28.6 0.0 9.5 28.5 42.8 19.3 5.8 5.0 31.4 17.8 0.0 26.6 7.4 33.0 0.0 0.0 17.3 16.4 3.4 32.1 7.3 16.0 3.0 14.6 19.1 6.6 11.6 5.9 11.5 7.9 4.4 11.9 9.2 34.4 6.0 13.9 8.2 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002086 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 141.1;Syncytiotrophoblasts: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: AB_2669210" "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 20.7 29.7 8.3 18.5 13.9 23.8 22.8 8.3 12.2 30.3 46.5 22.4 22.3 33.9 26.8 15.0 22.6 15.0 25.9 8.1 9.6 19.6 12.5 19.3 12.8 13.2 10.8 29.0 30.1 59.5 25.1 39.4 12.1 21.6 17.6 5.0 28.7 23.2 6.1 8.7 22.9 29.2 9.6 13.0 17.4 9.0 16.1 10.0 65.3 9.4 20.4 19.5 19.9 17.3 13.1 19.9 37.6 0.6 62.9 61.7 28.1 65.1 104.0 44.4 44.7 27.5 11.7 2.6 16.8 71.1 24.1 6.9 21.9 47.1 86.9 19.1 10.8 83.4 26.7 67.6 41.4 25.3 115.5 25.4 29.2 56.0 65.3 45.5 59.7 6.5 43.8 37.4 52.9 23.5 8.0 31.6 13.6 17.9 13.7 17.5 19.8 22.1 35.3 13.2 9.4 22.3 21.1 54.0 29.1 21.7 7.9 18.9 63.1 59.5 8.7 72.3 24.2 43.9 16.2 16.9 70.9 71.3 135.0 10.4 5.5 6.0 7.3 3.0 9.8 3.9 5.4 8.2 5.7 3.9 2.0 3.4 2.0 7.2 1.6 11.9 12.5 3.2 8.3 13.9 8.3 12.2 8.1 9.6 13.2 10.8 12.1 9.6 16.1 17.3 30.6 6.4 25.9 18.6 27.3 12.2 9.7 18.9 8.0 12.0 32.0 25.4 17.5 21.5 34.9 23.9 10.4 62.6 39.5 24.7 13.7 10.2 56.3 18.1 86.6 31.6 15.7 12.0 7.5 17.6 93.0 49.6 16.3 42.4 49.4 27.8 29.6 24.3 56.3 15.2 10.6 21.0 20.3 34.9 25.6 18.7 61.8 30.7 26.6 63.7 21.4 5.4 40.2 55.8 48.0 14.4 18.2 103.0 141.1 35.1 66.2 7.9 22.4 12.3 39.5 62.3 50.2 3.4 7.4 9.5 7.1 144.5 26.6 11.1 17.0 44.0 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor subunit beta" P32927 22 36913628-36940439 "CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 54.5;lymphoid tissue: 65.5" "Cell type enhanced" "Detected in many" "dendritic cells: 44.8;Extravillous trophoblasts: 37.9;granulocytes: 91.2;Langerhans cells: 68.3;Late spermatids: 41.2;Macrophages: 34.7;monocytes: 42.3;Plasma cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basophil: 238.1;neutrophil: 76.0" "Lineage enriched" "Detected in many" 16 "granulocytes: 238.1" "Group enriched" "Detected in some" 5 "HEL: 107.3;HMC-1: 321.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA078677 Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 10.1 2.0 1.0 65.5 1.1 54.5 5.4 1.2 5.2 2.5 1.3 9.9 10.3 2.0 0.7 6.6 2.6 9.8 2.3 0.9 1.6 1.8 2.6 15.1 40.1 2.6 2.1 0.5 2.1 0.9 0.7 31.3 3.1 1.6 8.5 0.0 4.9 1.5 1.0 5.4 11.0 7.0 2.3 22.8 9.3 2.1 3.0 9.8 2.7 4.0 62.5 18.3 2.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.3 0.0 0.0 0.1 16.1 0.0 107.3 0.0 0.0 0.1 1.7 321.1 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.1 12.6 0.0 0.0 0.1 11.2 0.0 0.0 0.0 10.7 0.0 40.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.1 9.6 0.3 1.0 0.1 0.3 0.0 1.6 1.1 6.8 0.2 15.6 0.1 238.1 9.1 23.5 0.0 7.7 0.0 1.6 0.2 0.0 4.8 1.1 0.0 0.0 76.0 0.0 7.0 14.4 2.3 10.3 1.0 1.1 1.2 5.2 0.9 1.6 2.6 2.1 3.1 2.3 3.0 2.9 4.3 0.0 9.1 1.6 9.1 7.1 0.0 0.0 0.0 0.0 0.2 0.3 1.2 2.8 1.8 0.0 0.0 3.4 44.8 0.0 0.0 0.0 13.4 0.0 0.2 22.0 0.0 32.0 0.1 0.2 37.9 2.8 0.0 0.0 91.2 0.0 4.6 0.0 20.1 0.0 0.1 0.0 0.0 31.9 68.3 41.2 0.0 34.7 12.4 5.6 42.3 0.0 2.1 0.0 0.0 0.0 0.0 0.4 49.5 0.1 0.0 0.1 2.9 0.0 0.0 0.3 0.5 0.0 0.0 0.1 6.3 16.6 2.9 0.1 0.0 0.2 CTBP1 BARS ENSG00000159692 "C-terminal binding protein 1" Q13363 4 1211445-1249953 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004217, HPA018987, HPA044971" Approved Enhanced Nucleoplasm NA NA 16000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161" "unprognostic (6.19e-2)" "unprognostic (4.78e-2)" "unprognostic (9.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.52e-2)" "unprognostic (1.04e-2)" "unprognostic (9.65e-2)" "unprognostic (2.24e-2)" "unprognostic (6.35e-3)" "unprognostic (3.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.46e-2)" "unprognostic (3.00e-1)" "unprognostic (3.22e-2)" "prognostic favorable (8.94e-4)" 76.1 88.1 92.3 86.1 91.2 71.5 72.7 96.6 104.3 94.7 73.6 94.6 91.0 98.4 47.5 85.0 89.2 61.4 100.0 92.7 98.1 88.4 109.2 82.6 108.7 99.2 94.1 93.5 141.1 58.8 140.0 45.7 94.6 94.8 41.9 38.8 90.9 50.8 170.1 74.3 97.1 48.1 77.1 118.7 79.5 47.3 90.0 98.1 86.2 91.5 62.4 87.5 79.8 89.8 108.5 156.8 118.4 146.6 81.5 58.6 101.7 83.4 76.8 101.8 102.8 135.0 255.1 131.0 93.8 97.5 156.6 84.1 72.3 109.9 30.4 101.0 86.6 119.1 185.6 177.1 135.7 108.4 163.3 101.3 82.5 86.5 49.8 97.8 76.8 147.1 138.1 219.6 56.9 178.1 351.4 338.3 140.5 87.8 148.4 244.4 71.4 173.2 65.8 135.9 222.0 138.1 79.6 85.2 114.5 70.9 187.2 164.5 99.7 168.5 94.2 97.8 182.1 157.7 164.3 155.2 133.4 166.4 135.6 12.6 15.6 17.4 31.8 23.1 24.0 20.1 22.3 27.4 20.6 19.3 17.1 25.1 12.7 23.9 23.9 34.6 20.9 16.1 92.3 91.2 96.6 104.3 92.7 98.1 99.2 94.1 94.6 77.1 90.0 89.8 33.3 41.7 39.0 17.9 36.8 34.2 21.1 22.1 13.1 32.1 52.0 39.5 54.9 37.1 19.2 36.8 4.2 25.4 72.4 57.2 11.7 29.4 4.0 34.0 46.4 35.7 46.1 42.3 19.4 40.6 32.0 37.5 37.8 41.6 24.1 31.2 45.0 85.0 43.0 40.4 21.2 49.7 20.3 72.9 31.8 5.5 45.1 37.7 46.2 21.5 45.9 46.8 82.4 19.6 17.7 45.0 35.7 35.7 42.0 36.9 42.8 37.4 25.7 17.8 6.6 31.2 32.9 10.8 13.4 30.3 37.8 19.8 41.1 32.0 57.5 27.9 CTDP1 FCP1 ENSG00000060069 "CTD phosphatase subunit 1" Q9Y5B0 18 79679803-79754510 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cataract, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 113.1;Late spermatids: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032641, HPA040394, HPA070389" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Vesicles "CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155" "unprognostic (1.71e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.64e-2)" "unprognostic (7.99e-2)" "unprognostic (3.47e-3)" "unprognostic (1.83e-1)" "unprognostic (2.54e-1)" "unprognostic (1.15e-1)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "prognostic favorable (5.51e-5)" "unprognostic (5.16e-2)" "unprognostic (8.58e-2)" "unprognostic (2.85e-2)" "unprognostic (4.74e-2)" 9.3 7.4 3.8 7.2 3.9 13.7 8.9 3.3 4.2 7.8 4.1 11.1 7.2 10.4 1.4 10.7 8.1 4.0 7.2 3.3 3.3 7.9 9.5 9.3 8.7 5.3 4.2 5.0 9.0 3.3 6.9 4.2 4.0 8.2 3.1 1.5 9.5 3.9 11.9 20.5 10.9 3.1 3.3 13.5 9.9 22.2 4.0 6.5 8.0 3.1 3.7 9.6 8.6 4.4 13.4 14.0 7.7 11.0 6.0 5.0 25.9 9.6 6.1 7.6 7.5 9.4 8.0 17.2 4.2 5.6 9.1 16.4 6.6 8.8 3.1 16.9 12.4 8.5 6.6 12.9 8.7 37.6 20.5 8.4 8.3 8.1 3.8 4.6 9.2 12.2 11.2 8.1 3.0 11.5 25.4 29.5 12.7 4.2 19.1 20.7 10.1 20.0 5.6 13.1 12.0 12.4 10.2 9.8 13.9 5.8 8.0 21.7 12.9 12.9 19.4 5.3 9.7 7.4 27.6 16.1 11.0 18.8 9.3 0.0 0.4 3.2 0.5 0.4 0.4 0.2 0.4 0.8 0.6 0.1 0.5 0.3 1.0 1.1 0.4 0.1 0.1 0.2 3.8 3.9 3.3 4.2 3.3 3.3 5.3 4.2 4.0 3.3 4.0 4.4 7.4 0.0 4.1 3.6 9.2 8.5 5.0 4.0 11.4 9.5 7.7 6.5 3.8 4.3 4.5 3.7 14.6 8.8 24.2 20.0 1.9 5.4 113.1 18.6 8.0 7.5 6.0 13.5 7.7 7.2 8.0 4.8 19.9 24.0 7.0 7.8 6.4 5.7 8.8 23.5 6.6 16.6 6.1 7.5 9.5 123.2 7.8 13.8 7.2 6.5 6.5 6.5 19.6 3.0 8.9 10.2 14.9 10.5 15.2 11.8 10.0 6.8 9.6 14.8 0.0 5.9 7.4 18.0 10.5 10.5 10.1 19.0 18.3 8.0 11.7 12.6 CXCR3 "CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR" ENSG00000186810 "C-X-C motif chemokine receptor 3" P49682 X 71615916-71618511 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3" "Cell type enhanced" "Detected in some" "dendritic cells: 87.6;NK-cells: 15.5;Plasma cells: 36.5;Proximal enterocytes: 17.6;T-cells: 48.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 306.7" "Group enriched" "Detected in many" 5 "dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7" "Cell line enriched" "Detected in some" 15 "RPMI-8226: 47.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA045942 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA045942: AB_2679507" "unprognostic (4.84e-3)" "unprognostic (3.05e-3)" "unprognostic (1.61e-1)" "prognostic favorable (3.44e-6)" "unprognostic (3.93e-2)" "prognostic favorable (3.35e-4)" "unprognostic (1.01e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.90e-4)" "unprognostic (6.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.67e-6)" "unprognostic (4.67e-2)" "unprognostic (2.18e-1)" "unprognostic (2.91e-2)" "unprognostic (5.76e-2)" 0.6 0.8 0.1 5.9 0.1 7.2 0.5 0.2 0.3 0.5 0.0 1.6 5.4 0.4 0.0 0.6 0.5 1.4 0.4 0.2 0.0 0.5 0.5 3.3 16.3 0.2 0.0 0.4 0.5 0.0 0.1 0.1 0.0 0.4 1.0 0.0 1.8 0.3 0.1 0.6 6.4 0.4 0.0 7.5 2.9 0.3 0.1 3.0 0.9 0.1 5.3 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.1 0.0 0.4 0.3 0.2 80.4 0.2 40.9 45.3 90.3 124.7 8.4 9.9 5.5 51.6 1.9 198.9 0.2 306.7 89.4 35.3 0.1 0.1 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 13.9 0.3 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 87.6 3.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 3.2 0.0 0.2 0.0 0.3 3.1 0.3 1.3 0.0 0.7 0.3 0.3 0.0 0.0 1.8 0.0 0.8 6.1 0.0 0.0 4.0 1.8 0.0 2.1 0.0 15.5 0.0 0.0 0.2 5.3 0.0 36.5 0.0 17.6 0.5 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.6 0.1 48.3 1.5 3.1 0.1 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348754-61362283 "Predicted membrane proteins" "Electron transport, Transport" "Oxidoreductase, Translocase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 251.4" "Cell type enhanced" "Detected in all" "dendritic cells: 145.1;Melanocytes: 320.2;Theca cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 314.5;naive B-cell: 386.6;plasmacytoid DC: 841.4" "Group enriched" "Detected in all" 9 "B-cells: 386.6;dendritic cells: 841.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 19.5 251.4 10.2 32.6 11.5 26.0 17.3 10.5 10.7 17.1 17.4 33.3 19.2 24.1 18.7 19.6 30.4 27.5 12.3 11.0 10.1 15.3 31.0 21.3 70.3 13.0 13.7 27.1 24.4 21.5 13.8 17.3 12.6 20.9 27.8 11.4 21.8 19.8 26.1 76.0 27.8 18.8 12.3 49.7 20.8 13.6 12.1 28.1 18.5 17.7 70.4 22.9 16.2 14.0 50.2 80.6 13.4 40.6 67.8 41.9 11.3 26.0 37.3 29.8 28.9 22.6 54.3 98.1 42.1 46.2 24.0 67.5 13.6 72.2 20.1 64.5 28.5 18.3 53.6 16.5 32.0 24.9 42.3 63.4 95.7 65.3 30.0 25.0 44.1 46.1 55.5 57.3 51.2 53.3 45.7 11.4 24.5 44.7 51.9 52.2 14.0 72.6 35.2 48.1 16.2 26.1 54.7 71.5 60.5 9.6 58.6 29.3 31.7 34.2 17.8 34.2 35.6 34.3 49.9 56.8 50.6 44.2 46.4 19.4 66.4 35.5 31.0 53.8 28.6 314.5 22.1 29.2 63.5 386.6 23.5 24.6 21.8 31.5 64.0 841.4 23.6 84.8 10.2 11.5 10.5 10.7 11.0 10.1 13.0 13.7 12.6 12.3 12.1 14.0 13.0 6.4 22.8 6.8 96.2 28.3 18.3 86.6 19.9 15.9 19.6 18.7 1.9 10.0 30.0 12.9 31.3 49.9 145.1 53.6 11.7 26.2 53.6 15.4 12.0 13.5 19.2 14.1 4.3 38.8 39.5 16.4 21.4 7.5 8.8 13.0 15.4 21.0 51.4 18.5 4.1 28.9 22.4 23.8 21.2 14.2 20.8 47.9 320.2 8.4 57.1 23.7 28.8 5.5 7.2 26.6 48.9 20.7 10.5 15.9 55.6 13.7 72.0 56.2 13.1 14.8 15.8 7.2 11.5 18.4 24.0 39.5 18.7 128.9 30.7 16.2 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924227-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 110.3;skin 1: 118.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 213.7;Cardiomyocytes: 105.8;Distal enterocytes: 135.5;Extravillous trophoblasts: 115.9;Suprabasal keratinocytes: 231.6" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in many" "RH-30: 44.6;RPTEC TERT1: 38.2;RT4: 122.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064895 Supported Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 14.6 0.8 32.9 9.4 40.9 0.3 10.0 38.2 37.5 12.3 15.4 25.9 35.7 10.0 4.4 27.0 9.4 13.8 110.3 29.7 38.9 16.3 4.9 8.3 5.7 34.3 37.5 2.1 4.3 0.3 3.4 25.4 32.2 9.1 20.0 15.2 11.2 12.0 20.8 118.2 40.9 11.7 31.9 4.9 37.7 1.1 42.9 4.9 2.8 6.4 9.8 51.3 20.8 36.1 31.1 8.0 0.9 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 8.2 0.0 10.0 0.1 0.9 0.9 15.0 29.4 0.0 3.1 8.0 8.3 20.5 1.0 0.0 0.0 0.4 4.0 14.5 0.0 0.1 0.0 0.0 2.3 16.9 0.0 0.4 2.7 0.7 0.1 24.3 26.7 2.8 0.0 44.6 11.1 38.2 122.9 6.2 7.0 2.0 11.8 3.2 18.2 12.0 0.1 0.0 0.2 3.2 0.0 1.8 0.4 6.7 0.1 7.2 0.0 0.5 0.0 0.0 1.8 0.1 0.0 0.0 0.0 1.2 0.9 2.6 0.0 0.1 0.1 0.1 1.1 0.0 25.5 0.0 0.9 32.9 40.9 38.2 37.5 29.7 38.9 34.3 37.5 32.2 31.9 42.9 36.1 6.0 0.0 0.6 36.2 1.6 213.7 49.0 56.6 3.4 11.6 16.0 17.0 105.8 4.3 24.8 9.2 2.1 11.4 16.0 135.5 9.8 15.6 1.8 42.3 8.5 25.1 16.2 0.4 1.0 6.9 115.9 16.8 74.9 17.2 1.3 0.1 12.5 0.3 3.1 1.7 4.3 31.6 12.2 1.9 62.8 4.9 2.5 10.8 40.9 0.0 0.9 11.6 0.0 6.6 54.2 46.6 41.9 0.7 0.4 17.4 59.7 20.5 37.2 2.4 0.0 17.7 9.4 1.7 0.3 4.1 231.6 103.0 4.5 1.2 14.1 25.7 EIF2AK4 "GCN2, KIAA1338" ENSG00000128829 "Eukaryotic translation initiation factor 2 alpha kinase 4" Q9P2K8 15 39934115-40035591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation" "Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 66.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011811 Approved Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 15: Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA011811: AB_2668543" "unprognostic (3.10e-1)" "unprognostic (4.78e-3)" "unprognostic (5.97e-2)" "unprognostic (7.18e-2)" "unprognostic (1.05e-2)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-2)" "unprognostic (6.47e-2)" "unprognostic (2.31e-2)" "unprognostic (5.11e-3)" 20.1 14.6 21.5 12.2 22.4 18.7 17.6 27.2 23.7 14.6 16.8 15.5 11.3 30.5 15.4 16.0 16.1 17.0 17.7 21.2 22.0 13.4 21.3 16.9 16.9 20.3 20.2 17.1 14.1 17.7 24.1 19.0 20.5 19.8 12.9 13.1 13.9 11.5 18.9 19.0 11.3 15.6 18.9 15.7 15.2 8.9 22.1 13.1 21.8 11.0 11.6 17.2 12.4 28.9 37.1 17.5 30.3 46.3 49.0 81.7 28.9 51.0 58.1 40.8 40.0 25.2 15.6 19.6 25.9 69.3 54.7 38.6 41.1 61.4 56.6 92.8 20.4 41.6 30.8 30.7 42.1 25.6 27.8 65.3 41.2 39.0 69.8 57.3 58.0 40.5 31.3 18.1 81.7 12.3 21.7 34.6 18.8 32.8 38.2 25.4 42.2 33.1 51.4 24.7 16.1 24.4 36.4 22.2 32.3 29.5 30.7 43.4 61.6 54.3 40.9 27.3 33.6 24.6 47.8 6.0 38.1 34.4 77.4 11.6 10.8 8.6 6.8 14.1 5.7 7.1 7.6 7.9 17.6 9.2 8.3 8.2 3.3 8.5 20.5 66.5 5.8 4.9 21.5 22.4 27.2 23.7 21.2 22.0 20.3 20.2 20.5 18.9 22.1 28.9 47.9 16.0 31.1 28.7 29.3 12.0 27.5 17.8 43.3 29.9 45.0 45.2 32.3 32.9 21.4 16.5 12.5 37.5 32.2 21.1 13.7 23.7 1.5 19.3 52.7 35.3 14.4 37.4 42.7 25.4 34.8 36.5 23.4 27.0 24.1 35.0 22.9 27.8 30.7 28.6 53.9 25.9 12.2 33.7 55.4 4.3 42.3 52.1 32.0 29.0 41.1 30.4 16.5 30.2 26.3 47.6 16.2 39.9 115.6 30.7 6.4 18.2 12.9 23.9 46.0 43.6 35.6 8.6 29.8 47.0 14.5 15.2 18.2 64.0 29.6 18.4 ENPP4 "AP3Aase, KIAA0879, NPP4" ENSG00000001561 "Ectonucleotide pyrophosphatase/phosphodiesterase 4" Q9Y6X5 6 46129989-46146688 "Enzymes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 21.9;U-266/84: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016594 Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA016594: AB_1848171" "unprognostic (9.87e-2)" "unprognostic (1.74e-1)" "unprognostic (2.75e-2)" "unprognostic (2.01e-1)" "unprognostic (2.92e-1)" "unprognostic (1.90e-1)" "unprognostic (8.13e-2)" "unprognostic (5.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-1)" "unprognostic (8.51e-2)" "unprognostic (4.36e-1)" "prognostic favorable (6.95e-7)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (2.56e-1)" 15.1 13.6 11.7 7.3 20.9 38.0 7.8 19.5 19.5 10.3 6.4 12.1 10.9 4.0 11.6 5.1 10.8 8.0 15.1 10.8 16.0 18.4 8.2 20.7 7.7 20.5 19.3 2.1 11.9 22.3 9.0 3.5 19.9 16.4 12.8 12.2 21.3 19.7 22.1 2.3 10.1 7.0 18.5 13.9 14.8 8.3 17.5 8.5 12.5 25.3 6.5 6.8 2.1 30.2 0.1 1.1 0.7 1.5 0.0 0.0 0.1 1.7 1.6 4.0 0.3 1.9 13.4 15.2 12.7 2.1 9.9 0.2 4.1 0.6 0.8 18.5 11.1 8.5 0.0 0.0 0.5 10.5 14.9 2.1 0.0 0.1 0.0 1.1 1.4 10.5 0.0 0.0 1.5 1.8 7.8 1.0 2.7 16.9 0.5 5.9 2.7 5.7 8.3 1.7 18.0 0.0 0.0 2.8 0.0 4.1 7.6 4.3 0.0 0.0 6.7 0.3 11.2 21.9 26.6 5.2 10.3 0.0 1.4 0.0 0.4 0.9 9.2 1.1 5.4 2.8 3.4 6.8 1.5 1.2 3.2 5.8 0.3 4.4 2.6 1.6 1.2 3.0 11.7 20.9 19.5 19.5 10.8 16.0 20.5 19.3 19.9 18.5 17.5 30.2 43.5 76.9 27.0 23.5 11.6 0.9 3.2 2.3 0.6 9.3 11.0 2.4 23.1 14.3 25.4 29.5 14.6 0.5 23.5 27.2 0.0 12.9 18.3 28.8 2.0 16.0 15.7 3.0 26.4 12.2 0.3 8.5 10.7 17.3 15.8 4.5 6.1 8.6 5.8 26.9 19.2 13.8 4.1 24.8 11.0 26.0 1.2 19.0 3.6 6.5 15.2 21.6 34.0 32.2 125.3 9.7 16.1 11.3 10.3 12.6 16.3 12.6 70.6 6.2 0.0 22.1 5.4 9.1 9.8 0.3 0.6 0.3 14.7 3.7 11.3 14.8 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659509-99711241 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 14.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 17.5;Urothelial cells: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 65000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 1.8 3.7 0.4 4.2 0.5 7.0 2.2 1.7 0.7 3.2 3.9 3.7 14.6 2.1 2.2 4.4 1.8 4.5 1.3 0.7 0.2 2.7 6.3 1.9 2.2 0.3 0.4 1.0 6.9 2.9 1.7 6.5 0.2 2.7 3.8 2.7 2.9 2.3 0.5 2.9 14.6 2.7 0.3 2.1 3.9 1.4 0.3 1.6 2.2 0.4 2.7 10.2 2.6 0.5 5.4 5.9 8.0 14.4 4.0 3.6 8.4 10.0 19.1 11.4 9.2 11.1 5.2 4.8 5.4 14.0 3.6 13.6 6.0 4.0 9.6 2.3 5.6 4.0 4.4 11.2 5.8 13.4 7.8 3.5 6.7 14.1 15.3 14.1 11.8 5.1 6.1 4.7 4.8 4.6 2.6 3.9 4.7 6.0 2.4 0.3 6.2 2.4 15.8 16.7 3.4 6.9 6.7 2.7 9.5 5.4 7.1 5.9 8.5 11.0 6.2 7.0 8.4 4.7 7.3 4.1 11.0 4.4 2.7 0.3 0.6 0.9 0.6 0.7 0.5 0.2 0.3 0.5 1.3 0.1 0.4 0.3 0.5 0.8 0.4 2.3 0.2 0.3 0.4 0.5 1.7 0.7 0.7 0.2 0.3 0.4 0.2 0.3 0.3 0.5 1.2 0.0 0.0 2.9 1.3 8.2 17.5 4.6 10.8 0.7 2.0 1.1 0.8 1.5 2.2 5.5 2.1 6.3 3.2 3.7 0.0 2.3 1.5 6.0 2.8 1.7 5.4 1.3 9.5 5.0 5.3 2.4 9.2 5.3 0.0 0.7 0.7 4.7 1.9 0.0 7.9 4.2 0.0 0.6 2.7 2.7 0.9 2.6 0.0 6.5 4.9 0.4 0.0 10.1 3.2 4.5 3.1 0.7 7.6 2.6 11.4 1.3 3.6 1.9 0.0 1.1 1.7 1.2 0.8 6.9 7.4 5.1 1.2 3.9 2.4 23.6 EZR VIL2 ENSG00000092820 Ezrin P15311 6 158765741-158819368 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004035, HPA021616, CAB047324, CAB075739" Enhanced Enhanced "Plasma membrane" NA NA 42000000 "Cluster 43: B-cells - Humoral immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane" "CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342" "unprognostic (4.79e-3)" "unprognostic (1.48e-1)" "unprognostic (1.97e-2)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.31e-3)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (5.59e-2)" "prognostic favorable (9.56e-8)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-2)" "unprognostic (9.00e-2)" 88.2 186.6 100.7 98.4 99.5 135.2 59.8 86.0 96.8 77.1 224.4 133.5 158.8 35.6 78.4 260.3 114.6 116.1 116.3 96.2 95.6 159.1 57.9 173.2 185.6 97.6 105.3 44.7 112.6 447.4 42.8 233.0 91.7 81.4 103.6 10.7 89.9 72.2 46.9 187.8 257.1 36.6 99.3 75.6 273.7 55.9 98.9 108.8 126.1 25.5 216.3 219.0 98.6 91.1 668.3 355.4 86.5 125.0 9.3 10.3 502.7 204.7 67.1 225.7 189.2 420.9 357.7 667.1 197.2 235.2 108.5 497.7 172.2 228.0 259.5 235.3 111.2 14.0 204.9 187.5 223.2 167.7 98.9 16.6 172.9 212.9 205.1 191.4 150.2 90.8 134.9 316.7 132.3 175.9 239.3 199.6 144.5 180.6 117.6 176.9 40.7 152.5 462.1 198.6 156.3 127.2 358.5 507.7 37.9 391.5 124.1 218.5 195.3 72.6 233.4 101.1 319.9 216.5 212.8 566.9 45.4 84.9 88.5 177.2 83.4 103.7 195.9 190.8 233.2 466.5 205.6 245.1 181.9 389.7 108.6 146.3 36.2 133.6 202.9 84.5 385.7 298.2 100.7 99.5 86.0 96.8 96.2 95.6 97.6 105.3 91.7 99.3 98.9 91.1 47.4 951.9 547.8 111.3 799.6 614.7 809.5 202.4 247.0 11.2 240.4 144.4 311.0 154.4 726.2 156.3 0.0 406.1 372.4 806.8 97.8 302.3 10.2 782.9 75.4 71.0 159.9 46.5 0.4 256.1 560.3 213.1 500.5 844.5 119.0 40.8 25.4 37.5 113.3 0.0 0.5 415.3 179.0 79.1 820.5 32.8 135.5 297.5 321.9 12.2 110.5 35.7 62.8 2.0 0.7 618.3 631.2 294.2 564.9 416.7 694.2 238.1 1248.4 5.1 249.8 205.5 136.3 52.5 61.7 430.4 726.5 1243.4 483.8 102.3 312.9 1142.8 FADS1 "D5D, FADS6, FADSD5, LLCDL1, TU12" ENSG00000149485 "Fatty acid desaturase 1" O60427 11 61799627-61829318 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 521.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042705 Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA042705: AB_10795709" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" "unprognostic (8.17e-3)" "unprognostic (1.40e-1)" "unprognostic (1.99e-2)" "unprognostic (3.23e-3)" "unprognostic (7.88e-2)" "unprognostic (1.94e-2)" "unprognostic (4.10e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (1.95e-9)" "unprognostic (2.29e-2)" "unprognostic (3.59e-2)" "prognostic unfavorable (2.79e-4)" "prognostic unfavorable (1.33e-4)" 26.2 67.7 43.1 19.8 39.2 9.7 13.6 38.4 40.7 19.6 70.7 9.5 5.5 21.3 6.6 5.2 17.4 14.5 22.6 39.3 58.5 9.7 52.8 20.3 9.8 57.9 62.1 27.5 10.0 27.2 21.3 21.1 52.2 19.6 4.9 35.1 6.4 15.8 17.5 15.5 6.7 20.5 46.4 8.0 9.4 11.9 68.7 8.1 6.0 7.8 9.2 12.7 10.2 56.0 66.3 170.1 159.1 41.1 313.2 521.2 46.4 42.0 204.5 69.9 118.9 53.3 143.2 2.3 43.4 60.5 177.2 84.7 130.8 114.1 51.7 12.2 18.4 107.9 191.2 98.9 169.1 23.4 10.4 238.1 38.3 154.7 74.7 73.8 64.1 104.7 59.9 118.6 70.1 18.6 78.6 23.6 94.2 5.5 63.0 85.4 162.5 231.2 81.5 29.0 80.7 89.6 106.7 1.7 90.0 58.4 38.6 98.6 62.1 71.8 70.8 74.2 50.6 112.9 111.3 55.4 42.6 108.9 61.4 7.5 33.2 6.2 12.1 40.4 2.6 2.5 4.0 4.9 28.0 8.7 2.3 5.4 2.6 6.9 17.4 23.6 2.9 15.7 43.1 39.2 38.4 40.7 39.3 58.5 57.9 62.1 52.2 46.4 68.7 56.0 10.3 6.4 77.9 28.7 3.2 2.7 2.5 48.5 1.2 78.9 2.6 3.7 30.4 8.6 25.3 12.9 27.1 9.5 12.4 0.9 0.0 15.2 8.7 4.9 30.7 16.6 9.7 46.3 9.4 33.4 50.0 34.9 6.1 7.8 37.9 65.3 9.3 74.5 37.2 69.0 14.7 0.6 16.2 21.7 21.0 16.4 29.8 27.6 32.0 12.2 32.0 70.5 6.2 13.6 27.4 7.6 0.0 21.4 2.1 6.4 0.1 1.1 8.0 91.9 0.0 40.3 31.9 6.5 17.5 2.3 1.4 9.3 5.5 75.2 1.4 1.6 FAM53B "bA12J10.2, KIAA0140, smp" ENSG00000189319 "Family with sequence similarity 53 member B" Q14153 10 124619292-124744378 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037751, HPA037752" Approved Approved Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA037751: AB_2675645, HPA037752: AB_10672285" "unprognostic (7.88e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.73e-2)" "unprognostic (2.92e-1)" "unprognostic (4.91e-1)" "prognostic favorable (1.97e-4)" "unprognostic (2.52e-2)" "unprognostic (5.03e-3)" "unprognostic (1.51e-2)" "unprognostic (4.02e-2)" "prognostic favorable (7.00e-6)" "unprognostic (1.93e-1)" "prognostic favorable (4.81e-7)" "prognostic favorable (3.26e-4)" "unprognostic (3.41e-1)" "unprognostic (2.03e-1)" "unprognostic (2.45e-2)" 12.6 19.2 21.6 14.3 33.3 25.8 8.3 18.1 30.5 12.8 8.4 12.4 15.4 23.6 3.9 13.2 11.2 5.7 18.9 21.1 16.5 10.6 4.2 10.7 31.0 30.3 25.6 19.1 7.2 12.4 12.7 4.9 22.7 8.9 7.1 6.3 15.2 7.0 55.0 14.4 17.1 12.8 17.3 20.1 9.6 15.6 35.9 32.9 16.2 22.3 21.7 8.6 8.0 51.7 10.7 12.5 9.6 27.5 11.3 5.8 26.2 4.8 6.7 5.6 4.9 6.6 6.7 37.2 9.7 6.5 5.5 20.8 12.7 15.4 2.4 44.6 13.2 18.1 6.3 16.7 7.6 16.6 11.8 5.6 16.2 5.2 8.3 7.0 9.1 21.2 13.2 17.0 5.5 20.4 18.7 22.4 5.9 9.5 10.9 32.9 3.6 18.2 4.6 19.3 12.8 12.2 4.7 17.8 60.2 3.8 7.2 21.8 5.0 6.7 5.5 6.6 10.7 2.7 5.3 23.8 5.1 13.6 3.8 0.8 2.2 2.2 6.9 2.1 3.3 3.5 3.0 3.7 1.4 6.0 1.2 2.0 3.2 0.7 2.6 1.9 3.6 3.4 21.6 33.3 18.1 30.5 21.1 16.5 30.3 25.6 22.7 17.3 35.9 51.7 13.4 9.6 12.6 14.0 22.4 3.6 5.9 8.5 12.5 6.1 4.3 2.4 17.9 1.5 6.7 3.7 10.4 4.7 31.5 25.9 1.9 3.1 19.4 12.9 18.6 8.7 15.0 8.6 27.1 4.0 4.9 6.0 6.6 8.3 5.1 9.0 16.8 3.7 13.3 1.7 15.0 17.4 10.2 27.8 5.1 6.2 5.6 16.4 8.8 24.4 14.5 4.5 30.9 16.1 79.4 2.8 12.2 10.5 20.0 3.7 22.4 4.3 14.1 25.6 0.0 9.8 4.6 7.0 8.6 12.1 5.7 0.8 21.4 6.9 15.3 6.7 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 90.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: AB_2680930" "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavorable (9.82e-4)" "prognostic favorable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favorable (7.21e-4)" 12.3 19.2 16.3 8.7 13.1 10.1 13.2 20.7 21.2 17.8 7.2 20.5 11.2 18.6 7.7 15.6 18.7 4.1 31.1 16.2 6.7 19.3 26.8 16.2 8.5 10.0 7.7 22.3 39.2 7.3 28.7 5.7 8.0 22.0 3.6 5.9 14.7 7.2 31.9 19.4 23.3 4.1 4.7 28.3 21.4 29.1 9.6 6.2 15.7 9.4 4.7 17.8 15.7 10.2 11.7 18.5 8.7 14.8 3.7 4.5 64.4 10.9 3.1 7.1 4.3 32.7 6.9 19.0 18.4 3.6 6.1 22.6 9.3 6.1 2.3 14.7 47.6 23.2 11.0 25.0 8.0 24.7 23.4 4.1 10.7 6.6 4.8 6.5 7.0 15.9 49.9 3.8 3.1 29.8 33.7 90.0 22.7 8.4 33.4 50.9 9.3 13.2 6.2 11.2 33.4 28.0 10.2 15.8 14.1 3.6 18.6 23.7 11.1 7.6 18.5 13.7 13.9 24.6 13.0 12.0 8.8 23.8 9.4 1.2 0.4 1.2 0.3 0.3 0.3 0.8 0.3 0.3 0.3 0.6 0.3 0.4 0.5 0.2 0.7 1.0 0.6 0.3 16.3 13.1 20.7 21.2 16.2 6.7 10.0 7.7 8.0 4.7 9.6 10.2 14.9 3.2 5.2 24.2 12.8 9.2 7.1 3.3 11.4 28.9 20.7 18.5 13.7 4.3 4.0 11.0 41.7 6.9 19.8 24.0 7.9 6.2 1.4 16.8 17.9 8.8 31.0 12.0 17.0 7.6 5.8 11.8 15.3 22.0 1.3 22.6 7.5 22.2 6.9 11.8 17.1 21.7 0.0 11.6 11.1 2.0 16.1 16.4 5.4 15.0 7.7 9.3 6.2 12.5 16.8 9.0 15.0 15.4 11.9 16.0 13.3 6.4 6.4 22.7 6.6 12.7 11.5 5.7 8.0 10.8 10.4 11.5 10.9 12.7 18.7 10.4 FBXW11 "BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696" ENSG00000072803 "F-box and WD repeat domain containing 11" Q9UKB1 5 171861549-172006873 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072204 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Vesicles, Plasma membrane" Nucleoplasm "HPA072204: AB_2686493" "unprognostic (4.04e-3)" "unprognostic (1.27e-1)" "unprognostic (2.69e-2)" "unprognostic (5.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (6.87e-2)" "unprognostic (9.43e-2)" "unprognostic (1.53e-1)" "unprognostic (8.14e-3)" "unprognostic (2.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.54e-1)" "unprognostic (3.76e-3)" "unprognostic (1.76e-1)" 19.5 20.4 33.3 13.6 38.2 8.2 17.0 34.7 41.6 19.9 27.4 14.6 12.6 22.9 12.4 24.2 27.0 17.5 36.1 38.0 35.5 23.0 20.7 17.6 16.7 33.3 34.4 25.6 29.1 33.1 14.2 13.9 33.1 19.0 16.0 37.2 13.5 20.3 34.5 13.7 13.2 26.1 34.4 18.1 20.0 14.3 37.7 17.3 21.1 35.6 22.0 19.2 15.8 42.4 35.4 35.6 52.0 45.2 39.9 40.2 26.4 37.1 51.7 45.0 54.9 36.7 23.1 32.5 44.3 46.4 72.0 22.8 37.6 56.3 74.6 42.7 37.3 26.2 35.0 28.5 35.4 29.8 36.0 28.5 38.2 36.8 59.8 48.5 38.6 27.3 16.6 31.7 55.7 26.5 20.7 15.3 19.8 20.8 39.5 30.1 43.7 22.0 34.8 29.2 21.6 37.2 32.9 27.3 70.8 38.7 34.2 31.0 33.8 44.3 22.0 27.4 37.2 31.8 38.9 22.2 31.3 27.8 34.6 25.4 7.3 7.2 5.8 5.1 6.1 8.5 4.8 5.7 7.3 8.4 4.3 5.7 7.1 14.1 5.7 8.6 5.7 6.6 33.3 38.2 34.7 41.6 38.0 35.5 33.3 34.4 33.1 34.4 37.7 42.4 35.4 25.6 21.2 75.4 52.7 19.1 15.6 21.8 32.5 43.5 26.4 22.1 59.1 42.9 20.8 27.6 8.4 8.5 49.8 25.1 43.0 33.7 32.9 42.0 47.9 26.3 28.8 27.4 86.5 36.9 7.8 24.7 38.2 51.0 20.8 25.8 29.3 43.1 12.8 35.3 85.3 21.6 20.3 29.6 25.3 34.3 29.5 26.6 12.4 62.8 24.6 63.6 16.5 75.9 94.4 54.1 14.9 28.6 36.5 30.2 21.5 52.4 17.1 34.3 46.0 28.2 33.5 34.5 16.0 28.7 23.7 12.0 28.8 17.2 15.0 32.9 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137032088 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;brain: 2.5;lymphoid tissue: 6.1" "Group enriched" "Detected in some" 8 "dendritic cells: 66.9;Langerhans cells: 38.7;monocytes: 20.7;NK-cells: 28.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 210.0" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "NB-4: 23.7;THP-1: 24.0;U-937: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.3 0.1 0.6 1.7 1.7 3.9 0.1 1.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.7 1.2 0.1 0.1 0.9 4.6 1.9 1.2 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.1 0.7 6.1 0.3 0.2 1.2 1.0 0.2 0.4 3.2 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 23.7 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 2.0 7.5 1.5 10.4 1.6 52.5 20.1 52.1 28.9 21.7 5.5 0.9 4.3 91.6 127.1 0.2 210.0 90.2 15.4 0.6 1.7 1.0 1.3 0.7 1.2 1.9 1.2 1.1 0.7 1.2 2.5 0.1 0.0 0.0 0.0 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.2 0.0 3.7 38.7 0.0 0.0 2.7 0.0 0.0 20.7 0.0 28.8 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.7 0.0 FYTTD1 "DKFZp761B1514, UIF" ENSG00000122068 "Forty-two-three domain containing 1" Q96QD9 3 197737179-197787596 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054474, HPA074880" Enhanced Supported "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear speckles" "HPA054474: , HPA074880: " "unprognostic (3.61e-2)" "unprognostic (6.01e-2)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.33e-2)" "unprognostic (3.80e-1)" "unprognostic (3.69e-2)" "unprognostic (9.57e-3)" "unprognostic (4.44e-2)" "unprognostic (1.66e-1)" "unprognostic (5.04e-3)" "unprognostic (8.74e-2)" "unprognostic (8.49e-3)" "unprognostic (3.40e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-1)" "unprognostic (3.15e-1)" 29.7 20.9 12.1 27.1 12.6 39.2 26.6 16.1 14.6 24.8 9.1 19.9 16.7 30.4 19.6 43.9 19.1 24.4 41.3 12.1 14.9 25.7 28.9 23.6 32.4 12.4 13.9 27.5 36.4 28.7 12.6 33.5 13.0 25.1 21.6 33.8 18.2 28.8 92.6 27.1 19.3 34.9 12.8 26.3 18.2 41.1 13.3 34.1 29.6 67.0 37.7 33.6 16.9 14.9 104.5 22.6 43.7 41.7 50.1 55.3 13.4 50.0 50.8 75.4 61.4 35.3 34.8 66.4 177.1 59.3 40.0 36.7 55.5 51.0 79.8 14.5 24.9 99.8 32.9 16.1 48.9 75.1 46.5 40.0 64.6 40.8 58.3 52.1 60.4 36.8 45.9 139.0 67.6 86.9 82.2 18.1 9.6 45.1 41.2 74.9 53.6 47.4 54.8 67.3 82.4 35.7 76.8 60.0 56.4 31.8 141.2 39.1 54.0 38.5 38.1 49.0 53.6 83.5 137.2 79.3 40.8 106.4 40.6 59.2 26.9 26.5 32.4 31.8 40.7 20.0 30.7 35.9 29.9 18.9 33.4 32.2 8.5 64.6 31.0 16.9 30.2 45.7 12.1 12.6 16.1 14.6 12.1 14.9 12.4 13.9 13.0 12.8 13.3 14.9 60.6 35.3 27.2 14.7 78.5 82.3 46.6 24.3 42.7 35.1 47.0 34.4 109.7 25.8 30.1 47.8 31.3 24.4 63.9 19.0 90.1 35.5 21.7 27.3 58.9 55.2 56.4 25.2 23.7 36.1 27.5 53.7 30.1 42.6 66.6 29.4 36.4 50.7 38.0 45.4 19.6 23.7 28.5 48.6 67.8 18.3 32.0 54.8 51.6 22.5 108.6 41.8 82.4 19.6 23.0 34.3 16.5 37.2 65.4 74.5 17.1 51.1 44.6 45.2 39.5 45.8 63.1 96.3 90.7 54.0 91.1 50.1 60.7 51.9 20.0 63.6 GALR2 GALNR2 ENSG00000182687 "Galanin receptor 2" O43603 17 76074781-76077537 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 7.7" "Cell type enhanced" "Detected in some" "B-cells: 1.7;Endometrial ciliated cells: 1.0;Macrophages: 1.5;Respiratory ciliated cells: 1.6;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;NTERA-2: 2.0;PC-3: 1.3;THP-1: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044513 Uncertain NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA044513: AB_10962510" "unprognostic (1.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (1.37e-2)" "unprognostic (2.62e-2)" "unprognostic (3.54e-1)" "unprognostic (3.49e-2)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-1)" "unprognostic (9.32e-5)" "unprognostic (2.31e-1)" "unprognostic (2.11e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (4.04e-2)" "unprognostic (8.14e-2)" 0.1 0.1 0.2 0.3 0.0 0.9 0.0 0.1 0.2 0.3 0.0 7.7 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.4 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 5.8 1.7 0.3 0.2 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.9 0.2 0.2 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 1.1 0.0 0.7 1.2 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 0.1 2.0 0.0 1.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.7 0.3 0.2 0.0 0.3 3.0 0.1 0.1 0.3 0.1 0.2 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.4 0.4 0.2 0.4 0.3 0.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.9 0.0 0.4 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.4 1.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.4 0.2 1.6 0.0 0.0 0.0 0.1 0.7 1.1 0.0 0.1 0.3 0.3 0.0 0.2 0.4 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 16.9;lymphoid tissue: 42.7" "Cell type enhanced" "Detected in some" "B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "eosinophil: 1000.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 1000.3" "Cell line enhanced" "Detected in some" "HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA011048, HPA011070" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA011048: , HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.7 0.8 0.7 28.5 0.7 16.9 2.3 0.7 1.1 2.7 1.3 2.7 3.7 1.3 1.1 2.1 1.6 5.7 0.7 0.7 1.0 0.8 2.0 4.2 25.3 1.3 1.1 0.4 1.1 1.1 0.6 1.0 1.3 1.8 3.8 0.5 1.9 1.2 0.2 0.8 6.6 4.7 1.0 18.2 3.7 0.7 1.1 6.9 0.6 0.7 42.7 6.0 0.5 1.8 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 71.5 0.2 0.0 0.0 41.8 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 43.3 0.0 0.0 0.0 17.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 33.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 118.4 0.0 125.5 66.7 1000.3 0.4 46.5 0.5 97.0 0.4 0.4 76.8 97.4 0.3 0.3 82.0 1.4 59.3 205.4 0.3 32.0 0.7 0.7 0.7 1.1 0.7 1.0 1.3 1.1 1.3 1.0 1.1 1.8 0.4 3.2 1.9 0.0 84.8 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.2 0.0 0.6 0.0 0.0 0.0 160.1 0.0 0.0 0.0 1.6 0.0 0.1 0.9 0.0 8.8 0.0 0.0 0.1 0.4 0.5 0.0 55.0 0.0 0.4 0.0 14.3 0.0 0.0 0.0 0.0 19.4 6.0 0.5 0.0 43.0 0.0 1.9 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;liver: 27.6" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 36.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 36.4" "Group enriched" "Detected in some" 7 "MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted to blood" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 2.5 0.2 7.0 6.8 7.3 28.1 0.2 1.5 9.8 2.4 5.6 0.4 0.1 3.6 1.0 0.5 3.0 1.7 0.8 7.1 11.1 0.8 27.6 2.8 0.3 2.9 2.6 0.2 0.8 0.6 1.4 0.7 3.1 0.8 0.3 5.7 0.2 1.5 9.0 1.1 0.3 3.1 1.2 12.7 0.3 15.5 4.3 0.9 1.7 9.6 0.4 1.4 0.5 6.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.5 3.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 36.4 0.0 2.0 2.3 0.0 1.6 7.0 7.3 1.5 9.8 7.1 11.1 2.9 2.6 3.1 1.2 4.3 6.8 0.0 0.0 0.0 1.6 0.4 0.9 0.0 0.0 0.0 0.8 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.0 4.7 0.0 0.0 0.1 14.6 0.6 2.3 0.1 0.0 0.0 37.6 0.0 0.0 0.4 0.0 4.8 0.0 0.1 1.1 10.4 1.4 0.0 30.2 0.0 0.0 8.5 0.0 41.7 0.3 9.4 1.8 6.5 12.4 10.4 1.0 34.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.3 0.0 0.2 0.2 4.0 0.6 0.0 0.3 0.1 0.2 0.0 0.0 0.0 GNA12 gep ENSG00000146535 "G protein subunit alpha 12" Q03113 7 2728105-2844308 "Human disease related genes, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 68.3;Syncytiotrophoblasts: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010046 Approved Supported Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "CAB010046: AB_2263416" "unprognostic (1.21e-1)" "unprognostic (1.19e-2)" "unprognostic (9.28e-2)" "unprognostic (1.54e-1)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.20e-6)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "unprognostic (4.45e-3)" "unprognostic (7.90e-2)" "prognostic unfavorable (4.71e-5)" "unprognostic (1.22e-2)" "unprognostic (2.52e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.27e-4)" 17.8 14.9 42.5 11.2 47.1 11.0 12.2 38.4 35.8 12.9 18.3 16.6 5.1 17.0 4.7 7.7 12.9 9.4 17.9 36.1 39.6 8.6 9.3 12.8 12.8 53.2 43.9 18.2 11.9 8.0 12.3 24.4 42.5 9.5 6.1 3.0 8.0 11.4 6.7 5.0 11.3 13.6 46.2 10.6 11.6 10.1 52.6 5.6 6.7 7.3 10.1 16.6 9.2 42.3 35.5 19.1 19.4 29.2 30.4 24.1 53.5 29.1 33.7 30.9 35.3 18.4 24.5 7.5 19.4 34.6 64.7 15.6 13.5 30.1 20.9 89.9 13.5 15.3 9.9 19.6 35.4 2.5 13.1 23.5 16.1 36.3 24.4 31.8 33.3 10.6 17.3 23.0 28.1 16.8 4.1 14.1 27.3 9.1 32.9 26.8 22.4 15.2 11.4 23.8 15.4 22.3 16.4 24.4 12.2 27.6 13.6 20.9 39.5 33.6 39.9 33.2 48.6 16.1 20.3 6.8 36.1 22.5 33.7 1.4 0.5 0.1 0.2 1.3 0.3 1.0 0.5 0.3 0.4 1.7 0.5 0.0 0.1 0.0 0.3 1.8 0.7 0.4 42.5 47.1 38.4 35.8 36.1 39.6 53.2 43.9 42.5 46.2 52.6 42.3 21.8 6.4 11.7 41.8 22.0 7.0 3.8 5.4 0.6 6.0 14.5 10.4 16.3 10.0 6.1 1.8 12.5 63.7 16.6 8.0 3.9 7.9 13.3 9.3 21.8 16.7 7.8 9.5 31.9 10.2 17.0 19.6 10.2 10.8 0.0 13.9 19.2 13.5 25.4 8.4 36.0 5.5 6.1 21.6 63.5 13.6 17.1 25.8 21.4 22.5 21.7 16.1 7.2 68.3 29.9 13.2 4.0 18.8 7.3 8.4 4.7 7.1 5.8 10.7 0.0 16.8 17.3 8.6 9.4 1.2 3.7 173.2 6.2 23.7 5.3 3.2 GNA15 GNA16 ENSG00000060558 "G protein subunit alpha 15" P30679 19 3136033-3163749 "Plasma proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 75.6;esophagus: 108.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8" "Group enriched" "Detected in all" 4 "cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 67.1" "Group enriched" "Detected in many" 4 "dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043113 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA043113: AB_10967343" "prognostic favorable (7.57e-5)" "unprognostic (6.06e-2)" "unprognostic (3.43e-1)" "prognostic favorable (2.01e-4)" "unprognostic (4.34e-2)" "unprognostic (2.09e-1)" "unprognostic (1.14e-2)" "unprognostic (5.38e-3)" "unprognostic (1.82e-1)" "unprognostic (3.22e-2)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (4.26e-6)" "unprognostic (1.04e-1)" "unprognostic (2.16e-3)" "unprognostic (2.36e-1)" "unprognostic (2.07e-1)" 6.8 3.1 4.0 12.4 3.8 75.6 4.6 4.0 7.3 13.3 4.7 2.5 1.7 1.3 0.4 108.8 2.4 4.6 1.9 4.1 4.1 2.0 1.4 13.1 4.2 5.4 4.5 0.8 1.2 0.4 1.4 7.6 5.1 11.6 1.8 0.1 19.5 2.5 0.6 50.8 2.5 3.1 4.9 8.8 4.3 1.4 6.6 32.0 1.2 0.9 12.1 28.1 41.6 6.4 44.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 18.7 0.1 0.1 0.0 0.1 36.2 0.0 65.4 0.0 0.1 0.0 19.1 0.1 0.0 0.0 27.2 152.1 0.0 40.0 0.2 26.2 0.0 0.0 16.6 0.1 0.3 0.0 0.0 162.4 59.8 0.1 2.9 0.0 119.3 0.0 0.2 0.0 23.6 0.2 0.0 4.6 0.2 0.2 0.0 0.0 62.1 0.1 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.3 29.8 0.1 19.4 29.1 14.3 0.0 21.8 1.1 0.0 2.0 0.3 28.8 0.0 0.0 0.0 6.9 4.4 15.5 67.1 8.7 13.3 4.0 3.8 4.0 7.3 4.1 4.1 5.4 4.5 5.1 4.9 6.6 6.4 1.0 9.6 8.8 0.0 2.2 67.2 141.5 65.5 9.1 0.2 7.4 3.7 0.5 0.0 39.0 3.7 0.0 0.5 27.6 0.5 0.0 0.7 0.5 1.4 0.5 3.1 6.6 21.0 1.3 0.0 0.8 2.5 3.6 3.9 34.3 0.0 0.7 0.0 66.5 0.0 0.4 2.2 57.0 36.2 190.6 0.8 0.0 78.3 21.4 7.5 32.0 0.0 0.0 0.0 0.2 13.2 0.3 0.0 3.6 69.3 0.0 0.1 21.7 0.1 19.7 0.3 3.3 4.0 2.0 38.0 95.8 0.4 19.6 0.1 1.4 173.8 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294539-99307399 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 112.7;lymphoid tissue: 84.5" "Group enriched" "Detected in many" 4 "Langerhans cells: 2572.5;Macrophages: 809.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 1050.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 23 "HDLM-2: 157.7;HL-60: 108.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033690, HPA075590" Approved NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "CAB033690: AB_2114269, HPA075590: " "unprognostic (3.28e-3)" "prognostic favorable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 26.2 12.8 1.9 84.5 2.1 112.7 11.2 2.2 3.5 12.6 7.1 14.8 8.0 6.6 2.4 15.2 6.5 40.5 13.1 1.8 5.5 3.8 17.1 20.1 67.7 8.1 3.0 3.5 4.6 3.8 5.1 27.8 5.2 9.4 21.3 2.0 5.2 3.9 2.0 5.9 23.6 21.9 3.9 35.1 15.7 1.5 3.5 31.8 15.2 4.1 75.6 52.3 5.3 7.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.7 0.2 0.8 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.4 157.7 0.0 1.4 0.4 0.0 0.0 108.6 0.3 0.0 0.0 1.5 0.0 0.0 0.0 5.7 2.6 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.8 0.3 0.7 0.0 1050.9 10.4 391.6 43.7 3.8 264.5 364.1 463.0 240.9 77.9 172.1 286.1 39.8 9.9 487.0 3.9 255.2 401.6 255.9 1.9 2.1 2.2 3.5 1.8 5.5 8.1 3.0 5.2 3.9 3.5 7.3 6.0 16.0 26.3 0.0 413.9 61.6 0.8 0.5 2.2 0.3 2.5 3.9 4.6 1.5 6.3 0.0 6.2 1.0 168.8 0.5 1.9 0.2 0.7 0.6 1.3 17.1 0.0 4.4 0.2 2.9 1.5 12.8 11.2 0.9 60.9 0.1 0.7 1.2 113.4 0.0 0.2 0.0 18.3 119.1 2572.5 2.8 0.3 809.4 145.9 46.9 248.7 0.1 1.0 0.5 0.3 1.0 0.0 0.0 85.5 0.4 0.0 0.8 3.8 0.9 6.6 2.1 9.1 0.4 0.2 1.3 53.4 1.8 245.2 0.0 0.3 0.6 GRAMD4 "DIP, KIAA0767" ENSG00000075240 "GRAM domain containing 4" Q6IC98 22 46576012-46679790 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 168.2" "Cell type enhanced" "Detected in many" "Astrocytes: 45.1;Distal enterocytes: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 96.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (8.67e-3)" "unprognostic (1.78e-3)" "unprognostic (2.19e-2)" "unprognostic (8.11e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.04e-4)" "unprognostic (1.08e-1)" "unprognostic (7.07e-2)" "unprognostic (5.72e-2)" "unprognostic (1.44e-3)" "unprognostic (1.54e-2)" "unprognostic (4.11e-1)" "unprognostic (1.61e-2)" "unprognostic (2.73e-2)" "unprognostic (2.08e-1)" "unprognostic (5.38e-2)" "unprognostic (8.69e-2)" 15.1 52.1 15.1 17.4 15.9 22.6 11.9 9.3 20.2 11.5 11.9 40.6 34.6 7.5 9.9 24.2 16.1 20.5 45.0 15.6 11.9 18.6 168.2 19.6 17.6 11.6 11.6 10.8 17.6 10.0 24.1 10.5 12.0 14.1 26.6 9.1 17.8 7.1 23.8 45.3 36.0 9.1 11.2 16.0 28.0 7.4 11.8 23.5 20.3 11.9 26.6 9.4 13.2 13.8 12.6 14.2 16.3 20.9 21.4 12.5 16.8 9.5 5.9 3.8 4.8 5.1 19.6 45.9 15.9 10.7 11.1 26.2 10.0 5.2 5.8 12.2 11.3 15.4 10.9 12.2 17.4 96.9 60.0 8.4 12.2 3.0 6.8 13.4 5.3 34.6 29.4 30.3 5.4 22.0 56.4 51.0 8.9 28.2 6.6 25.3 2.5 30.2 7.4 14.6 11.6 32.3 10.2 20.3 37.1 18.7 19.8 33.8 8.3 4.9 9.7 6.6 6.3 6.2 21.5 24.3 10.9 37.4 43.1 1.2 1.4 1.0 0.6 0.9 0.3 1.0 0.5 0.4 2.0 0.3 0.4 0.2 0.5 3.9 0.4 2.4 1.9 0.8 15.1 15.9 9.3 20.2 15.6 11.9 11.6 11.6 12.0 11.2 11.8 13.8 17.7 16.0 18.4 45.1 5.9 8.2 3.6 7.6 6.8 5.0 7.1 10.8 19.3 8.6 4.1 3.7 0.0 3.7 9.5 56.1 0.0 4.7 0.3 13.4 7.2 7.5 20.8 3.8 21.6 6.7 2.2 4.7 8.2 10.6 7.0 5.4 2.5 23.0 14.0 3.3 18.2 20.7 6.1 10.1 14.7 1.1 4.7 12.0 7.2 11.2 10.9 12.2 3.1 13.6 5.9 7.9 18.9 5.7 8.6 5.0 34.5 3.0 5.1 1.7 0.0 3.4 5.3 1.2 3.8 8.2 10.4 3.4 7.0 5.9 22.8 3.7 H4C4 "H4/b, H4FB, HIST1H4D" ENSG00000277157 "H4 clustered histone 4" P62805 6 26188710-26189112 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 33.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "naive B-cell: 3.4" "Lineage enriched" "Detected in single" 4 "B-cells: 3.4" "Cell line enhanced" "Detected in many" "HEK 293: 5.2;HeLa: 5.0;RT4: 8.9" HPA042201 Supported NA NA 25000000 "Cluster 24: B-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 15: RT4 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA042201: AB_2677898" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.09e-2)" "unprognostic (1.98e-2)" "unprognostic (2.06e-2)" "unprognostic (7.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.30e-1)" "unprognostic (7.77e-4)" "unprognostic (1.56e-1)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (6.11e-3)" 0.1 0.5 10.8 0.0 19.0 0.8 0.8 33.9 11.4 0.3 5.0 0.2 0.0 0.2 0.3 0.6 0.7 0.1 0.2 7.9 3.4 0.2 0.4 0.4 0.2 4.0 3.3 0.1 0.1 0.1 0.3 0.2 6.7 1.1 0.2 0.1 0.1 0.1 0.0 0.2 0.2 0.1 15.4 0.6 0.2 0.4 9.7 2.0 0.5 0.0 0.1 0.0 0.3 5.6 1.0 1.1 0.8 0.0 1.3 0.0 0.5 0.7 0.4 1.9 0.9 1.8 0.4 4.0 0.3 0.0 1.5 0.5 2.3 0.4 0.6 0.3 5.2 0.6 5.0 1.7 0.0 0.4 0.1 0.4 0.0 0.2 0.7 0.0 1.6 0.5 1.3 1.1 0.0 1.9 1.5 2.7 1.4 0.9 0.3 0.4 0.0 0.5 0.5 8.9 0.5 0.3 0.8 0.5 0.5 0.6 0.9 0.3 0.0 0.4 2.9 0.3 1.1 1.2 1.2 0.0 0.8 1.1 0.7 0.0 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.2 0.2 3.4 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.3 10.8 19.0 33.9 11.4 7.9 3.4 4.0 3.3 6.7 15.4 9.7 5.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932142-56944864 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 2680.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 497.6;U-266/70: 533.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 75.3 108.4 68.4 102.0 70.6 113.6 128.9 73.7 92.6 127.1 99.0 149.5 98.2 65.7 220.2 53.2 86.5 77.8 92.0 67.9 77.9 193.1 193.0 92.0 114.1 77.3 72.8 188.8 377.0 206.9 78.8 97.1 75.2 213.0 141.8 39.7 170.0 102.0 102.9 58.7 84.9 77.8 78.4 114.8 144.1 25.0 74.6 58.0 213.6 120.9 246.6 94.5 45.0 82.8 28.6 30.9 29.8 61.8 66.9 86.9 105.2 65.9 104.6 83.5 64.9 43.1 63.5 115.0 82.7 64.6 84.6 47.9 51.0 23.3 82.4 67.1 30.8 9.9 48.3 156.3 364.6 21.1 49.5 106.0 219.2 38.0 119.6 100.4 64.4 125.9 15.9 159.6 236.3 24.1 39.8 42.7 19.1 164.8 68.9 27.0 74.9 497.6 179.8 31.8 32.7 37.5 57.5 278.8 308.2 41.9 31.3 77.4 40.0 34.8 34.4 30.8 26.8 533.9 191.0 182.6 49.3 28.7 46.4 224.0 291.2 139.5 113.2 238.1 124.0 383.2 120.1 149.7 230.6 340.4 77.2 117.8 215.9 179.6 175.0 915.5 263.8 417.7 68.4 70.6 73.7 92.6 67.9 77.9 77.3 72.8 75.2 78.4 74.6 82.8 316.4 70.5 105.9 16.6 964.5 364.0 561.8 316.3 203.7 134.6 191.3 185.2 221.5 91.5 193.4 71.7 281.5 131.9 577.3 369.1 170.2 192.7 73.3 162.5 121.3 199.8 434.4 40.8 29.9 197.7 182.4 223.8 251.8 260.5 151.8 108.8 134.2 164.0 194.7 47.1 32.2 569.7 290.9 241.6 395.9 251.6 104.1 507.7 948.0 88.1 197.0 94.3 81.4 21.1 30.7 144.8 336.5 95.5 2680.7 447.4 156.1 209.0 95.6 117.1 98.6 178.8 215.6 54.7 10.6 146.6 255.3 693.8 342.6 137.4 311.4 456.8 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "HIVEP zinc finger 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 7.2 2.3 0.8 8.0 3.0 16.7 5.5 0.7 3.0 7.4 6.5 6.4 5.0 5.9 4.5 7.4 6.1 7.3 3.8 2.2 0.8 4.5 11.7 6.3 8.0 1.3 2.8 6.5 6.7 10.5 3.3 4.9 0.5 6.9 6.6 5.8 4.8 5.8 2.8 5.7 5.2 6.2 0.0 6.0 4.9 4.8 1.2 9.1 4.9 6.2 8.3 9.3 3.3 1.6 8.1 5.9 7.5 4.2 5.8 7.3 7.2 6.4 5.5 5.2 5.7 3.8 4.2 6.7 13.6 7.8 12.4 7.6 7.4 9.2 7.1 14.6 4.3 3.1 5.6 3.7 4.7 3.7 2.5 5.1 9.0 10.6 16.3 11.0 15.5 4.6 32.9 7.5 11.5 6.0 5.9 3.3 6.4 2.8 2.7 3.2 9.8 10.7 3.1 8.7 7.1 5.2 15.9 12.8 4.3 16.6 7.6 4.7 25.2 13.0 5.8 12.3 7.4 30.0 27.3 12.0 4.0 4.8 5.5 2.4 1.8 2.1 1.2 2.0 0.9 3.1 2.0 0.8 1.2 4.8 3.4 2.1 11.7 3.3 5.2 9.0 4.4 0.7 0.8 3.0 0.7 3.0 2.2 0.8 1.3 2.8 0.5 0.0 1.2 1.6 40.2 28.9 16.9 74.7 35.6 32.2 25.4 7.4 30.7 20.4 12.3 10.9 10.4 17.2 17.6 7.3 12.5 3.4 18.7 17.5 3.9 5.6 2.5 37.7 16.4 20.3 10.8 6.5 94.6 7.2 1.8 25.2 22.4 51.0 7.6 7.0 6.4 12.3 5.9 21.9 68.3 14.4 4.1 9.6 47.9 1.8 3.7 23.1 19.6 44.0 29.6 13.1 5.2 59.3 25.0 11.5 10.3 4.5 33.6 25.2 6.7 2.5 16.7 9.7 0.0 21.0 17.1 3.9 3.5 18.7 33.4 5.2 18.8 6.6 8.6 23.7 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301081-14349404 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.4;retina: 11.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6;dendritic cells: 32.5;Hepatic stellate cells: 25.7;Hepatocytes: 39.7;Syncytiotrophoblasts: 36.3" "Cancer enhanced" "Detected in many" "liver cancer: 5.3" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 35.1" "Group enriched" "Detected in many" 5 "dendritic cells: 35.1;T-cells: 26.2" "Cell line enhanced" "Detected in many" "AF22: 20.7;BEWO: 14.9;Hep G2: 18.8;HSkMC: 20.2;U-251 MG: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA064126 Approved Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA064126: AB_2685194" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 0.9 0.9 0.2 4.6 1.0 1.4 0.9 0.3 1.3 2.4 1.5 1.2 1.3 0.6 0.2 1.8 0.9 1.4 1.5 0.4 0.4 3.0 28.4 1.6 6.3 5.4 2.5 3.5 0.6 0.3 0.7 3.5 2.0 2.0 1.7 11.5 5.3 2.0 1.0 1.5 1.8 0.5 2.9 3.4 1.2 0.4 1.4 3.2 0.7 0.9 4.8 2.6 1.9 0.9 0.0 0.4 20.7 0.0 6.2 6.9 14.9 6.1 8.7 5.3 5.6 0.0 0.1 0.0 0.0 8.2 0.0 0.1 0.5 3.3 2.7 1.8 4.5 0.5 2.9 18.8 8.1 0.8 3.2 20.2 1.1 1.9 4.8 1.2 0.0 1.1 6.6 0.1 4.3 1.1 1.0 0.8 0.7 0.1 0.6 3.9 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.4 0.6 0.0 5.2 0.0 0.1 19.9 0.0 0.0 0.0 4.0 0.0 1.2 0.2 0.4 0.0 10.2 0.7 8.1 0.9 12.0 8.0 0.8 0.7 12.1 11.8 0.9 6.6 0.8 35.1 26.2 5.1 0.2 1.0 0.3 1.3 0.4 0.4 5.4 2.5 2.0 2.9 1.4 0.9 2.9 0.0 1.1 6.2 3.5 11.5 0.3 4.9 21.1 3.2 1.2 2.2 3.0 10.0 3.9 7.3 39.6 7.2 32.5 0.0 0.0 0.7 14.3 0.3 1.5 2.9 0.0 0.4 3.3 0.2 11.9 6.6 0.0 0.8 0.0 2.4 25.7 39.7 1.6 8.4 2.2 0.1 2.0 3.8 12.9 3.3 2.8 6.7 1.8 1.9 1.3 7.3 14.4 3.5 0.1 0.2 0.0 1.2 2.2 1.1 0.4 0.1 3.9 17.9 13.1 15.0 2.6 4.0 0.3 10.0 14.8 36.3 12.4 0.1 0.2 0.3 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044188-119057227 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 201.9" "Cell type enhanced" "Detected in all" "Plasma cells: 118.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 35.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 418.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 130000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 38.2 48.5 30.7 27.1 32.2 18.6 31.0 28.3 34.1 37.2 25.5 40.9 18.1 44.6 51.2 47.4 40.8 14.0 56.5 32.9 41.0 63.0 201.9 47.7 17.4 32.6 34.5 36.1 165.9 18.8 100.1 19.9 34.2 47.9 21.3 11.9 46.3 20.7 19.1 25.0 39.0 19.0 28.5 47.6 60.3 85.7 35.2 21.7 87.2 8.4 20.9 39.9 31.7 32.9 40.5 34.5 77.2 224.4 41.2 19.7 107.7 56.1 38.0 63.1 47.2 105.0 103.0 85.3 418.9 40.7 122.1 59.5 71.5 69.3 53.8 92.8 26.1 151.8 32.6 76.7 187.7 88.6 73.5 23.9 91.1 55.2 185.3 57.9 100.2 57.2 53.5 136.8 33.9 97.8 59.4 49.6 55.5 83.2 33.6 63.1 55.9 144.3 48.6 67.8 45.7 70.0 80.4 103.8 53.3 65.5 78.8 82.9 75.0 59.9 46.4 27.2 77.5 88.1 64.0 61.2 53.8 76.2 135.6 4.4 4.5 2.2 11.7 6.1 12.6 5.4 6.4 8.7 5.0 4.0 4.0 6.1 1.3 7.6 4.4 35.9 5.5 4.7 30.7 32.2 28.3 34.1 32.9 41.0 32.6 34.5 34.2 28.5 35.2 32.9 16.4 9.6 14.1 6.2 22.7 17.8 18.5 17.5 14.2 11.5 28.5 21.1 12.4 15.7 16.8 25.8 43.8 11.2 36.6 35.3 9.8 20.7 74.0 20.4 29.1 20.0 35.8 17.0 12.0 18.8 26.6 21.0 39.8 38.1 15.8 43.1 13.9 49.9 22.2 25.2 13.7 52.1 18.3 8.2 21.6 38.8 13.1 17.8 23.2 5.6 15.5 8.7 17.5 4.5 9.3 31.4 24.2 13.5 118.7 44.4 14.9 17.6 16.7 14.5 13.1 16.4 15.6 27.8 29.1 16.2 19.9 19.3 20.8 14.8 27.3 24.7 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969082-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 69.5" "Cell type enhanced" "Detected in many" "NK-cells: 264.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" NA NA 190000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.08e-4)" 20.3 21.9 1.8 11.4 3.7 13.3 16.0 3.9 4.3 15.2 11.7 17.4 7.4 19.3 4.8 16.7 13.9 10.7 21.8 3.2 4.2 14.8 23.9 22.2 8.2 4.3 3.6 17.0 16.6 14.3 9.5 15.3 3.8 11.0 11.6 3.2 18.4 6.7 69.5 16.5 14.7 16.0 3.2 23.2 15.5 7.7 4.8 15.9 14.5 27.2 7.8 15.3 16.5 5.9 20.8 18.1 32.6 44.6 108.4 76.4 36.9 30.1 80.4 30.3 52.8 28.3 37.2 7.3 30.9 38.4 101.7 25.4 27.0 140.0 52.0 47.7 19.4 3.6 30.0 32.1 49.2 20.7 31.2 52.7 45.4 57.6 144.8 65.4 19.2 36.0 42.2 48.2 46.4 10.1 8.8 13.4 13.1 19.3 23.2 23.2 20.6 46.1 29.9 20.8 11.3 25.4 45.0 34.5 44.8 41.4 15.7 49.4 25.3 27.0 27.9 57.3 60.4 16.7 40.2 9.1 49.0 23.7 38.9 0.5 1.0 0.8 1.1 0.3 0.4 0.2 0.5 0.4 0.2 0.2 0.5 0.7 4.4 0.7 0.4 1.3 0.2 0.3 1.8 3.7 3.9 4.3 3.2 4.2 4.3 3.6 3.8 3.2 4.8 5.9 44.7 48.1 47.3 34.6 16.7 22.2 10.0 16.0 17.1 13.0 20.2 14.7 33.6 24.3 22.1 16.5 20.9 7.5 107.0 46.2 0.0 29.3 7.5 25.8 38.7 29.6 22.3 9.5 33.0 19.4 12.3 29.9 16.8 39.7 3.8 41.7 28.9 63.4 22.2 15.2 34.2 18.4 12.2 59.4 12.8 5.2 47.5 37.6 12.4 31.9 65.9 11.7 264.7 30.7 40.0 40.8 17.2 38.4 35.9 17.1 23.2 23.6 12.2 15.1 65.7 63.7 32.6 10.9 10.4 28.9 19.7 9.3 38.8 38.8 20.9 16.7 IKZF1 "hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1" ENSG00000185811 "IKAROS family zinc finger 1" Q13422 7 50304068-50405101 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 173.0;lymphoid tissue: 112.5" "Cell type enhanced" "Detected in many" "B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009247, HPA035221, HPA035222" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525" "prognostic favorable (4.28e-4)" "prognostic favorable (2.02e-4)" "unprognostic (2.49e-3)" "unprognostic (2.41e-3)" "unprognostic (5.59e-1)" "prognostic favorable (8.63e-4)" "unprognostic (1.45e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-2)" "unprognostic (2.43e-1)" "unprognostic (6.63e-2)" "unprognostic (2.95e-1)" "unprognostic (1.69e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-2)" "unprognostic (6.77e-2)" "unprognostic (4.67e-2)" 5.0 3.2 3.5 53.0 3.4 173.0 4.4 4.0 3.9 3.6 3.3 7.6 7.0 2.5 2.3 4.8 2.2 7.7 1.5 3.0 4.0 1.4 4.9 11.6 87.1 7.7 5.2 1.6 0.8 0.8 0.6 3.6 7.5 2.3 6.8 0.2 4.6 1.9 1.0 2.0 15.6 4.0 7.3 48.6 12.0 1.7 8.7 112.5 2.1 1.2 73.8 9.6 1.8 10.3 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 258.6 0.2 52.1 0.0 0.0 0.0 84.5 220.4 0.0 0.0 0.0 0.0 0.0 0.0 128.9 72.4 15.4 0.0 0.0 184.3 80.9 2.4 0.0 0.0 192.3 0.3 39.6 0.0 0.0 1.6 2.0 0.8 1.0 0.8 0.4 0.2 112.1 0.2 0.0 1.9 0.2 0.4 80.8 49.4 342.7 0.5 89.5 0.5 21.2 14.2 25.0 35.4 43.9 29.1 46.7 36.3 35.0 15.1 40.7 48.2 35.7 20.2 24.3 43.3 23.4 32.6 26.4 3.5 3.4 4.0 3.9 3.0 4.0 7.7 5.2 7.5 7.3 8.7 10.3 2.8 3.2 12.2 0.7 120.5 2.8 0.1 0.0 0.0 0.0 2.8 1.9 1.5 2.8 1.8 1.8 0.0 0.4 221.4 0.3 0.0 0.4 3.8 0.5 0.4 2.6 0.0 89.8 0.2 0.0 0.4 2.5 4.6 0.6 23.4 0.2 3.9 2.0 30.6 0.0 0.3 0.0 0.0 64.3 61.0 5.3 0.0 72.1 19.6 91.8 106.6 0.0 150.4 1.0 0.3 0.1 0.4 0.0 128.9 0.1 0.0 1.0 1.5 0.1 0.0 1.5 1.6 0.1 2.1 0.5 2.7 0.7 182.8 0.1 0.1 0.1 IL3RA CD123 ENSG00000185291 "Interleukin 3 receptor subunit alpha" P26951 X 1336616-1382689 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 2665.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 2665.0" "Cell line enhanced" "Detected in many" "HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1" "HPA003539, CAB018374" Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "CAB018374: AB_2233620, HPA003539: AB_1078438" "prognostic favorable (9.78e-4)" "prognostic favorable (4.27e-4)" "unprognostic (8.13e-2)" "unprognostic (9.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" "unprognostic (5.77e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-3)" "unprognostic (9.41e-2)" "unprognostic (2.85e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" 25.2 2.9 7.1 15.8 13.6 25.0 20.6 16.1 11.7 6.4 0.2 8.1 5.5 8.7 1.6 5.4 8.0 11.3 13.0 5.9 8.1 9.2 1.8 25.0 25.1 11.7 10.6 8.8 5.4 3.4 2.8 6.2 11.1 7.0 6.6 22.0 9.5 3.2 12.1 12.7 9.2 12.3 7.5 11.1 6.9 3.5 10.1 4.4 10.3 8.6 13.0 12.4 6.3 20.5 0.2 9.4 3.6 1.3 0.1 0.0 1.1 1.2 0.3 0.0 0.1 0.9 1.5 1.2 7.2 0.2 0.6 9.6 0.0 0.0 0.0 128.8 3.9 0.6 2.1 0.4 0.0 0.8 15.6 0.0 0.0 0.0 0.0 4.1 8.2 0.9 0.3 6.1 0.0 1.4 0.7 24.9 3.1 0.8 0.5 1.4 4.2 54.1 0.0 1.4 0.6 0.4 0.6 0.3 2.8 1.8 1.2 17.8 0.4 0.5 1.5 0.5 0.3 12.5 3.9 1.1 9.8 2.8 0.1 2665.0 5.6 83.9 0.6 31.7 1.0 2.5 0.9 0.5 14.9 8.9 0.7 0.7 4.6 14.2 42.5 628.5 0.5 12.0 7.1 13.6 16.1 11.7 5.9 8.1 11.7 10.6 11.1 7.5 10.1 20.5 79.0 3.2 1.8 11.8 6.8 5.9 0.7 0.9 1.2 2.3 0.5 0.9 2.2 1.5 1.0 0.0 10.4 0.1 137.5 4.7 0.0 0.4 0.2 2.7 1.4 83.2 0.0 3.0 7.3 0.2 0.1 4.3 0.5 1.5 11.4 0.4 24.3 0.7 4.6 0.0 14.3 7.3 0.0 2.8 47.6 0.1 0.3 32.9 8.8 13.1 72.6 0.6 1.0 6.0 18.2 0.1 3.4 0.7 4.0 0.7 0.2 0.0 0.4 3.2 0.0 3.6 3.2 0.1 0.7 0.7 5.5 0.3 1.6 1.3 0.6 2.1 INAFM2 "LINC00984, OGU1" ENSG00000259330 "InaF motif containing 2" P0DMQ5 15 40323692-40326715 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 18.0;Early spermatids: 25.3;Hofbauer cells: 19.5;Spermatocytes: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;granulocytes: 2.6;monocytes: 1.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.59e-2)" "unprognostic (9.05e-2)" "unprognostic (8.01e-3)" "unprognostic (2.43e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (1.88e-7)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" 11.3 8.4 16.1 9.9 17.9 12.7 7.6 15.5 17.1 8.5 15.2 49.9 6.7 12.2 5.8 8.1 21.3 11.0 28.8 16.4 18.4 7.9 6.7 11.5 5.8 19.3 16.9 10.0 11.5 12.2 10.4 17.6 16.9 10.8 13.4 12.6 9.4 22.5 13.6 6.5 12.9 17.3 18.2 10.7 28.2 10.2 17.0 5.2 26.9 15.0 6.2 14.4 7.8 22.2 18.7 1.8 16.8 10.7 14.2 6.9 38.6 23.0 11.5 18.0 14.8 6.9 3.7 1.6 19.8 12.6 10.6 41.7 26.3 27.1 25.1 5.5 8.8 50.4 6.9 3.9 18.3 27.0 34.3 18.2 9.8 6.7 18.8 26.5 18.7 12.9 27.6 39.6 25.4 2.7 7.9 21.5 12.3 14.5 14.1 3.9 20.2 44.8 13.2 21.3 35.9 14.2 8.2 9.7 8.3 28.6 9.4 33.1 24.5 24.8 18.4 12.6 16.8 10.2 2.7 4.8 18.4 43.5 24.1 0.6 1.0 2.6 0.1 1.1 0.1 0.3 0.1 0.0 0.5 0.0 0.0 0.1 0.7 0.1 1.0 1.1 0.2 0.6 16.1 17.9 15.5 17.1 16.4 18.4 19.3 16.9 16.9 18.2 17.0 22.2 6.4 0.0 3.7 3.9 2.3 0.0 1.2 0.0 0.0 7.8 6.8 5.5 18.0 4.3 0.6 3.7 4.2 3.3 3.1 4.3 0.0 2.3 25.3 2.2 3.8 6.0 2.4 1.7 3.4 2.6 0.6 2.4 3.6 2.3 1.3 1.8 12.1 2.7 19.5 8.4 4.5 1.4 0.0 14.1 0.0 4.6 1.2 13.8 0.0 6.5 8.0 6.7 4.1 4.0 1.4 2.3 1.9 4.9 0.4 3.2 1.4 0.8 1.5 4.8 0.0 2.4 9.8 32.4 4.4 1.1 0.0 1.4 1.7 4.9 1.5 2.4 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594392 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 8.7 8.2 15.9 13.2 19.5 12.7 6.1 18.8 22.0 7.0 1.0 11.3 7.3 7.5 5.2 7.7 6.6 9.9 10.5 15.9 9.9 5.2 4.1 9.6 17.2 9.2 3.5 7.0 6.6 8.9 7.7 8.1 9.2 6.0 7.9 10.7 5.6 6.3 8.4 4.1 8.8 9.8 4.7 16.7 7.3 5.9 5.9 20.3 5.9 11.6 12.5 10.8 5.5 10.1 12.7 11.0 18.2 14.8 10.4 11.1 19.2 10.0 9.4 10.9 11.3 14.6 11.5 7.8 13.3 15.4 14.0 12.6 12.6 11.1 8.5 27.7 10.9 9.5 9.7 6.5 8.8 17.3 34.3 9.9 9.9 10.6 9.0 9.5 15.1 44.9 8.5 67.4 8.3 16.2 26.3 16.8 17.6 7.4 11.3 12.0 12.5 51.9 5.6 41.6 12.8 15.7 12.1 10.1 9.5 18.7 4.8 13.8 14.3 12.7 17.9 10.1 7.5 50.2 31.1 5.8 10.5 16.2 11.5 1.1 1.0 2.3 2.8 2.2 3.3 0.4 1.6 1.8 1.1 0.1 2.2 2.5 1.1 3.2 3.4 3.3 0.9 1.0 15.9 19.5 18.8 22.0 15.9 9.9 9.2 3.5 9.2 4.7 5.9 10.1 14.6 6.4 13.1 50.9 11.2 8.0 6.4 2.8 9.1 49.7 5.3 4.2 12.6 2.8 7.8 5.5 8.4 10.2 64.6 4.1 3.9 4.0 13.5 6.2 9.1 14.2 5.4 7.2 150.5 1.5 8.7 9.9 6.6 6.3 0.0 22.4 14.3 3.4 10.5 33.7 124.4 5.6 4.1 36.4 18.4 10.9 9.3 25.3 10.6 73.1 26.8 8.4 71.1 55.8 26.1 3.8 2.5 12.0 48.6 5.9 1.2 3.3 5.1 14.1 6.6 9.9 12.4 8.6 14.0 5.2 6.1 9.4 48.3 9.4 3.6 6.8 INSYN2A "C10orf141, FAM196A, FLJ45557, INSYN2" ENSG00000188916 "Inhibitory synaptic factor 2A" Q6ZSG2 10 127135426-127196591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 8.0" "Cell type enhanced" "Detected in single" "Endothelial cells: 1.4" "Group enriched" "Detected in some" 13 "breast cancer: 3.4;glioma: 3.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 2.7;U-87 MG: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035898, HPA035899" Uncertain NA NA "Cluster 65: Brain - Ion transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA035898: AB_10964352, HPA035899: AB_10961723" "unprognostic (4.00e-2)" "unprognostic (9.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.66e-3)" "unprognostic (2.18e-1)" "unprognostic (4.70e-2)" "unprognostic (7.30e-2)" "unprognostic (3.62e-1)" "unprognostic (2.18e-2)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (5.47e-2)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" 0.1 0.0 4.5 0.1 6.2 0.0 0.6 2.8 5.8 0.1 1.2 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.1 3.4 5.3 0.3 0.0 0.2 0.0 4.4 5.4 0.7 0.1 0.0 0.2 0.0 4.2 0.7 0.1 1.6 0.2 0.1 0.0 0.1 0.3 0.1 2.6 0.3 0.2 0.6 8.0 1.1 0.1 0.1 0.1 0.2 0.1 2.3 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.5 6.2 2.8 5.8 3.4 5.3 4.4 5.4 4.2 2.6 8.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRF2BP2 IRF-2BP2 ENSG00000168264 "Interferon regulatory factor 2 binding protein 2" Q7Z5L9 1 234604269-234610178 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 277.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027815, HPA062269" Approved Enhanced Nucleoplasm NA NA 13000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA027815: AB_10609994, HPA062269: AB_2684732" "unprognostic (1.15e-3)" "unprognostic (1.02e-1)" "unprognostic (3.90e-1)" "unprognostic (2.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.74e-3)" "unprognostic (1.97e-2)" "unprognostic (8.77e-2)" "unprognostic (2.19e-1)" "unprognostic (3.69e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.25e-1)" "unprognostic (2.70e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" 35.6 39.6 43.3 25.6 50.2 157.2 45.0 48.5 49.1 50.0 43.3 42.5 39.6 55.8 26.5 47.0 45.1 40.7 45.0 40.5 45.4 34.2 53.6 43.7 36.3 55.2 49.0 54.8 49.5 45.5 24.1 29.6 51.1 39.2 49.3 26.9 55.0 33.5 47.4 64.2 42.2 31.7 48.9 28.4 44.4 18.0 44.7 29.6 57.3 40.5 30.3 38.7 43.7 61.1 28.0 41.5 29.8 45.7 61.2 48.1 35.1 21.8 18.4 12.7 14.2 24.5 33.5 0.0 49.4 21.2 43.3 37.4 16.2 28.3 20.2 45.2 36.8 26.7 32.9 72.3 49.4 101.0 91.0 57.0 65.8 28.3 53.4 74.4 33.0 24.5 23.0 55.6 33.2 8.4 25.5 107.2 27.1 65.1 15.7 49.6 13.8 66.8 25.1 22.9 58.8 41.8 35.2 46.7 72.7 29.8 45.1 277.5 36.8 45.5 19.0 34.7 41.6 122.9 33.8 9.1 23.1 89.6 63.4 10.1 4.5 8.5 3.9 3.6 4.0 4.3 4.8 4.6 4.7 4.0 4.9 4.1 2.3 3.0 1.9 17.8 4.0 2.5 43.3 50.2 48.5 49.1 40.5 45.4 55.2 49.0 51.1 48.9 44.7 61.1 96.0 134.6 191.3 28.1 75.6 325.9 440.4 142.3 139.5 34.6 126.6 109.7 63.6 133.0 143.8 51.5 10.4 44.6 168.3 84.2 13.7 65.8 24.9 180.8 126.2 101.9 145.5 76.6 14.3 50.0 58.0 97.3 47.4 285.2 107.5 39.6 117.4 185.7 88.9 58.9 22.9 117.1 71.2 131.8 271.2 27.1 69.6 159.7 110.3 30.9 83.2 87.7 38.1 20.6 64.2 68.9 92.0 81.3 39.2 138.2 81.7 40.2 95.1 19.5 78.9 117.1 102.9 29.5 24.1 182.1 396.2 79.4 91.3 15.5 162.7 370.6 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391752-411443 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.2;cervix: 19.0;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in some" "B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8" "Cell line enhanced" "Detected in some" "HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 2: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 3.1 0.4 0.1 15.9 0.1 29.2 3.2 0.1 0.2 19.0 0.2 6.9 7.6 1.5 0.3 0.9 0.7 2.5 1.0 0.1 0.1 0.4 2.4 2.2 23.2 0.3 0.1 0.6 0.1 0.0 0.3 0.1 0.2 0.5 6.8 0.0 4.5 0.4 0.2 6.8 10.2 0.7 0.2 17.4 7.2 1.1 0.1 7.0 1.1 0.1 26.1 6.3 2.4 0.2 0.4 0.0 0.0 0.0 22.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 221.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.8 0.0 0.0 0.1 0.1 1.2 0.0 0.0 26.1 0.0 200.0 0.0 0.0 0.4 0.0 0.0 0.2 32.0 0.6 0.1 0.3 0.0 0.0 0.1 0.0 0.3 177.2 141.3 58.4 0.2 0.0 109.0 0.1 1.8 0.0 0.6 1.5 0.0 10.4 1.0 1.0 10.6 10.8 1.7 0.7 0.0 0.3 1.5 12.1 5.8 1.5 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.2 0.8 0.0 5.3 0.0 57.2 8.3 0.1 0.0 0.0 0.0 0.6 1.5 1.2 1.5 0.0 0.0 0.0 0.0 66.8 0.2 0.0 0.1 0.0 0.3 0.9 0.6 0.0 0.0 0.1 0.7 0.0 1.8 1.5 0.4 0.0 0.0 1.1 0.5 0.3 0.0 0.1 0.1 0.0 0.6 109.7 0.2 3.4 21.7 44.4 0.0 56.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 235.6 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 1.0 0.4 4.3 0.1 29.8 0.0 0.1 0.1 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615983 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 38.2;lymphoid tissue: 33.2" "Cell type enriched" "Detected in many" 7 "dendritic cells: 576.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 12 "plasmacytoid DC: 596.9" "Lineage enriched" "Detected in all" 12 "dendritic cells: 596.9" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017694, HPA052757" Approved Supported Nucleoplasm,Cytosol No NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: AB_2681937" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 10.4 2.6 1.3 1.6 1.6 1.6 7.5 1.5 2.1 11.2 2.2 8.8 0.0 3.4 0.0 12.7 4.7 2.2 7.9 1.2 1.6 15.6 38.2 14.4 0.9 2.7 1.6 4.7 5.9 0.2 6.2 0.7 2.4 9.2 0.3 0.3 8.8 0.8 11.3 7.8 15.3 0.9 1.3 33.2 8.6 1.9 1.6 1.4 10.7 1.3 2.2 5.1 7.3 1.6 0.0 0.0 0.7 0.1 0.0 0.6 0.0 0.4 3.9 15.5 9.6 2.2 0.1 0.0 3.7 0.6 3.7 0.5 0.2 0.1 1.0 0.2 0.0 0.1 0.0 0.2 0.8 0.0 0.0 1.6 0.6 0.0 0.6 0.7 0.1 1.9 0.0 6.5 0.1 0.0 0.7 0.0 0.0 3.1 1.3 0.1 0.2 0.0 0.2 0.1 3.1 0.0 0.6 1.8 0.4 0.3 0.0 1.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.7 20.4 30.6 8.1 46.1 7.8 16.5 6.7 7.0 24.3 20.8 7.5 8.5 12.9 18.7 49.5 596.9 13.5 19.7 1.3 1.6 1.5 2.1 1.2 1.6 2.7 1.6 2.4 1.3 1.6 1.6 65.0 16.0 19.0 2.9 59.2 34.4 32.3 19.6 18.8 0.4 27.7 20.2 4.3 18.6 18.2 20.2 0.0 6.1 576.1 70.1 9.8 29.9 5.9 20.1 6.3 33.0 26.3 4.8 0.0 16.9 39.0 19.3 40.8 21.2 31.7 20.1 17.9 31.7 37.3 0.0 0.1 42.5 22.4 23.2 65.4 28.9 12.2 67.4 37.4 3.7 65.2 2.7 40.2 1.0 1.3 29.9 73.8 4.9 65.1 24.8 37.6 6.3 25.5 4.6 13.1 8.8 19.8 0.4 5.9 8.0 28.4 24.1 42.7 4.6 18.9 34.6 IRF8 "ICSBP, ICSBP1, IRF-8" ENSG00000140968 "Interferon regulatory factor 8" Q02556 16 85899162-85922606 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 85.5;lymphoid tissue: 244.1" "Cell type enhanced" "Detected in many" "B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "plasmacytoid DC: 2477.4" "Lineage enriched" "Detected in all" 7 "dendritic cells: 2477.4" "Group enriched" "Detected in some" 4 "Daudi: 240.7;THP-1: 382.3;U-698: 928.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002267, HPA002531, CAB013480" Enhanced Enhanced Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904" "unprognostic (2.09e-3)" "unprognostic (7.51e-2)" "unprognostic (5.16e-2)" "unprognostic (1.19e-1)" "unprognostic (7.54e-2)" "unprognostic (3.46e-3)" "unprognostic (3.19e-2)" "unprognostic (5.31e-3)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (5.31e-2)" "unprognostic (3.14e-3)" "unprognostic (3.97e-2)" "unprognostic (9.66e-3)" "unprognostic (4.04e-1)" "unprognostic (1.10e-2)" 25.9 7.6 4.7 81.4 5.6 85.5 9.3 7.0 6.2 5.6 5.4 27.1 47.1 8.0 3.1 6.7 6.5 19.7 3.8 6.3 5.4 6.1 36.9 27.4 244.1 9.5 8.5 2.5 3.4 1.7 1.7 10.1 10.0 7.7 33.5 0.8 7.1 8.9 2.0 5.0 56.2 13.5 11.3 137.3 22.9 4.8 12.6 61.5 4.1 1.7 224.9 21.8 1.6 14.0 0.9 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 26.0 0.0 240.7 1.5 0.0 0.0 0.1 1.4 0.0 0.2 0.2 2.7 0.1 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.5 0.0 0.0 0.6 21.3 0.2 20.6 0.0 7.5 1.1 27.2 0.0 0.0 0.1 0.1 1.0 0.0 0.2 1.4 0.0 382.3 0.6 0.0 10.9 0.2 0.9 0.3 0.3 928.2 0.0 128.4 0.0 9.1 137.1 3.4 3.3 134.3 4.5 347.0 1.8 2.1 291.2 361.3 3.5 2.8 8.4 111.5 97.3 2477.4 0.7 150.1 4.7 5.6 7.0 6.2 6.3 5.4 9.5 8.5 10.0 11.3 12.6 14.0 3.7 0.0 4.2 0.0 225.8 10.5 0.8 0.0 0.6 0.0 2.4 3.4 1.5 2.8 1.3 0.0 0.0 0.8 492.3 13.0 1.9 0.5 1.5 7.3 7.6 7.6 28.7 7.4 0.6 1.4 5.7 10.8 15.3 12.5 2.5 0.4 1.8 6.5 64.1 0.0 0.2 11.8 0.0 105.1 366.0 4.6 0.3 122.2 44.4 33.7 35.3 0.4 23.7 1.0 0.4 0.1 10.7 0.0 14.1 2.3 34.2 3.5 0.0 0.2 6.6 0.7 6.7 0.7 6.7 0.4 9.2 1.1 23.1 48.8 25.6 2.5 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.8;skeletal muscle: 4.0;tongue: 4.9" "Cell type enhanced" "Detected in some" "Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;hTEC/SVTERT24-B: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 1.1 0.8 3.2 0.1 5.4 1.6 0.5 9.4 2.7 0.2 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.7 2.7 6.6 0.7 0.2 0.4 0.0 6.3 9.8 0.5 0.1 0.0 0.3 0.2 6.9 0.3 0.0 0.2 0.2 0.3 4.0 0.1 0.1 0.1 4.0 0.9 0.1 0.3 7.8 2.3 0.1 4.9 0.0 0.3 0.2 4.6 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.8 0.3 0.0 0.1 1.0 1.1 0.7 0.0 0.0 1.5 0.2 0.5 2.0 0.5 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.4 0.5 0.0 0.9 0.4 0.7 0.3 0.3 0.9 0.2 0.2 0.1 0.4 0.4 0.1 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.2 5.4 9.4 2.7 2.7 6.6 6.3 9.8 6.9 4.0 7.8 4.6 0.1 0.0 1.1 4.6 0.1 0.0 0.0 0.0 1.2 0.0 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.3 0.0 0.5 0.1 0.2 0.0 3.8 0.1 0.4 1.2 1.4 0.0 0.5 1.3 0.7 1.1 0.0 0.6 0.0 0.1 0.0 0.0 2.0 0.0 0.0 1.2 2.1 0.0 1.0 9.4 5.3 0.0 0.0 0.0 0.3 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.4 0.0 0.0 0.1 0.0 0.8 0.2 0.1 0.0 0.1 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314461 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 7.7;thyroid gland: 6.5" "Cell type enhanced" "Detected in some" "dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 34 "plasmacytoid DC: 63.8" "Lineage enriched" "Detected in many" 34 "dendritic cells: 63.8" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 83.8" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.5 0.3 0.3 0.4 0.4 1.2 0.8 0.3 0.6 0.7 0.2 0.6 1.9 1.2 0.0 0.3 0.8 2.5 5.8 0.2 0.3 0.1 4.0 7.7 0.7 0.4 0.5 0.2 3.9 0.1 1.8 4.0 0.3 0.6 0.5 0.0 0.7 0.2 0.1 0.1 1.1 1.0 0.2 0.7 2.9 0.2 0.5 1.3 6.5 0.5 1.1 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 83.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 63.8 0.0 0.3 0.3 0.4 0.3 0.6 0.2 0.3 0.4 0.5 0.3 0.2 0.5 0.3 0.0 0.0 2.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 7.9 0.0 1.8 1.1 0.1 6.3 0.0 0.7 0.2 0.1 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.9 0.0 17.8 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.3 5.4 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 KDM3B "C5orf7, JMJD1B, KIAA1082, NET22" ENSG00000120733 "Lysine demethylase 3B" Q7LBC6 5 138352685-138437028 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016610, HPA057202" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 12: NES - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA016610: AB_1852004, HPA057202: AB_2683367" "unprognostic (1.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-3)" "unprognostic (1.34e-1)" "unprognostic (6.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.21e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.68e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "prognostic favorable (6.67e-4)" "unprognostic (1.73e-1)" "unprognostic (3.05e-1)" "unprognostic (1.43e-1)" "unprognostic (7.60e-2)" 21.7 19.4 22.6 16.9 23.0 25.4 25.3 22.2 22.8 22.7 21.1 23.9 18.6 23.0 28.3 21.2 24.2 14.2 20.0 21.3 20.7 21.4 14.5 19.3 23.0 23.4 22.7 30.8 20.3 34.2 16.5 20.5 21.5 21.8 24.0 36.3 22.2 25.9 41.5 28.1 23.4 20.8 21.9 26.0 21.6 19.4 23.9 35.9 23.2 27.1 29.4 24.8 19.9 21.8 24.3 32.4 65.0 58.7 27.2 23.3 47.0 15.6 27.1 30.0 33.5 35.7 27.2 46.3 27.9 30.3 41.0 24.3 53.2 37.8 32.6 30.3 29.3 39.2 28.6 27.1 25.4 32.2 43.3 26.9 39.0 22.1 26.7 23.2 34.6 29.3 31.8 26.1 34.3 30.3 46.4 41.0 31.0 34.1 13.7 53.1 48.5 30.9 40.4 31.6 32.7 35.9 27.0 28.0 25.7 93.2 27.3 43.5 31.9 17.9 17.4 19.3 28.8 32.8 16.7 40.2 12.5 45.6 25.6 0.2 2.9 4.2 2.3 2.2 3.2 2.3 2.7 3.0 2.5 2.0 2.5 2.3 5.5 4.2 2.3 3.0 1.7 1.3 22.6 23.0 22.2 22.8 21.3 20.7 23.4 22.7 21.5 21.9 23.9 21.8 22.8 16.0 15.7 43.1 22.1 15.9 13.7 15.1 20.5 21.3 29.1 29.5 33.2 17.2 17.0 22.0 29.2 13.4 24.0 26.8 0.0 16.0 6.1 22.8 19.9 18.9 21.0 25.4 40.9 16.8 10.7 18.5 17.9 24.2 13.3 26.3 18.2 23.0 17.6 23.5 39.1 26.4 18.3 39.2 18.3 2.8 21.1 27.9 16.0 50.6 27.0 17.3 16.5 41.7 56.9 19.9 28.0 23.0 16.2 21.2 20.9 16.1 25.6 31.9 26.3 21.8 18.7 13.0 15.5 26.2 21.6 10.9 19.1 17.1 24.6 21.0 KDM5A "JARID1A, RBBP2" ENSG00000073614 "Lysine demethylase 5A" P29375 12 280057-389320 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006201 Supported "Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear bodies" Cytosol "HPA006201: AB_1079160" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (4.46e-2)" "unprognostic (1.60e-1)" "unprognostic (3.53e-3)" "unprognostic (1.81e-2)" "unprognostic (5.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.77e-3)" "unprognostic (6.11e-2)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (2.60e-2)" "unprognostic (7.69e-2)" 8.1 8.7 5.8 11.4 8.3 45.5 11.1 11.6 8.5 8.6 10.0 8.2 7.2 9.7 7.1 8.9 7.6 8.0 5.2 6.2 6.5 7.8 9.9 8.8 15.3 6.8 5.7 11.0 9.4 10.1 4.2 11.8 6.5 8.6 9.9 9.6 6.7 7.3 5.5 12.5 7.3 9.4 6.0 13.5 8.8 21.1 6.7 21.6 9.1 7.6 14.4 8.7 7.2 15.0 14.4 25.3 18.3 14.2 16.1 15.2 20.3 12.5 16.5 18.4 19.8 15.2 17.0 24.0 3.9 21.0 16.0 13.3 19.2 14.2 21.9 37.9 15.9 29.3 26.5 9.0 13.0 38.6 22.1 16.6 13.1 22.6 29.9 18.8 18.8 21.0 17.9 32.7 15.7 9.7 27.9 11.0 28.4 12.3 7.9 25.7 47.5 11.4 8.8 32.6 7.0 20.5 24.5 11.0 13.0 25.0 11.9 24.0 26.0 12.0 17.0 13.6 21.1 11.5 13.6 53.7 15.5 16.5 18.0 64.5 21.8 44.4 31.4 25.0 32.3 27.1 24.6 25.9 22.8 32.0 26.3 22.8 63.0 35.8 28.9 32.0 20.9 22.5 5.8 8.3 11.6 8.5 6.2 6.5 6.8 5.7 6.5 6.0 6.7 15.0 53.1 64.1 61.6 61.7 80.6 33.0 22.2 30.1 48.9 69.0 35.3 27.9 38.2 31.5 39.0 35.0 116.7 48.8 103.3 51.3 3.9 37.4 96.8 60.2 72.8 51.6 69.7 51.3 71.7 31.6 34.7 47.2 39.8 99.8 54.4 106.9 42.8 30.9 30.2 87.5 59.1 40.0 40.7 52.5 37.5 32.5 48.4 63.9 26.6 57.1 82.9 48.3 105.0 68.3 85.9 38.7 37.0 55.7 73.1 32.4 33.6 11.8 40.2 71.9 59.2 64.0 59.9 137.1 104.8 50.1 47.6 71.1 80.1 67.5 40.1 42.0 KRT71 "K6IRS1, KRT6IRS, KRT6IRS1" ENSG00000139648 "Keratin 71" Q3SY84 12 52543909-52553145 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "skin 1: 100.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "CACO-2: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA049404 Enhanced NA NA 110000000 "Cluster 61: Skin - Cornification" "Cluster 39: CACO-2 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA049404: AB_2680748" "unprognostic (9.12e-2)" "unprognostic (2.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.14e-1)" "unprognostic (1.69e-2)" 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.6;retina: 29.6" "Cell type enhanced" "Detected in many" "dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 15 "plasmacytoid DC: 141.3" "Lineage enriched" "Detected in many" 31 "dendritic cells: 141.3" "Cell line enhanced" "Detected in some" "Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" Yes NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.3 41.7 1.5 96.6 2.3 0.9 11.0 51.8 8.8 3.7 2.2 1.2 4.8 6.3 0.4 10.6 3.1 0.4 39.1 14.3 0.8 0.2 0.9 5.7 47.7 10.1 21.9 1.2 0.7 6.3 0.1 43.7 2.3 1.2 29.6 1.1 3.8 0.1 0.7 1.3 3.9 29.1 1.8 1.4 0.9 35.3 1.4 0.9 0.2 5.2 0.7 1.2 13.6 0.1 0.2 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 469.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 86.4 0.0 0.0 0.1 0.4 0.0 169.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 21.1 0.3 4.2 1.7 0.0 0.0 0.3 0.2 4.5 0.0 0.1 9.5 0.5 0.0 0.0 0.4 0.0 0.0 141.3 0.0 2.4 41.7 96.6 11.0 51.8 39.1 14.3 47.7 10.1 43.7 29.1 35.3 13.6 0.5 0.0 1.1 6.2 3.4 0.1 0.0 0.0 0.0 12.3 0.3 4.3 0.3 0.0 0.0 0.0 8.4 0.0 78.4 0.0 0.0 0.8 5.4 0.2 0.7 0.8 0.0 0.0 10.0 0.0 0.0 8.4 0.0 0.7 0.0 22.2 0.0 0.0 1.3 60.6 38.9 0.0 0.0 0.6 0.8 7.5 0.6 3.5 3.6 4.7 5.4 3.9 0.0 13.0 1.5 0.4 0.0 0.0 5.5 0.5 0.0 0.0 0.0 5.7 0.0 0.3 13.9 0.6 1.1 0.0 0.0 0.0 0.9 23.2 0.1 0.0 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2;lymphoid tissue: 49.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 338.9;Inhibitory neurons: 308.5;Late spermatids: 231.5;Microglial cells: 429.1;Oligodendrocyte precursor cells: 318.7;Oligodendrocytes: 284.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 35.3;JURKAT: 37.4;MOLT-4: 131.3;REH: 31.6;U-698: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA047633: , HPA065246: AB_2685444" "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 6.5 4.3 13.9 7.3 38.0 9.7 6.3 34.6 25.9 7.8 37.4 5.8 6.1 12.4 0.9 3.9 11.3 4.6 16.6 10.7 16.4 4.0 10.3 4.6 6.5 46.1 33.2 2.3 3.3 2.9 6.9 6.2 38.6 8.6 2.1 7.0 3.0 5.3 15.4 4.2 7.2 5.7 27.3 5.6 5.0 9.2 48.2 49.3 4.4 9.5 3.8 5.3 5.3 39.6 0.2 0.3 1.4 0.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 2.7 1.6 0.8 0.4 0.0 0.0 0.0 17.1 1.7 35.3 7.0 1.2 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.4 37.4 0.4 0.7 0.0 2.6 131.3 1.1 2.9 0.3 8.9 31.6 0.1 1.2 0.0 1.1 2.4 3.9 0.5 2.2 0.0 1.9 3.8 4.7 2.4 1.3 11.5 0.2 1.9 5.6 0.4 26.1 0.0 6.9 6.4 12.8 7.0 2.1 6.5 7.7 5.7 5.2 5.8 5.6 3.9 4.4 8.2 7.6 12.1 9.1 8.5 5.9 3.4 4.5 13.9 38.0 34.6 25.9 10.7 16.4 46.1 33.2 38.6 27.3 48.2 39.6 19.4 3.2 4.7 143.3 79.2 10.5 2.7 0.8 0.0 5.4 26.0 16.9 18.4 0.0 5.0 1.8 70.9 0.6 21.0 6.8 1.9 5.1 135.2 16.3 22.0 16.6 58.7 7.6 338.9 3.6 0.7 16.5 13.3 7.8 23.5 7.6 25.0 24.4 21.1 0.0 308.5 9.1 2.0 27.4 160.5 231.5 11.1 56.2 14.2 429.1 13.6 4.7 3.1 318.7 284.9 0.7 2.6 24.5 11.7 13.5 15.6 2.3 13.7 18.7 6.6 2.3 9.7 5.4 4.9 0.4 7.7 1.6 66.0 0.2 8.8 3.2 LILRA4 "CD85g, ILT7" ENSG00000239961 "Leukocyte immunoglobulin like receptor A4" P59901 19 54333185-54339162 "CD markers, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 10.9" "Cell type enriched" "Detected in some" 26 "dendritic cells: 336.0" "Cancer enhanced" "Detected in many" "glioma: 2.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 21 "plasmacytoid DC: 176.1" "Lineage enriched" "Detected in many" 21 "dendritic cells: 176.1" "Not detected" "Not detected" HPA049418 Approved NA NA 12000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA049418: AB_2680756" "unprognostic (5.11e-2)" "unprognostic (1.21e-4)" "unprognostic (2.65e-2)" "unprognostic (5.94e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-3)" "unprognostic (7.62e-2)" "unprognostic (1.36e-3)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (9.30e-2)" "unprognostic (8.28e-7)" "unprognostic (2.12e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-1)" "unprognostic (5.86e-2)" 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.4 10.9 0.0 0.1 0.6 0.0 0.0 0.0 2.6 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 1.1 3.9 0.0 0.0 0.0 0.4 0.0 176.1 0.0 1.1 0.2 0.3 0.4 0.3 0.2 0.3 0.8 0.4 0.7 0.4 0.6 0.8 0.0 0.0 0.6 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 336.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.0 1.6 0.0 0.0 5.9 0.0 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.1 LY6G5B "C6orf19, G5b" ENSG00000240053 "Lymphocyte antigen 6 family member G5B" Q8NDX9 6 31670167-31673776 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA048307 Approved "Secreted to blood" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA048307: AB_2680348" "unprognostic (2.69e-2)" "unprognostic (1.52e-1)" "unprognostic (8.53e-2)" "unprognostic (1.44e-2)" "unprognostic (5.80e-2)" "unprognostic (9.85e-3)" "unprognostic (5.04e-3)" "unprognostic (8.34e-3)" "unprognostic (5.45e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-4)" "unprognostic (7.27e-3)" "unprognostic (1.98e-5)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (3.00e-2)" "unprognostic (3.98e-4)" 30.1 13.5 3.0 9.5 3.4 29.9 25.9 7.4 7.2 26.3 3.1 25.6 6.9 24.9 11.1 15.8 25.0 6.3 15.0 3.2 3.9 15.5 15.0 27.8 12.1 3.5 3.3 33.2 14.5 2.8 20.8 8.2 3.6 22.1 11.4 11.3 20.3 7.4 15.4 44.6 27.8 9.4 2.7 30.6 19.2 13.0 3.8 7.7 24.7 3.3 13.1 21.1 20.4 3.7 5.4 5.8 11.4 15.5 2.6 5.5 14.5 10.4 3.3 7.3 7.2 7.1 6.8 12.9 2.8 13.0 4.7 8.6 2.7 13.7 11.6 5.2 18.0 12.4 8.1 5.7 2.2 15.6 9.9 11.8 7.9 10.7 5.0 10.3 3.9 9.7 7.7 7.8 5.0 4.9 8.4 12.0 6.4 1.5 2.6 11.8 3.5 5.7 3.4 14.7 8.0 12.9 4.7 1.8 3.6 13.9 4.7 10.3 7.6 14.2 7.5 6.6 2.6 13.6 10.1 11.5 5.1 14.6 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 7.4 7.2 3.2 3.9 3.5 3.3 3.6 2.7 3.8 3.7 0.3 3.2 0.0 0.0 1.4 1.0 1.2 0.7 0.0 1.1 0.7 0.3 0.1 1.5 0.2 0.0 0.0 0.4 0.8 0.6 0.0 0.1 0.0 0.4 0.8 0.5 1.2 0.0 0.5 0.2 0.4 0.9 1.1 1.1 0.0 1.2 0.4 0.4 0.5 0.0 0.6 0.9 0.0 0.0 2.2 0.0 0.6 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.3 0.0 0.8 0.0 0.6 1.1 1.8 0.0 0.1 2.3 0.0 1.5 0.8 0.1 0.3 0.4 1.3 0.5 1.4 0.4 1.0 0.8 MALT1 "MLT, PCASP1" ENSG00000172175 "MALT1 paracaspase" Q9UDY8 18 58671465-58754477 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Immunity, Ubl conjugation pathway" "Hydrolase, Protease" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 88.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004494, HPA048432" Enhanced Approved "Nucleoli fibrillar center,Cytosol" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoli fibrillar center" Cytosol "CAB004494: AB_627909, HPA048432: AB_2680389" "unprognostic (3.25e-1)" "unprognostic (2.31e-1)" "unprognostic (3.64e-2)" "unprognostic (3.25e-2)" "unprognostic (1.65e-3)" "unprognostic (4.67e-2)" "unprognostic (6.46e-2)" "unprognostic (4.50e-2)" "unprognostic (3.33e-2)" "unprognostic (4.16e-3)" "unprognostic (3.74e-1)" "unprognostic (2.07e-1)" "unprognostic (2.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.97e-1)" "unprognostic (1.03e-1)" "unprognostic (6.00e-2)" 7.1 2.5 2.9 11.2 2.8 10.5 6.3 4.8 3.6 7.7 4.2 5.1 3.6 5.4 4.2 12.5 5.1 5.8 5.4 3.1 4.1 6.7 6.9 7.3 21.1 3.2 2.6 5.3 4.0 5.3 4.7 4.0 3.0 11.5 5.5 8.7 5.8 3.8 8.3 9.4 7.7 4.2 3.0 11.5 4.6 8.2 4.1 15.6 5.3 2.8 23.1 7.1 9.6 3.6 11.4 16.0 16.8 5.2 3.1 6.7 9.2 19.7 12.1 15.7 12.6 13.8 13.5 27.0 10.3 24.0 11.1 12.0 10.8 7.6 20.8 17.0 6.8 9.7 9.0 21.8 4.0 20.1 11.4 4.0 12.2 11.8 10.4 6.6 3.4 7.7 15.3 42.3 9.6 3.3 4.7 9.7 6.3 4.1 7.1 14.8 11.5 19.7 88.9 2.8 2.5 4.5 11.7 6.0 9.3 12.0 5.1 12.2 5.7 22.6 9.1 7.1 20.8 38.5 54.4 16.3 10.6 15.6 9.9 0.3 0.5 0.2 0.7 0.7 0.6 1.1 1.4 0.8 0.7 2.1 1.0 0.8 0.3 0.5 0.5 1.3 0.8 0.4 2.9 2.8 4.8 3.6 3.1 4.1 3.2 2.6 3.0 3.0 4.1 3.6 35.0 22.4 19.2 24.2 67.8 33.0 32.3 4.8 26.2 14.7 13.6 11.0 14.4 10.0 7.0 11.0 85.5 6.2 53.2 11.1 3.9 16.6 12.7 10.4 17.5 31.1 6.7 0.8 61.3 8.5 6.0 15.7 13.7 24.7 31.7 28.1 10.4 11.1 11.8 55.5 42.9 8.6 8.2 21.0 96.5 8.0 10.2 55.9 12.4 34.7 79.5 26.2 20.6 52.3 11.9 16.2 21.9 7.2 42.2 46.6 8.0 30.7 5.8 18.1 19.7 16.1 12.9 40.1 35.6 25.4 24.7 9.0 55.2 5.7 10.7 38.1 MAP3K2 "MEKK2, MEKK2B" ENSG00000169967 "Mitogen-activated protein kinase kinase kinase 2" Q9Y2U5 2 127298730-127388465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 11.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021540 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA021540: AB_2670742" "unprognostic (5.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.58e-1)" "unprognostic (9.46e-2)" "unprognostic (1.02e-1)" "unprognostic (5.76e-2)" "unprognostic (7.19e-2)" "unprognostic (4.50e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.97e-3)" "unprognostic (7.56e-2)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (2.11e-1)" 12.6 8.9 12.1 13.4 16.3 37.6 10.5 13.5 15.9 12.0 9.9 12.5 15.3 11.2 8.3 9.5 9.0 12.9 6.6 10.3 14.3 11.9 22.3 10.8 12.9 18.0 14.9 10.6 10.6 14.0 7.8 9.9 17.4 8.9 10.1 15.6 10.2 9.0 13.4 12.6 14.1 12.7 15.2 13.5 14.7 11.3 18.3 14.4 17.9 9.1 13.8 10.4 8.3 24.8 29.4 12.3 9.6 9.7 13.2 17.4 16.0 17.9 19.4 17.2 13.9 14.8 12.7 19.2 30.0 25.7 16.0 24.3 15.6 12.0 19.3 48.6 12.1 17.9 22.3 13.0 15.2 18.2 37.2 15.7 12.9 21.0 25.5 15.1 8.1 14.2 8.6 37.3 17.2 10.7 21.4 12.9 9.9 8.2 15.8 14.0 18.0 14.5 7.0 27.1 19.0 10.2 26.1 15.8 16.4 7.8 10.3 13.7 18.7 33.6 31.3 15.7 24.5 38.4 30.0 19.5 16.1 11.7 14.8 3.4 2.5 1.7 1.3 1.5 1.6 2.7 1.2 1.3 2.1 2.2 1.5 1.6 11.3 2.0 2.0 4.2 1.1 1.0 12.1 16.3 13.5 15.9 10.3 14.3 18.0 14.9 17.4 15.2 18.3 24.8 45.7 83.3 46.0 53.8 88.9 72.0 36.9 34.3 55.2 53.6 42.2 32.1 30.1 45.8 44.2 29.5 106.3 20.5 107.9 72.6 13.7 21.2 4.6 77.0 71.0 36.9 45.4 27.8 60.6 34.0 19.8 54.9 42.3 90.2 60.9 42.2 25.4 69.1 47.7 72.3 57.7 40.1 30.5 80.1 113.7 7.6 42.3 107.7 56.9 50.6 79.1 25.9 30.9 49.8 87.7 49.0 28.8 51.9 57.3 48.3 54.5 33.1 58.5 59.2 19.7 69.2 47.4 42.3 52.6 43.5 78.6 26.3 65.5 51.7 31.8 46.1 MAPKAPK2 MK2 ENSG00000162889 "MAPK activated protein kinase 2" P49137 1 206684905-206734281 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 21.9" "Lineage enriched" "Detected in all" 6 "dendritic cells: 21.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: AB_2679367, HPA063708: AB_2685100, HPA064435: AB_2685263" "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 61.9 80.4 34.8 56.2 39.1 174.6 50.5 36.9 33.9 47.3 38.7 50.3 65.5 53.3 24.1 55.8 50.8 52.5 190.1 30.8 36.6 79.5 66.8 79.3 57.8 53.1 42.1 44.8 53.8 38.0 63.3 25.7 43.9 42.8 35.3 17.6 54.9 33.1 196.7 54.4 61.7 45.4 40.1 78.3 68.2 46.9 45.2 45.6 47.7 94.3 54.4 63.5 46.6 38.6 85.4 33.1 44.8 50.6 128.4 75.0 55.1 57.3 130.0 86.0 80.7 63.8 40.4 40.6 38.8 116.9 54.1 63.0 33.8 61.7 61.4 46.5 25.4 69.1 41.7 41.3 99.0 102.3 219.5 104.1 77.3 82.8 91.3 71.8 71.7 54.1 79.7 180.2 70.5 105.2 41.2 73.3 51.5 29.9 45.1 103.7 94.0 13.5 64.9 51.5 35.7 45.7 68.0 114.2 83.1 83.0 55.4 97.2 68.7 77.6 64.7 91.0 79.7 232.0 220.6 33.2 87.8 60.9 26.0 1.6 0.8 1.8 1.8 1.4 1.6 1.1 1.3 1.7 0.7 1.2 0.6 1.2 3.7 2.6 1.3 21.9 1.8 0.7 34.8 39.1 36.9 33.9 30.8 36.6 53.1 42.1 43.9 40.1 45.2 38.6 49.2 54.5 49.9 15.7 27.9 85.4 52.3 18.3 20.5 12.4 61.4 37.8 102.5 37.1 26.8 31.3 20.9 6.4 185.9 51.9 15.6 30.6 76.2 32.2 40.9 43.7 61.7 15.4 4.7 58.5 9.2 33.4 32.1 46.6 34.9 24.8 19.2 40.0 24.8 0.0 10.6 38.1 16.2 34.6 82.7 36.1 22.7 60.9 33.8 13.1 23.7 21.7 74.2 8.5 17.4 61.6 34.4 17.3 69.6 67.3 22.2 25.0 14.4 16.0 26.3 36.9 48.5 13.7 10.3 31.5 72.0 16.6 46.0 19.2 30.5 75.0 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 35.9" "Cell type enhanced" "Detected in many" "Early spermatids: 65.4;Late spermatids: 67.4;Spermatocytes: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 4.5 3.8 4.4 3.8 4.0 11.0 4.1 5.1 4.7 4.0 4.0 4.1 2.4 4.3 1.8 5.2 3.2 2.3 3.2 5.0 5.1 2.8 3.7 4.0 4.9 5.2 4.7 4.7 3.9 3.5 3.6 3.2 4.7 4.2 1.9 2.0 4.5 2.4 6.9 6.4 3.6 2.5 3.6 4.7 3.6 35.9 4.5 4.4 3.1 3.2 4.6 3.9 4.6 4.2 11.1 4.2 3.8 8.3 4.8 3.8 11.1 6.3 4.4 6.7 6.0 6.3 6.5 17.6 6.5 4.0 2.1 8.2 5.9 6.3 4.6 13.0 12.2 6.9 4.2 5.1 4.7 7.9 6.3 4.6 6.1 5.7 5.9 4.0 3.6 9.1 11.5 20.7 4.2 11.1 8.4 7.4 9.0 5.2 13.4 8.7 5.8 19.3 4.0 4.3 10.0 5.4 5.5 5.3 6.4 2.7 3.9 10.3 4.5 8.5 6.8 10.4 8.5 14.3 12.6 14.4 6.0 10.4 5.0 0.7 0.1 0.1 0.5 0.3 0.1 0.4 0.0 0.2 0.2 0.7 0.3 0.0 0.3 0.4 0.1 1.4 0.7 0.1 4.4 4.0 5.1 4.7 5.0 5.1 5.2 4.7 4.7 3.6 4.5 4.2 13.7 3.2 12.7 11.4 11.8 14.1 5.0 3.8 11.4 4.2 14.3 12.2 1.1 2.8 3.0 5.5 10.4 6.2 15.8 5.9 3.9 4.4 65.4 12.9 7.7 6.1 2.4 5.0 8.6 4.0 11.1 7.0 5.6 16.6 1.3 5.8 4.2 5.6 5.0 5.0 7.6 4.7 2.0 8.5 10.7 67.4 6.5 9.9 1.8 1.9 4.9 6.0 4.1 7.1 8.5 6.0 3.0 3.8 15.9 6.7 3.6 2.0 3.5 6.4 0.0 17.7 8.0 54.1 19.4 11.5 10.7 16.8 11.0 6.1 5.1 8.7 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271231 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoli "Golgi apparatus, Cytosol" "HPA051222: AB_2681393" "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favorable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 29.7 22.5 15.6 18.7 17.7 43.6 23.4 16.9 16.4 22.2 12.9 24.1 12.6 23.1 8.2 28.4 18.2 17.3 23.0 15.1 16.5 24.5 17.6 25.4 33.2 17.3 17.2 14.2 27.6 21.5 11.8 12.3 18.4 16.4 15.1 6.0 19.9 14.4 63.2 32.8 25.1 16.9 17.4 35.7 19.5 17.9 16.6 24.5 16.6 26.8 27.0 23.7 21.6 18.6 25.6 43.5 8.9 20.3 17.9 5.4 12.7 6.2 19.1 13.0 9.5 14.4 29.8 38.7 11.7 11.9 14.6 19.8 13.6 24.4 10.5 19.2 27.3 20.2 16.5 14.1 19.9 18.9 20.4 4.8 37.7 8.7 39.7 17.7 27.3 44.7 25.7 50.0 3.6 47.6 58.6 39.0 3.5 29.0 21.3 36.6 11.3 58.6 29.4 14.1 11.7 17.1 13.9 34.5 33.0 23.4 65.9 41.2 9.7 5.6 13.8 7.2 12.1 67.8 17.5 33.3 11.7 31.3 8.7 27.5 77.6 44.4 54.6 41.1 56.6 49.3 43.0 47.9 91.4 44.2 37.1 39.9 13.1 56.4 55.4 226.4 68.3 60.3 15.6 17.7 16.9 16.4 15.1 16.5 17.3 17.2 18.4 17.4 16.6 18.6 33.2 0.0 11.0 3.3 30.5 11.5 14.8 11.1 5.2 3.8 23.8 23.4 4.2 31.5 15.3 12.9 0.0 15.0 73.4 12.1 21.5 45.2 32.6 11.6 4.7 20.1 15.6 11.1 3.0 43.4 9.4 12.3 9.2 12.0 31.8 13.0 17.5 9.0 44.9 1.7 3.1 18.0 28.5 47.4 45.1 19.8 9.3 45.4 16.0 7.5 47.7 30.5 53.5 5.0 8.2 24.8 22.7 15.8 22.5 14.3 22.3 29.3 17.6 6.0 19.7 13.0 22.0 19.6 22.1 23.2 18.9 9.3 33.5 7.4 16.9 14.1 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 71.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 36: HEL - Hemostasis" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoplasm, Nucleoli" "HPA047088: AB_2679927, HPA071690: AB_2686432" "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 7.3 7.5 9.4 9.6 12.0 30.0 8.4 5.4 13.0 7.5 19.4 5.8 4.8 7.8 5.0 7.5 8.9 6.9 8.5 19.1 13.5 22.5 6.5 9.6 11.3 9.7 11.3 7.8 8.6 12.5 4.0 8.8 10.0 9.6 6.3 4.9 8.5 5.4 6.1 8.8 5.4 7.7 12.9 8.8 8.1 6.0 8.1 20.0 11.0 6.3 10.3 6.9 5.3 15.8 8.2 6.6 24.2 19.9 12.9 16.2 20.2 24.2 13.2 13.3 11.5 8.8 15.3 45.6 11.5 21.6 9.1 5.7 15.2 20.3 31.9 25.1 5.5 71.5 7.4 6.8 12.9 15.6 13.8 13.5 10.9 14.9 12.0 14.8 15.9 23.4 45.0 14.5 21.3 8.9 49.2 9.7 8.0 5.3 8.5 15.6 23.5 6.1 22.1 14.1 8.4 16.5 10.6 4.7 32.9 12.9 10.9 10.0 19.3 36.6 18.9 16.8 10.0 9.2 3.4 19.1 12.8 11.5 17.2 0.3 1.2 1.1 0.5 0.6 0.4 0.1 0.2 0.2 1.7 0.2 0.3 0.2 0.1 0.2 0.4 2.1 0.6 0.5 9.4 12.0 5.4 13.0 19.1 13.5 9.7 11.3 10.0 12.9 8.1 15.8 11.1 25.6 19.1 42.4 8.9 17.8 6.0 6.1 18.8 3.3 13.7 8.8 17.4 5.7 10.2 44.1 18.8 5.6 31.5 2.6 9.8 5.4 0.8 27.2 16.0 12.8 37.8 99.1 38.4 4.6 5.6 12.1 7.1 25.6 10.8 24.5 9.7 7.1 11.2 6.7 36.5 8.9 4.1 29.2 39.7 1.6 4.4 33.5 10.6 65.6 45.6 6.0 8.2 41.7 12.1 9.4 2.1 8.6 6.9 11.5 1.4 17.1 16.9 4.5 26.3 8.7 23.0 6.4 9.0 15.1 17.0 5.7 10.3 23.4 6.6 9.4 MTMR6 ENSG00000139505 "Myotubularin related protein 6" Q9Y217 13 25246222-25287488 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (8.68e-2)" "unprognostic (1.50e-2)" "unprognostic (1.21e-2)" "unprognostic (2.31e-3)" "unprognostic (1.91e-1)" "unprognostic (9.19e-2)" "unprognostic (3.21e-1)" "unprognostic (1.45e-1)" "unprognostic (3.41e-2)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-1)" "unprognostic (1.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.18e-1)" "unprognostic (5.06e-2)" "unprognostic (1.30e-1)" 13.4 19.0 9.6 14.2 10.6 31.9 12.5 10.6 14.2 10.7 6.1 10.9 8.5 12.2 7.7 10.8 8.7 12.8 15.6 11.0 11.8 14.8 13.4 13.0 15.0 11.1 9.6 9.3 12.8 16.3 6.1 12.2 11.0 12.9 12.1 21.9 16.1 13.3 11.8 7.7 8.8 15.8 10.4 14.2 10.9 18.6 10.4 16.7 15.3 14.9 14.4 14.3 6.5 14.0 12.3 12.6 20.3 17.3 21.2 22.1 9.9 38.0 42.6 36.9 28.9 8.4 21.4 18.8 11.0 35.7 18.7 14.9 13.1 22.5 42.6 22.7 8.6 23.1 8.4 6.9 25.5 48.5 40.8 15.9 25.9 26.8 35.8 21.1 30.4 24.8 10.9 20.9 37.5 8.7 27.8 13.1 6.1 23.6 9.4 11.8 28.5 25.9 26.7 14.2 10.7 15.2 12.4 21.8 20.2 19.2 8.4 30.2 39.4 22.6 11.6 25.2 22.5 11.3 14.0 24.6 11.4 18.6 37.6 22.9 9.8 8.0 5.8 14.0 7.4 6.5 6.1 6.2 7.9 4.2 6.2 6.4 18.9 6.0 13.0 4.7 8.9 8.9 9.6 10.6 10.6 14.2 11.0 11.8 11.1 9.6 11.0 10.4 10.4 14.0 24.5 16.0 32.1 20.5 44.3 11.0 8.0 8.7 8.0 0.0 16.7 10.4 29.5 8.6 11.9 16.5 0.0 5.8 21.8 14.5 13.7 13.1 64.0 19.0 18.9 20.7 16.7 6.1 29.4 15.0 6.9 16.7 14.8 10.5 19.0 10.6 27.1 23.1 16.3 0.0 63.9 16.0 12.2 40.5 27.7 23.4 12.5 36.4 19.6 26.2 28.1 0.0 5.2 33.2 51.6 22.3 10.0 19.9 28.3 10.2 7.3 31.3 26.6 0.0 0.0 20.4 17.7 62.1 20.4 10.3 11.9 8.2 26.3 17.5 12.3 11.9 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716495 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 91.8;lymphoid tissue: 55.5" "Cell type enhanced" "Detected in many" "B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 34 "plasmacytoid DC: 91.5" "Lineage enriched" "Detected in many" 34 "dendritic cells: 91.5" "Cell line enhanced" "Detected in many" "MCF7: 763.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.6 0.6 0.1 24.2 0.1 91.8 1.6 0.1 0.2 1.1 0.2 8.6 7.0 1.4 0.1 10.1 0.4 1.0 0.4 0.1 0.1 0.6 1.1 1.8 55.5 0.1 0.1 0.3 11.2 0.1 0.2 5.7 0.1 0.5 6.9 0.0 1.6 0.2 0.1 4.2 7.8 2.1 0.1 27.8 6.1 15.6 0.4 33.3 0.5 0.0 53.5 3.5 2.5 0.1 195.8 121.8 105.4 109.6 1.0 3.5 136.2 87.0 29.0 265.6 194.6 600.2 118.8 393.6 49.2 37.8 55.8 116.1 192.1 59.6 98.8 74.2 124.1 183.2 118.7 164.2 0.2 168.6 121.7 2.4 5.1 101.6 22.9 5.9 72.2 189.6 188.1 470.3 23.8 763.7 346.0 236.3 121.8 155.4 105.4 237.3 216.3 222.1 49.6 39.7 96.7 140.6 255.6 253.3 26.1 110.4 167.2 183.1 34.0 16.3 264.3 118.3 151.5 162.1 363.8 606.5 34.2 142.3 103.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.2 0.0 91.5 1.3 0.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.2 0.0 0.0 0.0 33.0 4.2 0.8 0.8 0.0 0.0 2.5 3.4 2.0 1.5 0.1 0.0 0.0 14.4 32.6 3.4 0.0 0.4 5.9 0.9 1.3 1.8 0.0 82.3 0.4 0.9 32.3 4.8 10.2 2.9 0.0 18.9 0.7 1.4 13.5 0.0 0.3 5.1 0.0 2.4 2.6 14.1 0.0 3.2 1.8 0.0 0.0 0.0 1.0 0.0 0.5 0.7 1.1 0.0 139.6 0.3 0.5 0.0 0.0 0.0 0.0 0.1 3.9 7.0 33.6 8.2 2.4 3.7 3.0 1.2 8.6 2.4 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056850-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.3" "Cell type enhanced" "Detected in many" "Horizontal cells: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 1.0 0.7 1.4 2.5 1.2 4.1 2.9 1.8 1.6 2.5 1.7 2.2 2.4 3.4 1.9 1.8 1.8 1.6 1.1 0.7 4.2 1.5 5.8 1.6 3.6 2.1 1.7 3.0 4.2 1.4 1.2 3.6 0.7 2.4 2.2 2.2 3.5 0.9 0.7 1.9 2.2 0.8 1.4 1.9 1.9 1.8 4.0 11.3 3.5 1.0 4.1 2.1 1.4 0.5 2.0 2.0 12.0 1.9 0.8 3.8 9.5 2.2 2.5 1.3 2.7 3.9 4.0 10.7 4.3 2.1 2.2 1.5 7.7 2.4 3.0 3.4 2.3 4.8 1.5 1.8 1.9 13.0 11.2 4.3 3.3 2.1 4.6 0.4 3.3 10.0 10.8 4.5 2.5 1.9 26.8 6.4 6.0 1.6 1.7 15.4 14.1 2.5 1.0 4.7 4.7 8.3 2.2 1.6 2.1 7.8 1.5 3.8 4.5 1.5 7.3 0.9 1.7 7.4 8.0 7.3 1.4 4.8 3.0 5.1 0.8 0.4 1.7 0.9 1.8 1.2 2.3 1.3 1.4 1.7 3.4 1.9 0.2 8.2 0.9 6.5 1.1 0.9 1.4 1.2 1.8 1.6 0.7 4.2 2.1 1.7 0.7 1.4 4.0 0.5 9.6 22.4 24.4 19.2 18.2 12.0 14.3 5.1 18.8 33.0 12.3 11.2 12.3 11.5 13.2 22.0 27.1 44.2 36.7 9.0 0.0 6.0 4.7 17.6 15.1 11.4 19.3 22.5 16.5 12.6 12.9 15.5 12.2 20.7 5.1 36.1 6.8 20.7 12.4 72.3 47.2 17.1 10.2 16.3 24.6 4.3 9.9 24.0 7.2 36.5 17.9 12.4 27.8 44.2 3.1 11.4 10.8 3.8 36.0 12.4 7.3 3.6 8.7 22.6 13.1 17.9 6.3 22.0 24.3 13.0 13.1 27.0 28.4 30.4 8.5 9.2 N4BP2L1 CG018 ENSG00000139597 "NEDD4 binding protein 2 like 1" Q5TBK1 13 32400723-32428311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 23.8;JURKAT: 22.2;NB-4: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038971, HPA057219" Approved Approved Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA038971: AB_10673408, HPA057219: " "unprognostic (2.66e-3)" "unprognostic (2.38e-3)" "unprognostic (3.63e-2)" "unprognostic (5.32e-2)" "unprognostic (5.09e-2)" "unprognostic (3.40e-2)" "prognostic favorable (3.11e-4)" "unprognostic (6.91e-3)" "unprognostic (2.30e-1)" "unprognostic (9.37e-2)" "unprognostic (2.30e-2)" "unprognostic (1.20e-3)" "unprognostic (4.56e-2)" "unprognostic (1.04e-1)" "unprognostic (2.30e-1)" "unprognostic (3.29e-2)" "unprognostic (2.57e-3)" 24.8 11.9 34.0 14.9 33.8 49.5 26.9 32.9 41.1 23.7 32.3 20.3 15.6 19.5 16.1 11.2 26.3 12.6 12.4 34.2 36.2 15.4 85.6 30.2 26.6 29.0 31.1 45.2 20.3 8.6 37.1 13.5 28.4 21.7 14.6 7.9 12.4 11.6 13.8 27.5 21.1 13.0 28.9 30.1 13.8 4.4 37.2 32.0 17.0 9.7 17.9 16.6 20.5 32.7 0.9 0.3 1.3 0.5 5.0 4.0 0.4 0.6 2.2 1.2 2.0 3.8 5.1 10.3 1.4 1.1 3.7 0.1 3.7 0.3 1.6 15.5 2.3 23.8 1.4 11.4 7.8 9.0 1.4 2.8 0.8 1.0 1.0 9.0 0.8 22.2 0.0 18.3 1.0 0.8 18.6 61.4 1.9 0.0 0.5 17.5 0.6 8.8 4.9 1.8 3.4 4.2 3.7 0.1 1.7 2.4 0.5 16.8 0.4 0.5 0.3 0.3 0.1 10.4 6.6 0.5 0.6 3.4 0.7 59.0 49.3 13.9 18.0 47.2 15.9 28.6 17.5 22.4 43.7 33.0 23.9 20.8 12.5 32.1 34.4 56.0 27.9 36.7 34.0 33.8 32.9 41.1 34.2 36.2 29.0 31.1 28.4 28.9 37.2 32.7 46.1 44.8 27.6 53.2 51.4 30.1 29.6 8.7 23.9 10.6 26.6 22.6 4.3 17.2 16.5 5.5 0.0 22.3 74.8 5.5 9.8 15.0 22.5 23.0 5.7 36.1 37.9 25.5 71.7 8.5 1.1 26.2 6.1 4.8 8.8 16.0 21.0 67.2 22.5 0.0 60.4 9.2 24.4 46.6 102.7 22.7 27.4 54.6 30.2 40.3 110.2 7.2 47.4 72.9 43.4 4.4 12.5 22.2 38.4 24.5 25.8 9.8 8.1 2.2 78.9 48.9 40.4 1.4 2.8 15.2 35.4 10.4 44.0 2.5 12.9 16.5 NEK8 NPHP9 ENSG00000160602 "NIMA related kinase 8" Q86SG6 17 28725897-28743455 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040661, HPA040679" Approved Approved "Nuclear speckles,Microtubules,Mitotic spindle" Yes NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 7: Kidney - Transmembrane transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Microtubules "Nuclear speckles, Mitotic spindle" "HPA040661: AB_10794065, HPA040679: AB_10796226" "unprognostic (2.63e-1)" "unprognostic (4.57e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (6.25e-2)" "unprognostic (2.23e-2)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "prognostic favorable (4.52e-4)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (1.51e-3)" "unprognostic (1.55e-1)" "unprognostic (4.87e-3)" "unprognostic (4.61e-2)" "unprognostic (3.58e-1)" "unprognostic (1.75e-1)" "unprognostic (4.67e-3)" 1.5 3.1 1.7 3.3 1.9 1.7 2.4 1.4 1.9 2.5 3.8 2.4 3.0 1.5 3.2 2.5 3.9 2.0 1.0 1.4 1.6 9.1 5.2 3.3 5.8 2.0 1.7 1.9 4.5 2.9 4.4 2.6 1.7 4.0 2.2 0.6 3.7 2.6 0.5 3.1 4.2 1.2 1.6 5.8 3.4 3.8 1.9 2.7 7.2 0.4 5.0 2.6 2.2 2.3 2.1 3.4 3.5 2.8 1.9 2.1 10.9 0.9 2.1 1.3 1.7 5.4 5.0 13.1 3.5 2.8 2.5 3.8 5.2 4.8 1.3 3.5 6.4 2.9 5.8 10.1 3.3 1.8 3.7 4.8 1.8 2.5 5.8 1.8 0.9 1.9 4.3 1.3 1.5 4.7 1.9 3.4 3.3 3.7 1.0 4.9 2.3 5.9 7.0 5.7 6.4 1.5 3.0 6.3 1.6 4.7 9.3 2.4 0.8 1.3 2.2 1.6 1.0 1.5 1.8 8.9 2.0 1.6 3.1 3.3 0.9 1.2 0.7 0.5 0.8 2.8 0.6 0.7 0.1 4.2 0.7 1.0 0.4 1.3 1.1 14.8 0.5 0.8 1.7 1.9 1.4 1.9 1.4 1.6 2.0 1.7 1.7 1.6 1.9 2.3 2.7 9.6 19.3 3.9 22.9 2.8 9.2 8.3 7.4 2.8 10.1 14.1 1.7 12.8 11.6 25.8 8.4 17.6 19.1 14.9 7.9 5.8 9.5 12.8 6.0 2.9 10.3 7.0 0.7 6.0 9.2 3.9 6.1 15.2 26.6 3.2 3.3 9.4 3.9 1.7 0.5 14.4 10.2 5.0 2.7 2.0 3.4 4.4 3.6 2.8 4.0 2.6 3.1 1.5 1.6 3.9 17.2 2.6 7.2 8.6 13.4 4.3 14.3 1.8 0.0 11.7 3.0 19.9 11.4 8.8 1.6 11.1 4.9 7.8 15.9 4.2 NIBAN3 "BCNP1, FAM129C, FLJ39802" ENSG00000167483 "Niban apoptosis regulator 3" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7" "Cell type enriched" "Detected in some" 8 "B-cells: 11.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 379 "memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7" "Group enriched" "Detected in many" 476 "B-cells: 52.1;dendritic cells: 110.7" "Group enriched" "Detected in some" 19 "Daudi: 50.1;REH: 23.8;U-698: 33.2" "Not detected" "Not detected" HPA043277 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.4 0.0 0.0 10.7 0.1 15.4 0.1 0.0 0.2 0.1 0.0 0.8 0.0 0.1 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.5 0.3 0.4 26.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 16.6 0.0 0.0 34.7 0.7 0.5 0.0 1.8 0.6 0.0 12.2 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 52.1 0.0 0.1 0.0 0.0 0.0 110.7 0.0 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NLRP7 "CLR19.4, NALP7, NOD12, PAN7, PYPAF3" ENSG00000167634 "NLR family pyrin domain containing 7" Q8WX94 19 54923509-54966312 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Cell type enhanced" "Detected in some" "dendritic cells: 8.2;Early spermatids: 8.3;Extravillous trophoblasts: 5.7;Late spermatids: 14.8;Plasma cells: 5.2;Spermatocytes: 6.4;Spermatogonia: 5.6" "Cancer enriched" "Detected in many" 30 "testis cancer: 146.9" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 1.9;RT4: 1.0;SuSa: 1.5;U-266/84: 5.0" HPA051382 Uncertain Uncertain "Golgi apparatus" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA051382: AB_2681461" "unprognostic (2.15e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-3)" "unprognostic (1.24e-2)" "unprognostic (5.29e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.34e-1)" "unprognostic (3.25e-8)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 8.2 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 5.6 0.0 0.0 1.9 0.3 0.0 0.0 0.6 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease variant, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 411.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 35.3 11.8 15.2 22.6 18.1 49.4 25.5 34.0 24.7 19.7 18.2 13.7 19.2 18.8 13.6 25.7 18.8 21.1 24.2 14.9 25.0 19.2 39.8 31.9 25.6 18.1 14.9 21.1 14.7 33.8 16.2 46.9 16.1 19.7 14.5 9.5 16.1 20.0 45.0 20.4 18.0 23.8 15.0 24.5 16.0 11.1 21.6 40.0 25.6 40.1 27.3 18.2 16.0 28.5 30.4 60.6 4.4 0.1 38.2 42.3 5.2 46.5 55.3 39.3 45.1 4.5 39.7 26.8 20.8 68.6 46.0 28.1 0.3 36.6 48.3 15.2 21.0 6.9 77.0 13.5 35.7 28.1 20.6 30.8 46.3 64.7 62.5 49.0 15.0 12.1 10.3 98.8 35.1 10.9 16.7 20.0 11.9 5.1 13.0 6.0 41.4 58.0 11.5 2.1 8.0 6.1 81.3 11.7 19.4 4.9 5.3 39.8 35.8 94.7 18.7 45.7 35.9 20.1 19.7 41.5 49.7 28.5 33.6 67.4 21.3 38.9 18.3 24.2 15.1 15.9 18.6 17.9 28.5 22.3 17.8 17.2 68.4 23.1 23.6 25.9 12.8 17.3 15.2 18.1 34.0 24.7 14.9 25.0 18.1 14.9 16.1 15.0 21.6 28.5 152.3 67.3 69.1 71.2 134.1 58.8 35.9 37.9 79.6 13.1 39.0 55.8 43.4 57.2 41.2 25.8 16.7 48.9 158.3 22.9 17.6 30.8 165.6 8.1 30.1 82.3 28.1 55.9 411.4 33.3 39.5 112.2 23.9 10.4 89.3 7.5 63.5 193.9 53.2 37.0 169.5 4.1 10.2 66.3 99.2 144.1 63.0 97.4 53.4 241.7 87.6 34.6 83.4 240.3 237.5 35.9 17.9 71.5 115.1 46.2 25.3 67.9 37.9 65.0 151.2 181.9 105.0 24.5 40.1 57.4 56.3 36.5 204.5 12.6 12.9 14.3 NUDT17 FLJ34433 ENSG00000186364 "Nudix hydrolase 17" P0C025 1 145845630-145848954 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 15.1;Muller glia cells: 9.1;Spermatogonia: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 8.3;eosinophil: 17.5;plasmacytoid DC: 26.6" "Group enriched" "Detected in many" 9 "dendritic cells: 26.6;granulocytes: 17.5" "Cell line enhanced" "Detected in many" "T-47d: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030145 Approved Approved Centrosome,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" "Centrosome, Cytosol" "HPA030145: AB_10603883" "unprognostic (8.93e-3)" "unprognostic (2.28e-1)" "unprognostic (2.63e-3)" "unprognostic (8.72e-3)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.07e-3)" "unprognostic (6.55e-2)" "unprognostic (6.03e-2)" "unprognostic (1.24e-2)" "unprognostic (5.40e-2)" "prognostic unfavorable (1.81e-7)" "unprognostic (5.59e-2)" "unprognostic (1.63e-1)" "unprognostic (6.16e-2)" "unprognostic (1.96e-1)" 1.7 2.3 5.8 1.7 6.0 3.3 2.0 6.3 7.1 2.8 5.1 2.6 0.5 2.0 1.2 2.1 2.8 1.8 3.4 5.8 6.2 4.0 2.0 1.8 4.2 5.9 5.7 2.6 2.8 2.3 3.1 0.8 5.5 2.7 1.1 2.6 1.9 2.2 3.1 2.1 2.4 1.2 5.6 4.1 2.1 4.0 6.6 2.0 2.5 2.2 3.3 2.8 2.3 5.6 3.7 2.6 2.4 1.3 1.2 2.0 2.4 1.7 2.8 1.8 2.4 1.6 2.6 5.3 1.8 2.9 0.4 0.7 1.8 1.0 1.2 0.6 3.0 2.1 2.5 2.5 3.8 1.6 6.7 2.0 1.6 1.2 2.0 2.2 3.6 8.6 4.6 4.8 3.3 5.8 1.8 3.1 2.0 2.2 0.3 4.8 0.9 1.7 3.0 0.9 1.1 2.7 1.1 2.2 3.0 2.5 12.2 7.5 2.1 2.1 1.3 1.0 0.7 4.2 2.1 1.4 1.9 2.3 1.6 8.3 0.9 17.5 0.8 2.5 0.5 1.4 0.7 0.5 0.9 0.8 1.5 1.1 0.1 0.3 1.7 26.6 0.8 1.1 5.8 6.0 6.3 7.1 5.8 6.2 5.9 5.7 5.5 5.6 6.6 5.6 3.1 3.2 5.5 0.7 1.8 1.8 0.8 1.4 2.2 1.9 2.6 4.6 0.8 2.8 3.4 0.0 0.0 0.6 15.1 0.8 1.9 1.0 3.3 3.5 1.7 1.8 1.2 0.4 0.6 0.7 0.7 2.3 2.6 4.1 2.5 1.7 1.8 0.5 3.0 0.0 0.7 0.5 2.0 0.6 1.6 2.1 1.5 2.3 1.8 1.9 0.5 9.1 3.1 2.0 0.9 1.4 1.4 0.4 3.8 1.0 0.7 0.6 1.7 3.8 0.0 3.7 1.2 6.8 14.8 1.6 1.3 0.5 2.2 1.8 1.2 0.8 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533104-71575892 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Yes No "Cluster 39: Non-specific - mRNA processing" "Cluster 50: Non-specific - Ribosome" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595" "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favorable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavorable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.85e-7)" 59.3 55.9 39.7 38.3 42.4 61.5 62.7 43.3 51.6 72.7 40.1 62.5 30.6 56.0 62.2 52.8 76.4 26.4 55.5 43.9 35.5 61.6 45.8 70.7 71.9 36.1 35.8 85.5 102.4 24.3 46.9 26.4 37.9 75.4 39.6 36.9 64.1 27.1 62.8 68.6 86.4 24.5 36.1 122.8 67.4 19.0 36.2 57.2 70.7 39.2 57.8 55.7 67.4 44.3 40.5 37.0 47.1 41.5 49.6 45.6 31.6 30.3 54.3 32.1 49.1 39.3 45.4 47.9 20.7 37.3 33.3 49.1 52.0 29.5 39.4 41.1 53.4 30.4 98.6 28.5 37.6 62.9 48.1 43.6 59.2 35.1 65.7 55.5 30.5 100.7 31.1 160.4 31.1 34.3 48.9 75.2 31.6 35.5 49.8 47.8 52.7 62.1 50.0 45.9 24.1 21.2 46.9 30.9 30.2 35.5 22.8 42.4 35.5 34.6 27.9 36.6 17.9 43.5 33.5 56.5 24.4 65.0 21.6 2.8 4.6 2.0 7.5 5.7 6.8 7.4 6.3 6.2 6.1 6.2 7.2 7.4 1.9 10.4 5.7 6.2 6.2 5.6 39.7 42.4 43.3 51.6 43.9 35.5 36.1 35.8 37.9 36.1 36.2 44.3 31.1 35.3 85.2 52.9 67.2 88.1 37.9 23.5 58.6 26.5 49.6 34.0 42.8 20.0 31.1 49.7 8.4 15.8 130.7 31.1 9.8 14.4 2.4 32.1 49.8 39.8 34.9 51.3 110.7 14.4 8.5 47.5 54.6 53.3 27.8 26.4 45.7 27.5 16.1 40.4 94.6 37.3 22.4 60.9 69.7 4.8 53.4 45.8 35.6 71.2 51.6 11.3 51.5 92.0 97.9 17.6 34.9 29.7 147.2 53.8 34.8 15.1 28.0 21.8 32.9 44.8 42.2 2.5 6.1 63.3 84.1 10.9 82.1 62.0 34.0 50.8 OPN3 "ECPN, encephalopsin, ERO, NMO-1, PPP1R116" ENSG00000054277 "Opsin 3" Q9H1Y3 1 241590102-241677376 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.7" "Cell type enhanced" "Detected in many" "Early spermatids: 133.9;Extravillous trophoblasts: 252.9;Langerhans cells: 206.8;Syncytiotrophoblasts: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 10.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 72.4" "Low region specificity" "Detected in all" "CAB013682, HPA064443" Uncertain Approved Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "CAB013682: , HPA064443: AB_2685267" "unprognostic (2.41e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (1.75e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (7.12e-2)" "unprognostic (5.10e-3)" "unprognostic (1.24e-2)" "unprognostic (2.39e-1)" "unprognostic (4.96e-1)" "unprognostic (2.66e-2)" "unprognostic (3.44e-1)" "unprognostic (9.13e-2)" "unprognostic (9.15e-3)" "unprognostic (2.61e-2)" "unprognostic (7.12e-2)" "unprognostic (9.44e-3)" 2.6 2.2 5.0 3.4 5.5 1.1 3.1 4.1 9.6 2.7 3.2 6.4 1.6 3.8 4.4 4.2 4.5 3.1 2.1 5.8 4.3 4.2 11.0 8.4 4.4 3.5 6.4 2.1 1.9 1.4 2.7 18.7 3.4 1.0 5.5 0.5 2.3 1.3 1.8 2.2 2.9 1.8 3.5 4.5 3.3 2.5 7.1 4.9 3.2 4.0 5.1 4.2 2.9 5.3 4.5 15.0 10.7 0.8 38.3 72.4 8.2 8.0 6.0 5.6 5.6 1.1 12.5 0.6 0.4 9.7 6.3 25.9 3.4 5.7 5.6 16.7 0.8 0.0 3.2 9.5 19.4 3.9 8.3 37.0 15.5 3.5 8.4 37.7 11.5 13.4 7.6 2.3 9.1 2.4 1.4 5.0 29.1 19.3 8.0 6.3 0.6 14.6 38.5 6.7 2.8 10.9 5.0 15.6 4.6 21.5 0.8 14.9 13.9 1.3 1.0 2.2 8.6 5.3 8.7 0.7 4.3 12.4 16.7 0.0 0.8 0.7 0.0 1.1 0.0 1.8 0.1 0.1 2.2 1.7 0.2 0.3 0.3 0.5 1.1 10.0 0.2 0.5 5.0 5.5 4.1 9.6 5.8 4.3 3.5 6.4 3.4 3.5 7.1 5.3 3.7 6.4 5.4 4.9 35.5 14.7 13.5 12.7 18.8 3.3 12.4 10.5 0.8 15.7 7.0 12.9 0.0 80.6 60.1 41.4 13.7 16.8 133.9 10.5 5.8 5.9 4.2 15.1 56.7 10.5 252.9 7.7 12.8 22.2 2.5 22.4 8.6 26.3 26.6 0.0 15.7 8.8 20.3 31.9 206.8 89.7 11.1 56.9 28.4 9.4 30.2 4.3 5.2 10.1 7.2 19.3 10.8 16.6 18.4 20.1 7.6 21.5 2.7 2.1 0.0 5.4 13.3 7.8 8.3 29.7 12.4 171.6 6.4 6.6 7.1 15.2 OR5B21 ENSG00000198283 "Olfactory receptor family 5 subfamily B member 21" A6NL26 11 58507175-58508105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 65: Plasmacytoid DCs - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922024-48958386 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 10 "U-266/70: 1503.3;U-266/84: 407.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 37.7 44.8 42.9 36.9 44.9 56.7 36.6 39.2 45.5 40.6 33.6 45.8 39.6 43.0 29.9 37.5 41.4 24.7 29.9 44.8 46.1 41.1 39.5 39.6 43.4 44.2 42.8 46.8 37.7 35.6 46.1 26.4 46.0 43.1 21.7 30.2 36.3 32.0 39.7 44.6 47.3 27.0 38.3 60.7 37.5 24.2 44.9 47.0 42.3 25.2 35.8 39.9 36.7 43.9 53.0 77.8 36.0 88.9 59.2 52.3 41.4 45.7 52.9 55.9 59.8 39.7 57.3 58.9 29.2 56.8 49.1 63.3 54.2 45.7 51.7 69.1 65.0 44.5 79.4 45.0 49.3 43.4 48.7 58.1 41.2 58.2 39.5 61.4 44.7 47.8 56.9 90.7 40.0 52.3 67.7 89.2 64.9 19.5 60.4 53.0 52.5 77.4 38.9 46.4 34.7 60.7 60.2 38.7 61.7 82.7 51.6 39.2 64.2 36.5 46.2 97.2 38.1 1503.3 407.1 56.5 56.3 58.9 25.7 5.5 3.3 7.6 6.6 5.2 5.6 8.6 5.1 5.7 4.8 5.3 4.8 7.1 8.5 20.3 5.1 6.2 7.3 3.6 42.9 44.9 39.2 45.5 44.8 46.1 44.2 42.8 46.0 38.3 44.9 43.9 21.3 9.6 22.3 17.3 33.3 22.2 21.2 13.7 13.1 35.5 23.7 19.7 11.5 15.7 16.3 27.6 27.1 13.3 38.2 28.4 9.8 13.6 1.9 24.5 23.2 19.6 48.2 32.6 15.5 18.3 16.3 18.4 21.4 33.1 7.0 28.5 22.1 24.3 16.7 28.6 15.7 28.5 10.2 22.9 33.9 2.9 20.8 25.7 26.6 15.9 22.6 18.0 30.9 14.1 14.1 21.5 19.0 23.7 38.1 27.5 28.1 21.7 21.6 27.9 13.1 19.9 20.1 10.4 12.6 15.9 25.6 30.8 33.3 28.6 20.1 27.4 OTULINL "FAM105A, FLJ11127, NET20" ENSG00000145569 "OTU deubiquitinase with linear linkage specificity like" Q9NUU6 5 14581792-14616180 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 3.1 2.7 1.2 6.8 1.1 30.3 4.1 1.3 1.6 3.8 4.8 12.3 6.6 1.5 1.4 1.7 1.4 2.7 0.9 1.1 1.8 3.6 1.4 13.1 5.4 2.3 1.5 2.0 7.6 1.2 2.5 4.2 2.1 8.3 13.3 0.5 1.4 10.0 0.4 1.7 9.4 2.5 2.4 7.9 3.3 2.5 1.9 3.4 2.8 0.8 3.6 5.2 3.1 3.6 0.0 0.8 1.6 0.0 0.3 0.0 6.9 2.0 1.8 0.5 1.0 2.8 1.7 0.1 1.1 0.9 2.8 0.1 3.7 1.6 0.7 1.1 4.9 4.6 17.7 0.4 1.7 0.1 55.6 0.1 0.3 0.2 0.0 0.0 0.1 2.9 0.0 7.1 0.2 1.4 0.0 1.7 2.5 16.1 11.9 0.5 0.7 2.0 0.0 13.9 6.0 7.0 0.9 0.6 0.0 1.7 0.6 16.9 0.0 0.9 4.4 0.4 1.6 0.0 0.0 0.1 1.0 27.2 0.4 0.2 33.4 0.3 5.5 16.2 7.3 0.1 6.7 7.2 33.8 0.1 9.0 9.1 8.6 19.2 12.7 25.0 12.8 24.6 1.2 1.1 1.3 1.6 1.1 1.8 2.3 1.5 2.1 2.4 1.9 3.6 10.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 7.4 7.9 0.0 0.0 0.0 29.5 0.0 0.9 36.7 0.0 1.9 0.4 0.0 0.9 16.6 1.1 0.0 0.0 0.0 6.2 2.2 1.4 0.0 1.2 0.0 0.5 0.0 0.0 100.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 12.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 8.8 0.2 0.0 0.0 P2RY14 "GPR105, KIAA0001" ENSG00000174944 "Purinergic receptor P2Y14" Q15391 3 151212117-151278542 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.6;placenta: 31.7" "Cell type enhanced" "Detected in many" "Astrocytes: 31.0;dendritic cells: 54.4;Endometrial stromal cells: 35.5;Excitatory neurons: 41.2;granulocytes: 45.7;Langerhans cells: 61.3;Oligodendrocyte precursor cells: 29.1;Sertoli cells: 26.3;Smooth muscle cells: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "eosinophil: 230.1;plasmacytoid DC: 98.0" "Group enriched" "Detected in many" 9 "dendritic cells: 98.0;granulocytes: 230.1" "Cell line enriched" "Detected in single" 68 "HMC-1: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022646 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 19: Lung - Lung function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "CAB022646: " "unprognostic (9.78e-2)" "unprognostic (7.47e-4)" "unprognostic (3.89e-2)" "unprognostic (4.52e-4)" "unprognostic (1.69e-2)" "unprognostic (2.57e-5)" "unprognostic (2.68e-2)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (1.64e-3)" "unprognostic (6.30e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.72e-5)" "unprognostic (3.79e-2)" "unprognostic (6.89e-2)" "unprognostic (1.58e-1)" "unprognostic (2.58e-2)" 7.9 0.8 2.6 10.8 3.8 0.7 7.0 3.4 7.1 5.9 24.6 11.7 6.9 8.0 0.6 20.2 1.1 5.2 5.3 3.2 1.8 2.0 1.0 7.2 9.6 1.3 2.2 1.5 0.6 2.4 0.9 31.7 1.1 0.7 9.7 0.4 1.2 1.3 2.5 1.9 12.0 4.1 1.0 5.7 11.2 0.5 3.8 4.8 2.5 6.4 6.7 9.2 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 67.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 10.3 0.4 230.1 1.1 0.3 19.0 3.7 0.6 2.2 13.8 17.0 0.1 0.0 8.9 11.7 0.1 98.0 1.1 2.0 2.6 3.8 3.4 7.1 3.2 1.8 1.3 2.2 1.1 1.0 3.8 3.3 5.8 3.2 0.5 31.0 13.9 2.3 0.0 0.0 0.0 2.1 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.1 54.4 0.0 0.0 0.0 0.4 1.0 35.5 5.9 0.0 0.4 41.2 0.0 0.2 3.9 0.0 0.7 45.7 0.0 0.0 0.0 0.6 0.0 16.4 0.0 0.0 0.8 61.3 0.5 0.0 22.7 3.6 5.6 1.2 0.4 1.0 29.1 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.4 26.3 1.6 29.3 0.0 0.1 0.2 1.7 0.3 4.8 1.5 0.1 0.1 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144284-117176894 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA 250000 "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoli, Plasma membrane" "HPA051836: AB_2681630" "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavorable (9.44e-4)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favorable (4.25e-4)" "prognostic unfavorable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 23.1 34.3 35.1 21.2 42.2 41.2 20.6 43.9 45.0 20.8 28.4 21.7 22.4 23.8 22.7 23.9 20.9 19.9 28.2 33.9 45.4 25.3 23.8 21.7 20.7 47.6 45.0 23.3 20.3 21.9 24.5 25.4 51.0 22.3 20.0 23.2 17.4 16.1 15.7 22.0 19.4 20.4 48.7 20.4 23.0 30.0 43.6 21.5 31.9 20.3 22.2 26.9 20.9 51.6 43.4 48.5 54.9 79.7 60.1 41.7 42.6 71.0 61.7 38.8 35.2 89.2 92.9 46.6 99.4 85.8 38.7 67.7 80.6 92.0 50.9 41.8 31.1 120.0 41.3 57.9 53.8 42.1 44.0 46.6 71.7 77.4 96.7 42.4 64.8 25.6 65.0 34.6 60.3 27.7 40.8 61.7 50.4 60.0 37.8 44.9 62.2 51.2 59.8 66.7 60.9 80.5 82.2 61.6 28.1 46.6 68.4 35.6 103.8 70.4 46.3 34.8 51.4 10.8 17.9 61.5 28.3 78.8 60.4 63.4 51.4 48.6 39.0 58.7 46.4 43.8 44.7 41.0 37.4 41.2 45.8 49.2 63.7 33.1 66.3 27.4 35.1 53.1 35.1 42.2 43.9 45.0 33.9 45.4 47.6 45.0 51.0 48.7 43.6 51.6 48.5 28.9 34.8 17.9 41.4 122.4 44.5 45.9 54.7 38.6 55.4 32.1 37.6 58.6 32.8 66.2 47.9 40.4 44.4 48.0 46.9 61.3 13.1 63.6 54.8 64.8 82.6 39.4 29.2 39.5 86.7 40.8 33.6 78.4 19.0 36.8 79.6 47.0 43.0 47.1 32.5 41.8 36.7 65.4 175.9 13.7 45.4 52.1 49.8 20.6 59.3 36.2 21.6 13.0 61.2 99.0 50.5 34.3 28.9 67.0 33.7 54.8 32.9 38.3 13.1 42.8 40.0 54.7 84.7 53.2 115.9 54.6 41.6 35.2 45.4 50.6 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 153.1" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 13.9" "Lineage enriched" "Detected in all" 4 "dendritic cells: 13.9" "Cell line enhanced" "Detected in many" "THP-1: 90.1" "Region enhanced" "Detected in all" "olfactory bulb: 167.4" "Group enriched" "Detected in all" 5 "basal ganglia: 46.3;olfactory bulb: 161.9" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 10.9 56.0 10.4 12.9 14.6 6.9 10.0 17.4 13.2 27.2 7.0 47.9 6.8 9.8 20.0 11.8 14.2 22.5 38.0 7.2 15.0 7.1 18.1 13.0 8.0 19.7 21.0 58.2 18.8 153.1 12.6 6.7 19.4 30.9 13.7 28.0 11.8 28.0 8.5 19.4 14.3 22.6 18.8 12.8 21.5 8.2 15.3 16.7 35.1 5.7 6.9 20.7 21.9 21.7 11.6 11.0 50.0 43.1 13.1 19.1 8.5 29.9 16.8 19.2 14.5 14.3 21.1 11.3 3.6 22.1 20.8 8.5 28.3 12.3 38.3 12.4 20.5 9.7 7.9 5.8 17.2 9.6 15.5 9.5 13.7 14.5 10.0 45.3 23.1 7.2 0.4 10.3 43.5 5.9 10.0 4.9 35.8 14.2 7.4 18.9 73.3 1.5 15.6 6.4 25.9 45.1 20.2 3.8 9.4 18.8 15.7 90.1 26.6 40.0 10.2 23.8 57.1 7.2 12.8 11.5 19.7 15.2 20.6 2.3 1.7 2.2 0.8 1.4 0.9 1.0 0.9 0.7 1.9 1.5 1.7 0.7 1.4 3.2 1.3 13.9 0.8 1.0 10.4 14.6 17.4 13.2 7.2 15.0 19.7 21.0 19.4 18.8 15.3 21.7 7.3 9.6 16.7 17.9 10.0 22.7 10.3 3.0 6.8 7.5 11.5 8.3 60.3 2.8 8.6 12.9 37.5 0.6 20.7 1.3 7.9 13.5 15.2 1.1 14.0 11.9 11.5 6.3 44.3 2.5 0.9 23.4 5.6 1.5 16.5 9.4 9.7 12.6 15.3 42.1 19.3 5.7 6.1 29.0 23.7 11.4 19.9 22.9 7.2 91.8 13.6 11.5 6.2 136.2 192.2 3.1 12.1 11.3 3.8 13.0 0.9 2.8 8.5 43.1 0.0 5.3 13.0 33.7 16.0 10.4 26.3 0.4 10.5 8.7 3.4 8.7 PFKFB2 ENSG00000123836 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2" O60825 1 207034366-207081024 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 83.3" "Cell type enhanced" "Detected in many" "Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 20.8;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 8 "dendritic cells: 23.8;granulocytes: 20.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049975, HPA063575" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 54: Non-specific - Microtubule organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA049975: AB_2680977, HPA063575: AB_2685046" "unprognostic (1.30e-1)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.27e-1)" "unprognostic (3.76e-2)" "unprognostic (9.96e-3)" "unprognostic (9.74e-2)" "unprognostic (7.27e-2)" "unprognostic (2.27e-2)" "unprognostic (6.01e-2)" "unprognostic (1.30e-1)" "prognostic favorable (3.23e-7)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.63e-4)" "unprognostic (1.86e-2)" 4.3 6.8 13.2 8.3 14.5 23.5 6.4 8.6 15.2 9.1 42.5 22.2 32.2 5.0 11.6 9.6 5.7 5.8 36.0 13.9 11.4 29.7 4.0 13.3 7.0 13.3 13.8 5.2 16.0 15.3 23.1 3.9 12.2 4.8 24.1 83.3 7.6 4.1 49.5 8.1 22.2 5.0 9.7 15.0 15.5 7.0 19.3 20.2 51.7 42.7 6.7 4.2 4.2 18.4 15.0 6.5 4.2 7.3 8.4 4.1 6.9 2.1 2.5 3.6 2.0 16.0 21.1 2.7 3.3 3.3 10.8 20.8 3.1 7.9 2.1 0.6 3.2 21.1 17.4 5.9 7.0 0.0 14.2 5.9 11.7 3.5 19.1 4.3 0.8 8.7 14.6 0.1 2.0 4.5 3.6 0.6 5.8 7.2 9.7 0.0 0.0 0.4 4.9 15.3 6.6 4.0 13.7 22.8 17.4 4.5 15.6 1.8 0.4 0.0 7.6 11.0 1.9 6.6 7.0 1.4 8.8 0.0 3.9 1.6 1.2 20.8 0.3 2.6 0.4 1.9 0.2 0.4 1.1 2.3 0.5 0.6 3.5 1.6 1.9 23.8 0.0 0.7 13.2 14.5 8.6 15.2 13.9 11.4 13.3 13.8 12.2 9.7 19.3 18.4 1.0 6.4 54.8 105.1 5.0 15.2 3.8 5.0 10.2 7.0 3.7 4.2 79.0 4.3 8.7 16.5 0.0 0.7 24.6 53.8 25.4 5.0 51.0 18.0 3.7 4.2 6.0 0.8 14.5 7.6 0.4 4.6 14.8 21.3 9.5 2.3 2.5 5.8 5.6 3.3 13.0 20.1 8.2 13.6 4.9 158.2 2.8 8.5 21.4 11.2 5.4 9.8 5.2 4.5 10.6 16.6 26.2 3.0 3.8 13.5 45.4 32.8 15.3 110.5 0.0 3.3 3.1 5.1 3.2 9.9 11.6 1.5 1.6 7.5 36.9 11.5 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924713-104937761 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3" "Cell type enriched" "Detected in many" 7 "dendritic cells: 284.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 3621.6" "Lineage enriched" "Detected in all" 5 "dendritic cells: 3621.6" "Group enriched" "Detected in some" 4 "HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2900000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.4 1.0 5.1 5.7 4.7 13.4 1.5 7.0 7.1 1.0 0.4 0.8 3.8 1.0 0.2 0.6 1.8 2.4 0.5 4.5 7.3 0.8 0.5 1.8 11.3 15.7 6.8 0.5 1.1 1.2 2.1 0.8 10.3 1.7 0.5 0.5 3.5 1.8 0.3 0.6 5.1 0.5 13.9 10.4 2.8 0.6 9.4 2.8 0.6 0.0 9.4 1.9 0.4 16.7 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 127.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.1 10.7 0.1 0.0 0.1 30.0 0.1 85.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 191.5 0.0 0.1 0.3 0.1 0.2 0.4 0.0 0.1 0.2 1.6 0.3 4.6 43.0 699.5 1.0 188.4 1.9 222.7 0.8 1.2 545.8 198.4 1.7 0.4 9.8 25.4 297.9 3621.6 1.0 72.9 5.1 4.7 7.0 7.1 4.5 7.3 15.7 6.8 10.3 13.9 9.4 16.7 0.8 0.0 0.0 0.3 34.7 0.4 0.1 0.0 0.0 2.7 0.6 2.8 1.4 0.0 0.0 0.0 0.0 0.2 284.8 0.0 0.0 0.0 0.7 0.1 0.3 2.7 0.0 5.5 0.1 0.0 0.4 1.1 1.1 0.4 3.8 0.0 0.0 0.0 30.6 1.7 0.1 0.0 0.0 1.3 32.0 4.7 0.0 38.0 5.4 22.5 11.3 0.1 2.1 0.5 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.1 0.0 1.1 6.6 1.6 0.3 1.6 1.6 0.0 0.4 0.3 2.2 0.0 0.1 0.0 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 254.5;Late spermatids: 133.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 280.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011616, HPA049104, HPA069013" Enhanced Uncertain Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "CAB011616: AB_731977, HPA049104: AB_2680632, HPA069013: " "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.65e-4)" 12.4 17.5 26.6 13.5 27.4 51.3 27.4 82.3 35.5 18.9 24.3 12.3 10.8 12.9 19.7 26.5 13.2 17.4 26.1 28.1 29.0 18.0 33.9 14.2 20.2 27.1 27.8 20.4 16.9 18.8 26.7 11.1 28.9 24.8 13.2 18.0 30.3 11.3 85.3 23.1 10.8 10.6 27.6 17.2 14.0 53.1 30.2 24.8 14.2 70.0 22.2 30.8 18.9 28.9 40.2 23.5 40.6 80.4 21.8 20.7 33.8 25.2 29.3 41.5 37.7 33.1 46.0 36.4 31.1 16.5 43.4 20.0 34.1 29.5 50.3 23.8 36.7 26.5 18.2 45.3 34.1 18.6 280.6 18.8 34.4 30.1 35.4 51.8 32.1 77.2 58.4 22.4 40.3 23.6 78.0 52.6 54.4 48.4 26.7 44.2 40.8 31.4 78.4 32.1 22.7 41.8 29.9 19.9 79.0 41.4 52.5 31.5 17.8 19.1 27.0 48.8 24.6 32.5 58.4 52.2 19.3 39.4 52.2 47.6 15.1 48.1 12.0 18.8 13.3 12.2 12.5 13.0 15.7 11.1 14.1 13.3 63.6 22.2 26.3 84.9 19.3 11.5 26.6 27.4 82.3 35.5 28.1 29.0 27.1 27.8 28.9 27.6 30.2 28.9 13.9 3.2 13.6 6.8 20.2 16.8 30.1 14.2 31.3 2.9 14.3 15.1 21.6 7.2 20.7 7.3 8.4 7.5 51.9 3.1 5.9 11.7 254.5 13.8 7.7 12.5 6.0 7.6 15.8 9.6 7.0 9.7 10.2 9.9 23.4 12.7 8.6 12.7 7.4 6.7 20.3 5.4 4.1 5.7 9.9 133.9 7.2 18.2 7.2 19.7 11.2 8.3 13.4 12.5 16.7 33.6 5.8 3.8 21.9 41.6 4.3 6.8 16.4 4.4 0.0 6.6 12.3 19.4 15.4 27.3 20.0 11.1 16.2 7.8 6.6 31.6 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Mitochondria "HPA056821: AB_2683247, HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 13.3 11.1 6.8 4.0 5.0 2.6 12.0 4.8 6.3 12.0 4.5 13.3 5.5 12.9 0.4 14.6 11.2 0.9 13.8 6.1 3.5 10.1 12.9 13.8 3.0 9.0 5.8 10.8 10.7 2.9 8.4 2.5 6.5 10.5 0.9 1.4 12.3 2.2 25.0 16.0 14.5 1.3 5.4 16.2 11.9 5.4 5.7 7.3 10.5 10.9 2.4 12.2 12.7 6.3 8.0 17.0 6.7 10.0 7.7 1.6 16.4 16.4 2.7 7.9 5.9 28.0 10.9 14.4 33.6 5.9 16.9 11.8 14.3 4.8 0.9 35.8 31.3 19.4 19.5 11.1 10.8 21.3 33.6 2.4 8.7 7.0 3.0 8.3 12.2 26.8 19.5 5.4 6.1 22.8 16.3 16.5 8.7 13.7 8.2 18.2 13.7 17.4 3.2 19.2 24.5 6.9 26.8 9.6 16.8 6.0 7.7 10.8 17.3 12.8 15.6 28.5 14.2 17.0 9.4 18.6 9.5 14.3 11.6 3.3 4.3 6.1 5.5 4.0 4.3 2.0 4.6 6.8 6.0 3.0 3.7 4.4 1.8 5.0 3.5 4.1 3.3 5.3 6.8 5.0 4.8 6.3 6.1 3.5 9.0 5.8 6.5 5.4 5.7 6.3 15.7 12.8 11.9 11.4 17.2 12.2 11.0 10.7 9.1 7.6 12.0 10.3 19.0 11.5 9.5 11.0 2.1 15.0 33.8 17.2 9.8 10.4 1.3 8.4 9.4 12.4 5.4 9.0 12.9 10.9 15.8 11.9 21.4 11.3 8.2 14.8 14.6 17.8 12.7 3.3 9.9 24.9 4.1 18.5 14.7 1.5 14.3 17.2 19.6 8.4 21.8 6.1 30.9 9.5 11.9 11.4 15.9 10.5 16.8 17.7 10.5 7.5 7.8 6.4 6.6 13.3 12.9 9.2 11.1 11.8 11.9 21.8 21.7 14.8 17.6 15.5 PPP1R14B "PHI-1, PLCB3N, PNG, SOM172" ENSG00000173457 "Protein phosphatase 1 regulatory inhibitor subunit 14B" Q96C90 11 64244479-64246943 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 653.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 75 "plasmacytoid DC: 382.3" "Lineage enriched" "Detected in all" 75 "dendritic cells: 382.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053882 Approved NA NA 190000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA053882: AB_2682291" "unprognostic (1.36e-1)" "unprognostic (7.12e-3)" "unprognostic (1.74e-2)" "unprognostic (1.20e-2)" "unprognostic (3.74e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (1.75e-6)" "unprognostic (1.14e-1)" "unprognostic (9.87e-2)" "unprognostic (3.04e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (6.86e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.77e-3)" "unprognostic (3.43e-1)" 90.7 107.4 31.1 49.6 32.0 49.0 71.5 33.1 38.2 82.1 34.4 76.2 51.6 54.2 14.5 238.8 48.9 19.1 128.5 30.4 33.3 97.6 139.5 64.3 32.7 35.7 33.1 40.4 247.8 19.8 39.3 38.1 32.8 49.6 24.2 3.9 83.6 18.3 217.3 172.4 65.0 22.1 32.4 83.8 74.6 61.2 38.6 31.0 52.9 53.2 36.5 92.3 107.9 31.6 409.8 236.0 147.4 237.1 69.9 93.6 224.7 211.4 130.8 215.4 95.2 138.6 351.1 204.0 369.8 198.0 181.1 264.8 112.2 214.0 80.6 178.7 176.0 145.3 260.5 218.4 126.8 227.7 137.3 86.4 223.9 165.5 283.4 189.5 194.1 149.3 201.2 108.4 240.2 483.3 246.2 341.4 416.4 209.3 520.0 236.8 475.2 540.3 191.4 190.8 220.3 319.0 165.2 227.3 314.3 72.5 156.3 138.4 180.0 311.1 291.1 614.7 320.2 102.2 70.2 204.7 269.0 189.7 362.2 0.0 2.3 1.9 1.5 3.1 3.1 5.0 2.4 1.7 4.0 3.8 1.3 1.2 4.8 3.0 2.8 382.3 0.7 2.7 31.1 32.0 33.1 38.2 30.4 33.3 35.7 33.1 32.8 32.4 38.6 31.6 107.4 9.6 11.7 6.5 49.3 228.5 90.0 66.2 41.5 21.9 211.7 273.7 38.7 41.5 32.2 79.1 8.4 58.4 333.8 69.9 76.3 131.9 6.3 60.8 180.6 81.8 83.0 37.6 3.0 234.2 653.6 77.5 45.3 126.1 27.3 273.4 46.8 101.4 87.4 20.2 4.6 109.8 44.7 33.0 119.5 9.0 9.3 75.2 60.5 2.8 72.8 38.7 12.3 6.6 1.8 306.8 51.2 11.7 55.0 365.5 129.8 63.1 10.2 19.3 26.3 332.6 136.6 5.9 14.8 169.1 259.0 132.8 37.4 179.6 107.4 258.3 PTPN1 PTP1B ENSG00000196396 "Protein tyrosine phosphatase non-receptor type 1" P18031 20 50510321-50585241 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 227.6;monocytes: 207.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009329, HPA012542, CAB015217" Approved Enhanced "Endoplasmic reticulum" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" "Endoplasmic reticulum" "CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915" "unprognostic (1.67e-1)" "unprognostic (7.78e-2)" "unprognostic (1.48e-1)" "unprognostic (1.05e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-3)" "unprognostic (3.95e-2)" "unprognostic (2.40e-2)" "unprognostic (6.47e-3)" "unprognostic (5.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.66e-2)" "unprognostic (6.70e-2)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (2.58e-2)" 26.3 30.8 13.0 44.5 14.0 55.4 22.1 12.3 14.7 23.2 28.6 24.8 13.9 23.0 18.7 29.6 22.0 23.1 31.9 17.5 13.0 46.7 21.0 55.2 52.9 16.1 14.4 25.6 15.9 48.3 19.7 34.2 13.7 25.0 18.8 9.9 18.9 18.2 35.4 23.9 28.3 21.9 13.7 46.5 21.0 18.3 14.2 35.5 18.7 21.6 52.6 35.8 23.5 14.1 66.1 32.4 38.4 26.6 24.6 33.6 54.5 43.2 40.8 123.8 44.9 96.1 134.3 32.5 74.8 40.0 48.7 56.9 30.8 123.8 78.2 48.5 27.6 45.9 30.9 51.3 49.0 48.2 60.2 39.6 84.9 55.9 68.2 54.3 72.3 38.5 81.5 28.9 68.3 36.5 52.1 38.1 20.4 36.2 44.2 45.6 44.6 31.1 71.2 48.4 30.8 35.3 62.0 77.6 71.3 32.1 50.4 50.9 108.2 107.3 43.1 48.8 54.2 31.4 27.3 38.9 67.1 32.3 40.6 19.8 7.1 25.2 12.9 12.1 9.5 19.2 10.8 10.0 7.1 17.4 8.9 9.8 15.4 5.3 22.8 11.8 9.4 8.7 13.0 14.0 12.3 14.7 17.5 13.0 16.1 14.4 13.7 13.7 14.2 14.1 34.0 227.6 83.6 22.9 147.8 86.0 61.7 37.1 56.3 25.1 23.9 24.4 30.0 11.5 40.0 36.8 47.9 54.0 68.7 26.1 23.5 26.2 67.7 45.0 44.0 36.3 18.6 32.0 61.6 19.3 20.9 52.1 32.1 65.9 70.8 14.2 41.4 20.8 37.4 43.7 43.3 16.4 20.3 40.6 169.5 37.4 14.0 100.7 37.4 32.8 207.8 12.1 38.1 27.6 42.1 41.7 14.5 12.0 178.7 26.6 8.9 65.2 30.2 27.5 19.7 55.5 57.7 20.8 24.5 48.7 47.2 54.3 83.8 44.3 14.6 53.5 RANBP2 "ADANE, ANE1, NUP358" ENSG00000153201 "RAN binding protein 2" P49792 2 108719482-108785809 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway" "RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564" Supported Supported "Nucleoplasm,Nuclear membrane,Vesicles" NA NA 160000 "Cluster 38: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear membrane" "Nucleoplasm, Vesicles" "CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (1.28e-2)" "unprognostic (9.30e-2)" "unprognostic (5.47e-2)" "unprognostic (2.91e-1)" "unprognostic (4.02e-2)" "unprognostic (2.54e-1)" "unprognostic (4.23e-1)" "unprognostic (5.23e-2)" "unprognostic (1.62e-2)" "unprognostic (8.74e-2)" "unprognostic (3.08e-1)" "unprognostic (3.40e-2)" "unprognostic (2.53e-1)" 20.3 24.3 8.6 16.3 11.6 42.1 19.7 14.4 17.1 18.1 20.3 15.6 13.4 17.7 20.5 14.3 14.6 13.7 14.9 11.8 9.4 18.1 17.4 14.0 18.6 9.2 8.1 24.4 20.2 30.1 21.5 16.5 9.5 20.9 15.2 26.5 16.4 17.2 30.3 17.2 13.4 15.2 8.6 15.0 17.6 21.3 8.2 23.3 28.4 23.6 18.0 16.9 12.1 12.2 40.5 24.2 34.1 31.0 38.7 34.5 32.9 35.5 28.0 28.7 25.1 60.7 18.9 63.2 26.8 37.2 35.3 33.1 58.9 36.9 41.5 38.9 28.5 65.9 30.3 43.2 22.5 77.9 21.3 29.1 27.5 44.9 34.7 28.3 44.5 27.1 71.9 34.0 38.4 22.3 34.8 31.6 43.0 20.3 28.7 32.3 52.3 30.7 25.3 49.6 49.4 22.6 31.5 26.7 34.7 20.4 17.2 35.4 53.5 29.8 39.6 21.2 40.2 27.9 44.4 55.8 23.1 34.4 23.5 5.4 2.6 2.7 3.7 1.7 4.1 2.7 3.0 3.4 2.2 2.7 2.9 3.3 3.9 2.2 3.6 2.6 2.7 1.4 8.6 11.6 14.4 17.1 11.8 9.4 9.2 8.1 9.5 8.6 8.2 12.2 54.5 76.9 85.3 48.6 91.5 55.7 34.5 39.1 61.5 51.2 34.1 25.8 103.9 38.6 63.0 58.8 73.0 28.8 96.1 28.9 1.9 34.7 77.3 83.6 65.3 55.7 106.4 50.5 125.5 50.9 17.5 56.5 68.3 142.1 84.9 52.2 31.4 56.6 47.9 32.0 92.2 59.5 44.7 44.9 80.7 32.9 38.5 114.0 48.0 55.3 57.0 20.0 34.0 44.2 80.0 41.5 29.9 56.1 118.4 44.1 28.8 15.6 67.0 40.5 46.0 56.9 59.0 78.3 65.4 53.3 67.8 40.6 104.8 25.3 38.3 38.7 RBM12 "HRIHFB2091, KIAA0765, SWAN" ENSG00000244462 "RNA binding motif protein 12" Q9NTZ6 20 35648925-35664956 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043258, HPA043621" Enhanced Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA043258: AB_2678395, HPA043621: AB_2678584" "unprognostic (8.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-3)" "unprognostic (7.57e-2)" "unprognostic (1.04e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (7.96e-2)" "unprognostic (8.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.47e-2)" "unprognostic (3.34e-2)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (4.44e-1)" "unprognostic (3.92e-1)" "unprognostic (6.87e-2)" 24.5 20.2 2.6 28.7 3.5 30.2 22.6 23.2 8.0 18.2 7.6 24.5 20.3 28.6 12.4 23.4 26.6 23.7 18.4 2.9 9.6 17.7 18.5 22.9 39.9 4.1 4.1 39.0 19.9 25.2 13.9 30.2 3.7 23.4 24.1 27.4 19.3 19.3 19.2 17.6 20.2 28.5 0.9 27.0 22.2 23.0 6.2 50.6 23.0 17.2 44.8 36.4 17.0 10.4 87.9 57.6 121.3 74.5 29.1 57.0 74.5 47.7 56.1 65.5 64.0 80.4 60.3 157.5 51.8 96.0 68.3 60.7 144.8 121.9 83.3 74.8 52.2 132.0 56.6 54.2 50.0 145.1 67.9 82.0 61.7 75.2 49.7 41.8 73.9 84.0 128.1 73.9 58.0 64.3 172.8 40.8 88.4 56.7 59.2 104.2 149.0 77.0 47.0 142.2 63.9 82.9 85.1 66.0 64.3 99.2 85.1 52.4 104.9 54.8 81.0 54.3 71.7 79.7 93.4 165.3 48.3 55.3 72.9 6.7 10.5 8.9 11.7 11.6 13.6 12.2 10.4 13.7 12.7 11.5 10.7 9.8 7.5 9.9 9.8 8.1 10.1 11.5 2.6 3.5 23.2 8.0 2.9 9.6 4.1 4.1 3.7 0.9 6.2 10.4 22.6 25.6 24.1 0.0 28.7 29.6 23.8 17.4 19.4 15.8 19.4 19.3 22.5 17.2 19.2 3.7 27.1 21.5 35.8 17.1 1.9 14.9 4.8 20.7 24.0 18.7 24.6 25.2 0.0 17.8 18.5 22.6 11.2 24.9 26.6 31.5 20.0 14.0 18.5 8.4 0.0 20.4 20.3 24.6 20.6 4.8 14.6 25.7 16.0 0.0 23.7 13.5 21.6 0.0 0.0 21.0 14.6 16.6 22.9 18.5 15.0 9.8 25.3 14.4 6.6 28.0 22.6 15.1 17.4 21.8 29.5 17.5 29.7 18.7 19.8 27.8 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.7" "Cell type enhanced" "Detected in many" "Adipocytes: 30.5;Microglial cells: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 59.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 13.5 2.4 10.6 4.9 15.5 25.6 7.8 20.1 14.9 5.1 9.3 8.3 6.2 5.5 2.7 6.4 5.1 6.1 6.0 8.0 13.3 3.9 4.8 6.6 4.7 29.7 19.3 3.5 2.3 1.5 1.4 6.1 27.7 3.0 6.6 3.1 3.5 3.8 15.8 12.4 5.5 6.0 24.4 7.3 12.3 1.6 20.1 3.7 12.5 4.3 4.8 7.8 4.1 39.7 4.8 5.1 12.9 11.1 10.8 6.2 10.8 8.0 6.9 5.5 7.2 16.8 5.7 1.3 5.7 6.9 9.8 4.3 4.1 7.2 9.6 0.2 2.1 1.8 4.7 18.2 8.1 6.0 4.5 10.6 10.2 7.5 8.2 3.4 24.9 3.3 3.1 5.0 6.4 4.4 7.5 8.3 3.2 6.9 1.5 2.5 45.0 2.2 13.2 5.9 2.9 8.5 6.1 6.6 10.6 3.2 18.0 3.2 29.6 13.8 8.7 10.1 9.5 2.5 2.6 7.3 11.7 12.8 11.4 0.8 15.2 27.4 5.1 5.7 6.3 0.7 6.2 4.9 8.5 0.2 5.3 7.0 59.3 7.7 5.5 9.8 5.5 5.1 10.6 15.5 20.1 14.9 8.0 13.3 29.7 19.3 27.7 24.4 20.1 39.7 30.5 9.6 3.1 16.3 2.9 3.3 2.5 1.7 10.8 0.4 8.1 9.5 2.1 5.7 3.9 0.0 0.0 1.4 9.8 8.4 0.0 3.1 6.5 5.5 9.9 14.4 1.2 3.4 3.3 8.6 3.6 10.7 22.4 2.4 2.5 0.5 6.4 0.9 2.6 3.3 2.4 1.6 0.0 3.2 2.7 8.1 3.7 9.2 1.8 36.5 4.1 4.0 0.0 22.6 12.5 10.3 2.9 6.0 15.5 2.7 6.7 0.2 3.3 1.4 13.1 18.8 16.4 0.8 0.3 5.5 4.7 5.2 10.6 5.1 1.1 3.8 RREB1 HNT ENSG00000124782 "Ras responsive element binding protein 1" Q92766 6 7107597-7251980 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001756, HPA034843" Approved Supported "Nucleoli fibrillar center,Nuclear speckles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear speckles" "Nucleoli fibrillar center" "HPA001756: AB_1856477, HPA034843: AB_2674357" "unprognostic (1.69e-1)" "unprognostic (3.16e-2)" "unprognostic (2.93e-1)" "unprognostic (5.05e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-3)" "unprognostic (2.53e-1)" "unprognostic (1.32e-2)" "unprognostic (2.45e-2)" "unprognostic (6.51e-2)" "unprognostic (3.31e-2)" "unprognostic (1.16e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.92e-1)" 10.9 12.1 4.3 7.8 3.6 31.6 10.8 4.4 2.2 10.2 12.5 10.8 11.9 7.8 5.6 26.2 8.7 6.4 8.3 2.7 4.2 8.2 18.3 9.1 6.5 9.1 6.6 9.8 18.1 12.2 6.3 8.1 6.5 8.1 9.8 5.7 15.0 6.2 16.6 16.2 13.1 6.2 5.4 10.7 10.7 11.6 7.6 9.2 12.0 7.9 7.9 7.9 14.2 5.5 13.1 12.3 10.3 11.9 9.5 6.3 40.1 5.2 7.3 6.2 7.6 20.3 10.0 6.6 10.9 9.9 6.9 9.3 14.7 16.5 5.9 9.2 11.3 24.8 9.6 23.5 13.1 15.0 18.5 10.5 12.7 9.3 13.8 4.2 7.5 15.2 44.6 0.1 6.5 16.5 8.8 35.2 4.9 10.6 10.0 13.1 12.4 10.4 9.0 25.1 2.8 2.6 12.4 16.0 11.1 15.3 12.3 31.0 13.0 11.4 7.1 8.8 6.4 4.1 4.7 9.0 3.3 11.4 9.3 5.5 2.7 6.6 1.5 2.1 1.3 2.2 1.0 1.0 1.7 1.0 1.6 1.3 2.0 3.3 2.4 5.7 0.5 1.7 4.3 3.6 4.4 2.2 2.7 4.2 9.1 6.6 6.5 5.4 7.6 5.5 39.3 25.6 28.7 44.4 19.0 31.5 22.4 30.1 27.9 0.9 27.0 16.9 24.2 31.5 31.4 36.8 70.9 25.8 31.9 62.7 7.9 14.7 46.2 35.5 24.7 22.5 31.8 31.1 3.9 16.3 32.8 16.3 30.1 63.0 10.1 20.7 30.7 70.4 33.4 0.0 0.7 35.7 14.2 66.1 54.9 9.0 19.9 42.1 23.2 78.7 32.6 9.5 13.4 2.0 0.9 22.3 36.3 19.2 27.7 37.1 34.5 16.8 23.9 27.5 52.6 25.5 15.2 13.7 17.4 48.9 34.7 45.8 15.7 27.4 45.0 54.3 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102238961 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.5 21.2 10.5 11.5 12.1 7.1 12.1 13.6 11.5 12.5 26.5 15.3 15.0 11.6 15.1 11.2 13.5 11.9 16.7 10.1 13.7 24.4 22.6 22.0 20.1 13.6 12.4 12.0 13.5 45.0 10.3 13.8 13.9 15.7 15.5 21.9 10.9 13.8 30.4 11.0 10.1 11.7 14.1 14.3 9.5 9.7 12.6 10.1 39.9 34.9 19.6 11.2 5.4 16.8 15.3 26.5 30.7 18.3 43.7 41.3 24.6 34.8 41.4 18.1 21.0 9.6 11.9 97.5 31.8 38.7 18.5 5.7 15.1 35.2 25.3 15.8 16.2 24.4 10.3 20.9 35.3 7.6 50.0 53.1 66.1 20.2 30.5 43.0 51.8 16.3 18.2 14.6 59.1 15.2 13.1 14.6 17.7 16.5 19.2 8.2 12.7 20.1 43.1 17.1 7.8 15.4 17.9 9.7 21.1 76.3 25.5 17.1 39.4 27.8 53.7 19.6 9.6 15.3 15.3 88.0 41.0 11.5 30.2 15.7 6.3 7.0 2.7 5.4 3.8 6.6 2.3 3.2 7.7 8.6 2.6 2.8 23.1 4.1 11.5 2.2 1.8 3.3 10.5 12.1 13.6 11.5 10.1 13.7 13.6 12.4 13.9 14.1 12.6 16.8 16.2 57.7 29.3 10.1 33.5 19.4 8.2 11.8 34.1 13.5 17.0 9.4 22.8 20.0 23.9 40.5 14.6 13.8 13.9 7.3 25.4 6.8 2.3 36.2 11.1 14.9 29.4 3.8 14.6 8.2 5.9 14.8 6.1 11.8 11.4 11.2 18.5 23.6 12.6 10.1 17.6 9.7 10.2 26.2 39.5 1.4 14.3 23.8 17.8 20.6 18.2 24.5 7.2 16.1 12.1 5.7 5.7 14.7 9.3 10.7 8.1 22.7 39.9 18.3 6.6 16.2 16.8 13.2 14.5 26.2 18.5 4.8 12.2 8.6 12.1 6.7 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "Rubicon autophagy regulator" Q92622 3 197668867-197749727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 67.5;Plasma cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Vesicles, Cytosol" "HPA050908: , HPA054497: AB_2682507" "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 8.3 7.5 16.2 11.6 16.3 8.5 7.2 10.5 17.0 9.2 4.4 10.4 7.3 8.8 4.0 12.0 8.5 7.2 11.4 17.0 19.0 7.7 5.6 11.8 15.3 20.0 17.8 10.7 9.1 6.8 15.8 5.8 15.9 7.4 5.7 10.9 7.3 7.2 8.9 9.1 13.1 7.8 14.5 19.2 8.1 14.6 23.7 8.8 7.1 8.1 16.1 8.9 8.4 17.4 30.9 7.4 8.2 16.2 14.4 8.3 8.6 13.8 9.2 17.0 14.2 12.7 8.4 33.6 26.7 15.8 16.1 17.0 15.0 8.0 13.6 9.3 13.9 21.6 13.4 4.9 8.4 12.0 18.0 7.0 9.6 14.8 17.6 7.9 10.7 14.4 12.3 87.7 11.5 24.4 15.7 7.5 7.1 8.8 23.2 14.9 8.6 22.6 9.6 13.9 34.3 7.9 10.2 19.8 10.8 5.5 29.2 8.1 13.7 9.9 9.9 27.8 18.9 36.5 34.2 27.0 13.6 22.4 8.7 0.8 2.6 17.5 3.7 3.9 2.4 7.7 3.1 4.7 1.6 8.5 2.2 3.2 2.9 1.8 4.8 16.6 4.4 1.7 16.2 16.3 10.5 17.0 17.0 19.0 20.0 17.8 15.9 14.5 23.7 17.4 8.5 6.4 11.2 0.0 33.9 0.0 6.0 0.0 8.0 21.0 7.3 7.0 0.0 7.2 4.3 12.9 18.8 1.8 28.9 3.8 1.9 5.8 21.7 4.8 6.2 6.7 0.0 5.7 0.0 6.4 3.7 4.8 7.1 9.8 2.5 6.1 9.3 3.5 9.2 21.9 0.0 3.7 0.0 16.3 0.0 16.4 5.0 18.7 0.0 0.0 67.5 15.0 14.4 0.0 0.0 8.5 1.5 6.4 48.3 8.9 5.8 2.7 0.7 14.3 6.6 9.7 6.8 34.1 21.3 5.6 0.0 6.4 15.9 4.9 2.8 12.3 SEC61B ENSG00000106803 "SEC61 translocon subunit beta" P60468 9 99222064-99230615 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 1573.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049407 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "Endoplasmic reticulum" "HPA049407: AB_2680750" "unprognostic (1.11e-1)" "unprognostic (5.99e-3)" "unprognostic (3.46e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.96e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.09e-1)" "unprognostic (6.67e-2)" "unprognostic (1.87e-2)" "unprognostic (2.90e-2)" "unprognostic (7.07e-2)" "unprognostic (1.22e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-1)" "unprognostic (6.87e-2)" "unprognostic (2.75e-1)" 173.5 235.8 101.0 154.7 104.0 255.5 153.4 104.3 120.8 179.4 105.3 139.3 155.0 167.7 259.4 169.8 155.0 129.8 106.7 104.4 110.8 213.7 465.3 169.0 184.0 104.5 102.1 158.5 546.0 145.9 209.5 98.3 105.8 168.0 102.8 48.5 347.7 124.3 61.0 122.5 132.9 106.3 106.8 173.1 186.5 76.4 103.8 188.8 179.8 44.2 146.7 148.8 139.1 111.6 226.5 213.3 244.1 243.7 234.5 296.0 293.9 327.6 335.8 299.9 259.2 307.3 172.6 305.3 244.3 298.7 328.9 272.0 171.9 259.5 143.1 325.4 238.7 160.7 200.7 440.3 509.9 278.9 198.3 268.0 389.4 237.3 210.3 268.1 369.8 246.7 255.0 581.1 285.6 407.7 255.6 404.9 196.3 533.9 497.7 244.2 207.7 398.1 332.3 158.3 252.7 179.2 183.6 421.1 441.5 190.8 163.4 378.6 265.1 215.3 260.0 363.5 277.7 312.0 226.6 200.7 359.3 176.6 145.6 875.3 460.3 453.3 354.6 387.9 480.8 356.5 389.3 360.4 481.0 257.1 242.9 267.7 388.5 325.7 350.8 1661.8 388.0 525.0 101.0 104.0 104.3 120.8 104.4 110.8 104.5 102.1 105.8 106.8 103.8 111.6 255.6 102.5 206.1 18.3 370.9 395.8 308.3 712.8 213.9 59.3 499.1 530.7 55.5 271.7 416.8 200.5 31.3 336.6 605.9 239.9 633.9 498.6 184.2 274.7 410.2 286.1 302.0 226.8 16.2 792.5 577.9 343.2 214.1 391.3 214.8 258.8 213.8 822.0 509.8 53.8 15.5 534.0 406.9 295.3 553.2 51.8 328.0 316.3 496.2 17.8 1573.9 197.3 284.2 15.6 25.9 633.4 280.0 304.3 1190.6 654.2 290.3 767.6 331.4 81.5 138.1 237.1 404.7 218.4 171.0 337.5 443.4 553.8 270.1 333.0 334.0 501.5 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747433-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 128.3" "Cell type enhanced" "Detected in many" "B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 82.1" "Group enriched" "Detected in many" 4 "memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2" "Group enriched" "Detected in many" 4 "B-cells: 42.0;dendritic cells: 38.2" "Cell line enhanced" "Detected in many" "Daudi: 287.9;OE19: 217.9;U-698: 187.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 100.4" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 9.3 5.5 8.7 61.5 11.3 13.6 9.3 82.1 11.1 54.0 8.7 72.1 82.0 7.9 68.8 8.7 11.0 53.6 5.3 12.5 4.2 14.5 11.6 40.7 124.8 2.8 5.2 5.6 48.5 45.5 3.7 37.5 4.7 18.9 68.8 35.2 38.3 4.0 2.9 2.9 72.4 7.8 2.9 63.2 104.8 6.6 8.2 18.7 10.9 2.8 128.3 42.4 2.2 5.9 21.5 23.0 16.7 5.6 2.7 3.3 2.6 10.4 28.3 7.9 25.2 14.6 97.0 287.9 48.9 72.0 66.7 13.3 12.4 45.1 10.6 15.7 7.2 3.3 35.4 19.6 70.0 40.1 2.0 5.7 35.8 27.8 10.9 31.3 105.7 5.8 19.3 0.3 5.6 16.2 0.1 2.8 48.2 217.9 20.1 1.5 91.3 40.6 60.9 71.2 41.0 8.0 69.2 1.0 7.1 23.0 3.3 49.0 46.6 0.5 32.6 0.6 30.6 1.8 0.5 187.9 125.0 16.7 19.3 0.9 0.2 0.0 5.7 0.0 6.8 42.0 7.0 6.4 1.4 41.8 3.0 4.8 0.7 8.0 0.3 38.2 9.6 3.3 8.7 11.3 82.1 11.1 12.5 4.2 2.8 5.2 4.7 2.9 8.2 5.9 13.2 12.8 36.0 57.1 114.7 0.9 3.4 16.8 1.2 4.0 1.6 0.9 1.8 61.5 51.9 3.7 0.0 30.7 71.0 46.3 0.0 64.9 60.8 6.0 1.5 11.5 11.5 10.5 40.1 33.2 1.3 2.5 71.9 19.3 2.5 3.4 13.6 4.2 4.9 0.0 26.6 92.6 22.4 23.1 4.6 78.3 1.5 14.4 8.8 4.7 14.6 33.2 10.3 128.7 1.4 38.3 22.6 0.4 271.7 13.6 46.9 10.7 24.2 32.8 0.0 0.8 4.7 0.7 2.5 0.7 1.6 16.4 27.8 0.2 36.8 6.1 SELPLG "CD162, PSGL-1" ENSG00000110876 "Selectin P ligand" Q14242 12 108621895-108633894 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 86.6" "Cell type enhanced" "Detected in many" "dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5" "Low region specificity" "Detected in all" "CAB002431, HPA011256, HPA069062" Enhanced Approved Vesicles NA NA 2700000 "Cluster 38: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "CAB002431: AB_563509, HPA011256: , HPA069062: " "unprognostic (2.32e-2)" "prognostic favorable (1.46e-4)" "unprognostic (3.64e-3)" "unprognostic (1.02e-2)" "unprognostic (6.32e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "prognostic favorable (2.92e-4)" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (5.88e-2)" "unprognostic (2.37e-2)" "prognostic favorable (2.74e-4)" "unprognostic (5.44e-2)" 17.5 9.1 12.1 47.4 10.5 21.1 6.9 11.7 12.1 9.2 8.2 9.6 8.6 3.7 2.1 8.6 7.8 17.0 5.0 12.0 14.1 4.0 6.5 40.8 62.2 17.8 13.5 2.8 3.4 4.4 3.0 13.0 16.4 3.3 8.4 0.7 7.0 3.9 2.2 4.7 15.5 11.5 17.0 86.6 11.3 2.2 17.2 52.1 3.4 7.3 30.6 21.5 3.3 24.5 0.5 0.4 1.4 0.8 0.7 1.5 0.8 4.9 4.8 1.8 1.4 0.3 1.9 0.5 1.7 7.4 2.0 0.3 0.1 0.1 1.3 136.2 0.0 45.7 0.2 0.2 0.4 35.1 130.0 1.8 0.5 2.5 0.6 5.0 0.4 102.2 0.8 195.1 6.0 0.0 28.3 18.9 0.2 0.1 1.6 0.3 0.5 286.7 2.9 0.0 0.3 0.0 0.6 0.2 2.2 3.3 0.1 42.6 1.7 2.6 0.8 3.5 1.4 326.8 214.5 6.4 1.5 74.2 1.9 1543.6 297.6 940.2 419.2 509.2 344.3 22.0 396.6 362.9 299.9 22.3 300.3 323.7 1257.2 309.2 762.7 518.3 662.2 1035.5 12.1 10.5 11.7 12.1 12.0 14.1 17.8 13.5 16.4 17.0 17.2 24.5 1.2 3.2 12.4 0.0 11.6 3.4 0.1 0.2 0.0 0.2 0.6 1.4 2.2 4.3 2.7 0.0 0.0 0.5 159.7 0.2 0.0 0.3 8.2 1.8 0.6 2.6 0.0 10.9 0.2 0.2 2.3 2.4 2.6 0.9 29.7 0.4 3.6 2.2 40.1 0.0 0.3 0.0 0.0 84.9 49.6 12.2 0.3 64.8 7.2 15.9 123.8 0.0 154.5 0.0 0.1 0.5 0.0 0.0 65.1 0.1 0.0 0.5 6.4 0.2 0.0 1.2 0.9 0.8 0.5 0.5 1.8 1.0 65.9 0.1 0.0 0.0 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 60.1;retina: 34.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 1.8;eosinophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 38000000 "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.0 2.5 4.6 7.0 11.0 9.9 1.9 19.1 14.4 2.2 0.9 2.4 1.5 2.9 0.9 4.8 1.4 1.8 2.3 5.1 8.2 2.8 1.6 8.1 13.2 19.9 11.6 7.8 0.9 1.9 2.7 16.3 22.9 1.8 0.9 34.6 2.2 1.2 2.0 8.5 10.8 1.1 10.6 60.1 3.5 29.5 17.2 9.4 1.3 0.3 12.9 8.2 2.5 20.2 16.7 0.2 4.8 1.4 6.0 20.1 39.7 75.2 30.1 15.5 23.8 6.5 26.6 0.1 4.3 34.2 12.6 4.9 1.5 4.8 16.0 1.3 0.9 30.0 0.1 8.3 1.3 0.9 275.8 14.3 0.2 108.7 6.0 39.0 0.2 2.0 17.5 10.1 51.2 1.4 4.3 9.9 5.2 0.4 11.3 0.6 3.3 4.4 6.5 7.1 0.3 0.5 0.5 13.4 6.1 4.1 1.0 6.0 3.0 28.8 19.2 14.1 166.3 1.8 1.3 0.3 92.4 3.4 1.5 1.8 0.0 3.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 4.6 11.0 19.1 14.4 5.1 8.2 19.9 11.6 22.9 10.6 17.2 20.2 1.8 3.2 0.0 1.0 22.6 0.4 1.6 3.1 0.6 13.7 1.2 1.3 1.4 0.0 4.0 1.8 68.8 25.6 5.2 0.6 0.0 19.8 0.5 4.6 1.5 5.3 0.0 21.7 12.4 13.9 58.8 1.8 1.5 10.6 8.2 65.1 0.7 0.7 7.2 1.7 5.9 0.0 0.0 0.3 12.0 2.5 3.7 4.8 8.8 0.0 28.6 6.8 1.0 4.0 16.3 91.0 0.1 1.9 6.4 3.3 0.1 0.1 2.0 58.3 0.0 0.2 9.0 0.9 0.8 0.2 1.4 166.4 5.7 22.0 0.0 24.4 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317428-13348298 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA 21000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 27.8 28.6 23.2 23.6 23.9 25.3 33.5 25.3 22.3 25.6 28.1 31.2 23.2 32.3 35.9 24.6 35.3 23.8 30.8 21.7 24.1 56.5 48.6 24.3 29.3 26.7 28.4 35.7 33.6 48.1 23.5 27.8 23.1 26.4 32.7 25.0 26.9 24.7 33.3 20.9 24.6 33.2 25.9 21.8 25.6 22.1 24.6 64.3 55.4 36.6 34.3 24.8 17.4 24.4 127.7 90.8 182.4 176.3 59.4 45.1 85.8 55.4 42.6 115.6 97.9 103.5 116.4 123.1 67.2 65.0 55.9 79.6 195.2 91.4 120.5 186.7 80.9 67.4 66.8 132.9 61.4 92.0 41.4 39.6 64.6 67.7 39.5 53.9 95.0 255.9 90.7 97.5 83.2 168.1 228.8 39.3 301.8 119.8 40.9 176.3 88.8 73.7 62.2 51.0 64.5 119.5 169.6 74.1 75.7 157.7 93.8 96.1 64.1 51.1 96.3 67.6 117.6 71.3 143.4 228.1 41.2 67.6 41.9 10.2 11.6 8.8 7.7 17.1 9.5 9.5 7.8 8.9 13.6 6.4 10.0 9.4 1.7 15.4 24.8 15.4 13.3 8.3 23.2 23.9 25.3 22.3 21.7 24.1 26.7 28.4 23.1 25.9 24.6 24.4 24.1 12.8 13.1 8.1 12.3 17.2 16.5 19.3 9.6 17.1 23.8 19.4 14.1 20.0 18.0 22.0 0.0 31.6 27.1 17.6 33.2 26.4 13.5 16.9 15.4 26.1 16.7 19.3 8.2 30.1 45.2 18.0 11.7 16.1 15.8 27.7 19.6 32.7 21.1 21.9 8.3 13.7 20.3 10.1 11.7 14.1 14.9 13.1 16.0 4.7 8.0 35.2 9.2 4.0 12.9 34.1 15.3 18.4 18.7 17.5 16.4 44.6 13.4 15.6 6.6 14.2 26.1 17.6 21.2 15.0 16.9 25.6 13.2 25.9 18.0 15.1 SFT2D2 "dJ747L4.C1.2, UNQ512" ENSG00000213064 "SFT2 domain containing 2" O95562 1 168225938-168253021 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 142.6;Late spermatids: 142.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 53.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042207 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA042207: AB_10794789" "unprognostic (4.34e-1)" "unprognostic (8.62e-2)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (8.62e-3)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.37e-1)" "unprognostic (1.91e-1)" "unprognostic (8.54e-2)" "unprognostic (4.00e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (2.15e-3)" "unprognostic (9.22e-2)" "unprognostic (1.22e-3)" "unprognostic (1.71e-1)" 7.2 6.2 11.0 6.7 11.1 32.3 10.3 6.4 8.3 9.1 8.7 8.0 4.9 17.7 7.1 13.2 8.2 6.1 5.2 11.4 10.0 8.4 9.7 8.7 10.6 14.3 10.2 14.6 6.2 6.8 12.4 5.0 12.4 6.5 8.1 3.0 11.6 4.7 3.8 15.3 9.0 10.0 8.8 11.0 6.8 18.5 11.7 8.4 6.5 3.5 11.3 5.4 8.6 15.2 15.6 19.4 7.7 14.2 22.0 12.4 15.8 10.7 7.9 8.3 9.3 20.7 15.6 13.9 16.1 15.8 7.5 51.3 13.2 11.9 11.1 19.4 4.9 10.3 26.3 15.0 11.8 17.3 15.7 14.5 8.9 11.0 9.8 6.4 11.6 18.9 9.8 17.8 9.5 6.5 15.0 12.8 9.2 23.1 4.4 16.4 10.6 10.8 12.3 18.4 4.9 9.4 13.4 16.8 14.6 12.5 13.4 15.4 12.8 10.8 8.2 11.6 14.3 6.8 13.5 20.6 8.6 12.1 11.6 20.6 12.1 4.4 8.9 22.0 5.2 7.3 5.2 5.8 16.9 6.9 4.8 5.5 5.7 7.1 27.5 53.2 6.4 8.1 11.0 11.1 6.4 8.3 11.4 10.0 14.3 10.2 12.4 8.8 11.7 15.2 22.3 44.8 33.1 3.3 43.4 28.0 16.2 30.0 23.3 0.7 39.7 37.3 5.1 25.8 39.1 38.6 4.2 9.5 142.6 63.9 1.9 23.6 65.7 64.2 45.6 32.9 31.8 31.6 1.2 20.5 26.4 44.9 32.1 86.1 49.4 35.7 33.5 54.3 45.5 3.3 0.3 24.8 18.3 99.4 77.3 142.5 24.2 60.5 42.7 13.1 58.5 11.3 40.2 3.0 9.4 37.0 21.4 33.8 23.0 33.0 36.8 37.3 46.6 6.5 26.3 25.7 22.2 30.6 10.1 44.8 48.3 9.9 38.2 23.4 28.6 23.0 SH2B3 "IDDM20, LNK" ENSG00000111252 "SH2B adaptor protein 3" Q9UQQ2 12 111405923-111451623 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.7" "Cell type enhanced" "Detected in many" "Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005483 Approved Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA005483: AB_1079260" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.09e-2)" "unprognostic (1.23e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.65e-2)" "unprognostic (8.17e-3)" "unprognostic (9.08e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (2.86e-1)" "unprognostic (3.89e-3)" "unprognostic (1.11e-1)" "unprognostic (2.24e-2)" 22.2 10.9 10.2 21.9 6.8 60.7 13.3 3.5 9.3 8.6 8.5 11.4 8.1 8.5 3.3 7.7 8.1 18.6 23.4 5.8 6.5 14.3 17.4 20.5 21.0 12.0 7.3 5.5 10.2 5.8 8.0 24.4 10.0 7.3 13.5 3.7 5.3 5.9 9.6 4.1 12.5 13.6 10.1 37.1 7.1 9.5 12.1 10.5 11.1 9.5 15.8 15.7 6.0 14.7 9.2 5.5 7.0 7.3 23.9 35.5 4.8 29.2 79.5 21.9 23.3 8.4 5.2 15.6 20.3 44.6 73.6 1.7 5.5 16.9 35.2 13.3 2.7 53.2 2.6 6.2 23.3 23.5 122.2 21.2 3.8 140.7 12.7 48.4 119.1 12.8 38.9 6.1 80.2 3.2 9.7 46.7 11.0 2.4 21.0 9.5 15.9 10.2 10.5 3.7 4.6 4.9 5.4 0.6 42.2 6.2 3.5 33.4 93.0 20.0 11.3 17.4 48.1 13.9 15.8 17.6 211.6 16.6 165.3 0.9 3.5 1.2 1.2 8.4 1.0 1.5 1.1 1.3 4.8 0.5 0.7 1.0 3.0 1.8 6.6 4.9 0.4 1.8 10.2 6.8 3.5 9.3 5.8 6.5 12.0 7.3 10.0 10.1 12.1 14.7 26.8 3.2 22.0 2.6 26.2 6.8 1.5 4.2 1.2 4.6 4.3 3.8 17.5 4.3 4.3 1.8 2.1 0.4 40.6 15.0 1.9 3.6 13.1 1.0 2.2 39.2 3.5 11.2 11.0 9.0 1.4 8.1 0.5 1.2 38.6 0.8 46.1 11.1 40.4 3.3 7.3 3.0 6.1 113.6 130.9 5.3 2.8 84.1 16.0 38.4 67.1 1.1 18.6 11.1 9.0 7.2 5.9 4.1 4.9 3.0 0.8 1.5 3.5 3.4 0.0 4.0 12.7 12.5 4.5 0.7 4.1 1.0 12.1 4.4 3.2 1.2 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2 leucine rich repeat scaffold protein" Q9UQ13 10 110919593-111013666 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 25.0 16.3 16.4 22.5 17.8 45.7 19.3 19.3 22.1 20.3 12.0 20.4 16.4 20.7 21.0 21.6 16.4 20.1 19.5 19.4 22.3 21.9 23.7 17.9 29.9 16.6 21.7 19.8 20.4 30.3 14.6 20.8 22.0 18.0 21.5 19.7 14.2 17.5 21.3 15.4 18.4 23.3 16.4 22.2 17.3 36.4 18.2 26.9 25.2 26.8 31.2 25.0 14.8 15.5 29.2 17.8 22.7 38.2 50.9 51.2 14.5 35.0 51.9 31.9 38.5 16.5 25.8 63.1 17.1 62.8 19.9 24.1 27.8 25.0 46.2 34.7 16.5 28.8 25.7 16.2 37.0 49.6 49.4 57.3 38.6 36.9 69.1 43.6 32.8 22.1 18.3 43.8 45.7 15.6 24.7 38.9 14.1 15.6 18.6 34.8 45.2 18.1 33.3 19.4 11.7 23.4 30.7 15.0 34.9 25.8 77.2 41.5 33.3 25.6 22.6 32.5 24.3 40.2 44.0 100.1 30.6 50.3 18.6 52.3 22.8 33.5 12.6 26.8 15.5 30.3 14.8 15.0 22.3 24.4 15.6 15.2 65.8 19.5 27.8 15.2 19.2 23.9 16.4 17.8 19.3 22.1 19.4 22.3 16.6 21.7 22.0 16.4 18.2 15.5 73.8 54.5 48.1 35.6 95.4 55.8 35.2 37.5 27.9 27.6 51.4 39.1 83.6 45.8 42.3 31.3 16.7 22.2 77.5 80.8 64.6 48.5 44.2 65.1 54.6 63.5 26.3 67.5 59.9 59.2 23.0 50.7 49.5 54.9 73.4 20.2 53.2 69.0 29.4 30.3 53.1 36.2 46.8 78.3 67.3 89.7 65.6 76.0 49.8 57.1 116.5 31.5 57.7 46.3 61.0 64.0 51.6 80.9 53.4 37.1 51.7 67.7 57.0 32.7 72.3 59.9 58.7 108.8 69.3 38.1 69.9 60.6 65.8 17.0 30.1 49.7 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532555-113629575 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.8" "Cell type enhanced" "Detected in many" "B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 33.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035862 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.2 2.8 5.2 5.2 5.6 3.4 5.4 4.7 6.4 3.1 0.0 6.2 2.0 0.7 0.2 1.4 1.9 3.7 0.4 6.4 3.6 0.8 0.6 1.8 8.8 2.8 3.5 0.2 0.7 0.5 5.4 1.0 2.1 5.1 10.2 0.4 10.8 1.5 0.3 0.5 5.4 0.7 5.7 7.1 3.5 0.9 4.9 5.2 0.4 0.4 8.8 4.5 0.9 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 1.5 0.0 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 4.2 0.0 15.4 4.2 0.2 0.0 16.2 21.0 6.2 0.0 0.5 0.0 14.9 0.2 0.1 0.0 4.2 0.2 0.0 13.8 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 7.0 0.1 7.1 7.5 4.7 5.8 1.5 6.6 5.9 5.1 0.3 9.1 0.0 33.7 3.9 3.4 5.2 5.6 4.7 6.4 6.4 3.6 2.8 3.5 2.1 5.7 4.9 3.3 1.6 6.4 3.3 7.2 47.4 0.4 1.4 1.9 0.0 1.4 9.7 4.7 1.1 4.3 4.2 1.8 0.0 0.0 34.5 17.2 0.0 0.4 5.0 3.1 0.7 1.0 10.2 0.8 117.8 1.1 0.2 0.4 8.2 6.3 3.8 0.0 0.4 0.5 11.2 0.0 86.8 23.3 2.0 3.5 1.8 1.5 0.0 10.1 5.4 23.4 2.6 0.1 21.6 4.5 4.0 0.8 3.9 0.0 14.5 3.9 2.2 0.1 9.3 0.2 0.0 0.7 0.7 0.2 0.1 0.9 0.3 0.1 16.4 0.3 7.0 1.9 SLC12A3 NCCT ENSG00000070915 "Solute carrier family 12 member 3" P55017 16 56865207-56915850 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 101 "kidney: 101.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 20 "plasmacytoid DC: 14.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 14.9" "Group enriched" "Detected in some" 11 "BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA028748 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 20: HeLa - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA028748: AB_10603886" "unprognostic (1.54e-3)" "unprognostic (7.09e-5)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.38e-4)" "unprognostic (1.81e-1)" "unprognostic (9.70e-2)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.84e-2)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.3 0.4 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 101.7 0.0 0.1 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.4 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 4.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.1 0.3 0.8 0.0 1.0 0.6 0.0 0.2 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.7 0.0 0.0 4.2 0.0 5.9 0.0 0.4 2.1 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 4.2 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SLC15A4 "PHT1, PTR4" ENSG00000139370 "Solute carrier family 15 member 4" Q8N697 12 128793194-128823958 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 125.8;Early spermatids: 92.3;Late spermatids: 110.1;Muller glia cells: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 31.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016713 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA016713: AB_1856978" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (3.63e-2)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (6.78e-4)" "unprognostic (5.14e-3)" "unprognostic (6.39e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (2.06e-2)" "prognostic unfavorable (7.56e-6)" "unprognostic (1.28e-1)" "unprognostic (2.06e-1)" "unprognostic (2.34e-2)" "unprognostic (2.57e-1)" 11.0 6.3 3.5 10.8 4.8 22.1 9.0 5.3 4.3 10.1 27.4 6.8 6.0 12.5 5.0 9.4 9.2 10.4 9.9 3.8 4.7 7.3 15.1 10.1 17.5 6.2 4.4 10.3 7.7 7.5 3.6 9.6 6.4 7.6 5.7 23.3 6.1 8.8 27.8 10.1 6.0 12.5 5.6 11.5 7.4 11.3 4.6 11.4 7.5 19.9 19.6 10.3 7.2 7.6 12.0 19.3 4.9 10.8 41.9 26.9 17.9 20.6 17.1 14.3 16.1 8.9 16.9 43.7 10.6 18.0 14.3 13.5 13.5 12.8 15.5 21.6 12.5 6.0 11.1 15.8 43.7 20.2 6.2 17.4 22.9 11.9 31.0 42.9 10.1 8.8 9.9 26.9 29.5 8.4 10.8 5.5 17.4 13.0 11.3 9.0 10.6 17.2 28.3 15.4 8.8 7.3 8.5 15.8 22.5 13.1 21.0 5.8 15.5 15.9 8.9 8.1 12.7 9.0 21.1 20.3 21.5 14.2 0.2 0.0 2.8 7.2 7.3 3.8 3.6 2.9 1.3 4.4 1.7 2.8 1.4 3.5 18.8 6.8 1.6 31.8 0.7 3.1 3.5 4.8 5.3 4.3 3.8 4.7 6.2 4.4 6.4 5.6 4.6 7.6 8.6 19.2 8.0 15.7 14.8 10.3 8.7 10.4 8.6 11.4 10.2 12.3 8.5 12.8 9.0 22.0 12.5 5.5 125.8 4.5 1.9 24.9 92.3 9.3 14.1 6.5 10.8 11.8 23.6 11.1 7.0 14.5 6.6 40.1 11.4 9.7 12.8 20.0 22.0 15.2 23.0 4.4 4.1 24.6 28.2 110.1 12.5 24.5 24.9 21.5 33.0 91.6 45.3 37.7 25.7 24.8 6.8 13.5 11.6 9.3 5.5 6.1 5.1 15.6 6.6 14.4 11.4 51.1 10.6 7.5 9.1 4.0 16.7 10.8 6.5 6.9 SLC1A4 "ASCT1, SATT" ENSG00000115902 "Solute carrier family 1 member 4" P43007 2 64988477-65023865 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.9" "Cell type enhanced" "Detected in many" "Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 294.5;U-266/70: 132.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034963, HPA034964" Approved Enhanced Centrosome NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Centrosome "HPA034963: AB_2797223, HPA034964: AB_2674386" "unprognostic (7.61e-2)" "prognostic favorable (3.59e-4)" "unprognostic (2.49e-1)" "unprognostic (3.19e-3)" "unprognostic (1.26e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.23e-5)" "unprognostic (1.26e-2)" "unprognostic (2.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.28e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.37e-3)" "unprognostic (4.14e-2)" "unprognostic (3.53e-2)" "unprognostic (1.98e-2)" 4.3 26.4 49.1 9.1 46.8 13.4 13.6 32.1 48.6 14.0 18.0 9.4 6.1 12.8 8.2 7.5 4.8 3.9 6.2 43.4 56.6 1.9 9.0 4.9 10.7 37.2 43.1 13.2 29.6 5.5 13.7 6.6 52.1 9.6 8.4 19.3 7.5 7.1 40.1 18.6 5.6 12.3 29.5 7.5 8.1 11.7 59.9 20.5 5.7 17.0 19.0 4.8 6.2 30.3 15.3 11.6 6.6 34.9 14.7 9.5 9.4 28.5 14.0 11.7 19.8 3.2 2.2 49.7 6.5 44.8 14.7 43.2 13.7 3.6 12.0 20.1 5.4 26.0 13.1 30.9 31.0 43.8 23.1 4.4 73.8 15.8 24.2 3.9 7.3 49.1 20.7 122.0 8.4 13.5 37.7 29.1 4.7 20.1 13.9 13.5 1.9 125.5 4.9 7.7 29.3 14.1 17.9 16.1 294.5 3.0 19.3 47.8 1.6 16.0 19.0 31.2 17.5 132.8 71.2 118.8 23.6 86.5 86.2 0.0 2.1 1.8 0.9 4.8 1.2 0.9 0.9 1.5 3.9 0.3 0.0 0.8 0.0 5.1 9.4 7.2 3.5 1.4 49.1 46.8 32.1 48.6 43.4 56.6 37.2 43.1 52.1 29.5 59.9 30.3 3.6 0.0 2.7 69.9 13.6 20.0 2.1 6.7 46.1 6.3 21.0 7.1 5.5 1.5 1.7 1.8 33.3 2.4 20.2 2.9 0.0 2.0 32.4 5.4 8.2 5.3 8.4 6.1 20.6 9.3 1.3 4.0 5.1 5.6 7.0 49.2 7.5 13.1 17.7 6.7 25.5 9.0 6.1 6.8 11.8 47.5 11.1 11.1 85.4 8.4 5.1 14.6 2.1 5.0 3.9 7.1 0.8 29.7 65.7 2.6 0.4 1.5 5.4 17.7 0.0 5.1 7.3 2.0 0.9 5.9 6.1 2.5 10.9 0.4 5.8 1.0 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724486-38729372 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.7;Horizontal cells: 58.9;Inhibitory neurons: 20.7" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported Approved Cytosol NA NA "Cluster 65: Brain - Ion transport" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 0.0 0.0 12.4 0.0 39.8 0.2 0.0 3.4 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 36.5 0.3 0.0 0.0 0.0 14.2 6.8 0.0 0.0 0.0 7.6 0.0 8.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.4 39.8 3.4 22.0 2.4 36.5 14.2 6.8 8.7 6.3 5.1 1.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 14.7 0.0 0.0 0.4 0.0 0.1 0.0 4.2 0.0 1.3 0.0 0.0 0.0 2.5 0.2 0.0 0.4 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.9 20.7 0.0 0.0 0.0 0.4 0.6 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.0 0.0 0.1 2.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572415 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: AB_2684713" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 10.7 9.8 5.9 5.6 4.8 8.0 9.6 3.7 6.6 9.6 6.3 9.2 6.6 8.5 5.9 11.5 7.4 6.1 10.1 5.6 4.7 7.8 11.4 9.1 7.1 4.8 5.9 8.8 22.3 15.2 11.2 7.2 5.0 11.7 6.1 7.4 15.4 10.0 20.5 11.9 7.7 6.8 3.6 6.7 15.3 4.1 9.1 8.5 9.2 14.0 8.1 10.1 8.7 4.5 26.2 10.4 6.9 16.2 25.2 19.8 16.4 17.8 20.3 15.1 18.2 11.8 18.7 13.6 30.2 29.3 14.9 17.6 19.7 21.5 15.2 15.8 29.5 11.9 11.6 14.4 21.1 19.6 14.5 16.5 24.2 17.0 24.5 19.2 14.8 16.0 19.9 17.3 19.4 25.3 15.3 9.3 8.1 24.8 34.6 14.9 10.6 16.6 15.7 16.1 11.9 11.9 12.3 19.6 11.5 8.3 14.7 9.9 15.3 19.5 9.6 26.9 21.2 23.6 26.9 15.1 29.3 21.4 12.6 1.8 1.3 3.2 1.3 0.9 1.8 2.2 1.4 1.3 1.0 0.8 1.0 0.8 1.3 1.8 2.0 1.1 1.8 1.1 5.9 4.8 3.7 6.6 5.6 4.7 4.8 5.9 5.0 3.6 9.1 4.5 21.7 38.5 42.5 6.8 14.9 21.9 15.3 22.1 5.7 28.8 34.1 21.5 16.1 22.8 31.3 29.5 35.5 14.4 43.3 25.2 0.0 20.4 3.6 26.6 20.1 20.2 18.5 13.7 13.9 36.8 29.8 14.8 13.3 50.8 8.2 21.2 22.9 26.9 17.4 30.3 13.9 29.7 8.2 21.1 28.0 4.2 17.1 23.3 8.8 10.3 22.8 19.4 17.5 9.0 6.2 41.7 13.1 21.1 29.3 30.9 22.1 7.0 24.0 29.4 6.6 30.1 14.3 10.2 14.3 13.6 25.9 32.6 29.4 16.2 20.4 28.4 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869507 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 110.7;brain: 121.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 178.7;Microglial cells: 109.6;Plasma cells: 135.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 17.2" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.2" "Cell line enhanced" "Detected in all" "HBEC3-KT: 1326.5;hTCEpi: 2229.0;MCF7: 1264.6;SiHa: 1873.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA 51000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Cytosol" Vesicles "HPA052673: AB_2681909, HPA056077: AB_2683031" "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 10.6 3.9 121.9 18.3 87.8 110.7 6.0 89.5 119.4 11.0 64.5 11.4 6.6 5.2 35.7 100.2 6.4 6.6 21.1 96.0 91.0 18.0 26.6 9.8 14.1 111.3 104.3 8.1 14.0 1.8 22.8 17.0 104.9 9.8 2.7 42.5 28.6 10.4 30.1 25.1 8.9 3.2 93.0 16.7 34.4 65.6 117.1 6.9 3.9 2.8 11.5 24.6 22.6 88.1 187.4 693.5 13.2 192.1 5.1 10.6 487.3 147.1 52.8 87.4 56.3 456.3 260.4 170.1 126.7 187.6 30.5 818.3 142.5 1326.5 61.0 179.9 71.9 140.3 618.0 331.2 199.5 131.2 246.0 35.9 2229.0 107.8 791.4 28.5 18.0 588.8 212.6 185.1 71.1 1264.6 159.2 192.7 63.3 116.7 166.0 152.0 52.4 264.1 98.3 15.7 109.2 43.5 1873.1 368.9 406.9 123.0 170.0 171.8 14.3 30.9 201.3 127.8 114.5 237.9 213.2 728.2 120.1 322.1 296.4 1.0 0.0 0.0 1.0 0.0 1.3 0.5 0.5 0.9 0.4 0.0 0.1 0.4 0.2 0.2 0.0 17.2 1.6 0.5 121.9 87.8 89.5 119.4 96.0 91.0 111.3 104.3 104.9 93.0 117.1 88.1 3.7 0.0 0.6 8.1 23.0 73.3 17.9 27.0 178.7 15.2 12.0 8.9 2.9 2.8 6.3 1.8 16.7 15.4 80.0 3.4 0.0 18.1 1.0 20.5 7.6 29.1 86.3 86.3 12.0 9.6 35.4 9.5 43.3 51.0 66.9 4.5 1.8 17.3 9.2 10.1 13.2 6.3 8.2 3.0 50.5 5.0 1.8 51.0 39.2 109.6 2.6 14.8 2.1 15.1 1.6 25.7 2.3 1.5 135.1 18.2 1.0 0.4 3.2 52.7 0.0 33.6 31.5 1.6 4.5 58.8 37.5 107.4 65.8 2.7 4.2 42.8 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 2.9;salivary gland: 3.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 9.7;Excitatory neurons: 20.4;Horizontal cells: 21.9;Inhibitory neurons: 13.3;Oligodendrocyte precursor cells: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.0;HeLa: 3.7;hTERT-RPE1: 3.2;U-138 MG: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013843, HPA073230" Uncertain Approved Vesicles NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA013843: AB_1857233, HPA073230: " "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.1 1.3 0.0 1.9 0.0 0.1 0.8 2.6 0.1 0.0 0.3 0.0 0.0 0.4 0.1 2.9 0.0 0.1 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.0 0.0 0.7 0.1 0.7 3.7 1.3 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.1 1.5 0.0 0.9 0.1 0.1 0.0 0.5 1.1 0.0 0.7 7.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.3 0.9 3.7 0.0 0.4 0.0 0.0 1.5 0.1 0.0 0.6 3.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.7 0.1 0.1 0.2 0.0 1.1 0.1 0.0 0.2 0.0 0.0 0.5 1.7 0.0 2.4 0.0 0.0 0.4 1.1 0.0 0.0 2.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.3 1.9 0.8 2.6 1.9 0.6 0.0 0.1 0.0 0.2 1.5 1.1 0.0 0.0 1.1 1.3 0.0 0.1 1.5 0.0 0.0 9.7 0.6 1.7 1.8 1.5 0.0 0.0 4.2 0.0 5.9 0.2 0.0 0.4 0.7 2.1 0.5 1.0 0.0 2.7 20.4 0.0 0.0 1.6 0.0 5.0 1.3 0.5 0.0 0.0 0.0 21.9 13.3 1.9 0.0 0.0 0.0 1.0 5.9 0.5 0.0 1.0 0.1 7.0 0.0 11.1 0.9 0.0 0.1 4.9 0.0 2.5 0.0 0.1 1.5 1.6 0.0 4.6 0.3 5.5 0.2 0.4 0.0 0.0 0.1 0.0 0.2 1.1 SMIM41 ENSG00000284791 "Small integral membrane protein 41" A0A2R8YCJ5 12 52079704-52108255 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lung: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 56 "plasmacytoid DC: 5.5" "Lineage enriched" "Detected in single" 56 "dendritic cells: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 65: Plasmacytoid DCs - Unknown function" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.4 0.0 0.1 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.0 3.5 0.3 0.4 0.0 1.3 0.1 0.0 0.4 0.1 1.9 0.6 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.1 1.4 0.5 1.1 0.0 1.7 0.0 0.1 0.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46780245 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.0 10.2 7.6 6.3 7.7 7.7 13.0 15.9 9.6 13.0 7.5 9.7 5.2 14.1 9.1 8.5 9.3 11.3 11.3 8.1 7.6 9.2 6.7 8.7 6.7 8.3 8.3 23.2 6.2 14.2 5.6 7.3 8.5 9.9 6.6 12.7 8.7 12.4 9.0 7.5 6.7 13.9 8.5 9.0 6.6 10.3 8.2 7.6 9.9 16.0 6.7 9.3 8.5 8.6 14.5 10.8 9.3 13.8 29.9 42.3 11.4 66.5 121.0 31.5 18.6 10.3 6.9 7.5 12.7 121.9 9.7 7.1 9.9 10.8 41.2 7.3 9.4 11.8 10.0 13.2 18.4 6.9 12.7 33.9 15.8 26.7 10.7 35.8 11.0 3.0 10.2 8.1 21.5 5.3 5.9 12.0 10.4 15.1 8.7 7.8 15.9 9.5 13.2 11.1 7.3 19.8 16.4 10.7 13.0 8.9 4.4 10.3 12.8 80.0 17.7 26.9 13.2 9.7 6.4 6.5 36.9 13.7 25.5 0.5 0.4 2.5 0.9 0.4 1.1 1.8 0.5 0.6 0.5 3.0 1.1 1.5 0.4 1.0 1.7 0.5 1.0 0.7 7.6 7.7 15.9 9.6 8.1 7.6 8.3 8.3 8.5 8.5 8.2 8.6 17.2 3.2 6.1 18.9 11.3 16.6 7.2 8.3 16.5 12.8 15.1 12.2 14.2 18.6 8.0 3.7 22.9 3.7 6.2 11.0 5.9 7.3 12.3 9.9 29.2 24.3 10.8 6.1 43.4 6.8 2.5 18.8 10.2 12.0 17.1 17.4 17.2 7.9 4.5 18.5 51.5 7.1 2.0 8.4 15.2 8.1 17.4 7.7 7.2 18.7 8.4 9.7 6.2 38.2 25.4 6.8 8.8 17.0 7.0 11.0 5.1 7.3 5.3 5.5 13.1 13.8 20.1 13.3 18.8 9.9 14.5 2.7 7.0 7.3 5.6 7.8 SPIB SPI-B ENSG00000269404 "Spi-B transcription factor" Q01892 19 50418938-50431314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 27.9;lymphoid tissue: 99.4" "Cell type enriched" "Detected in many" 4 "Paneth cells: 787.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 54 "memory B-cell: 307.8;naive B-cell: 260.6;plasmacytoid DC: 572.6" "Group enriched" "Detected in many" 106 "B-cells: 307.8;dendritic cells: 572.6" "Cell line enhanced" "Detected in some" "Daudi: 166.3;HDLM-2: 107.3;Karpas-707: 52.8;U-698: 238.2" HPA018523 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA018523: AB_1857443" "prognostic favorable (4.76e-5)" "unprognostic (1.06e-5)" "unprognostic (9.15e-3)" "unprognostic (3.70e-2)" "unprognostic (9.72e-3)" "prognostic favorable (2.14e-5)" "unprognostic (2.33e-1)" "unprognostic (4.79e-3)" "unprognostic (1.18e-2)" "unprognostic (7.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (3.96e-8)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" 1.2 0.1 0.4 41.7 0.5 6.1 0.2 1.3 0.6 0.1 0.5 22.2 13.1 0.4 0.2 0.7 0.8 1.6 0.2 0.4 0.6 0.6 0.5 1.0 87.0 1.4 0.2 0.1 1.5 0.0 0.1 0.2 0.5 1.2 18.2 0.2 2.7 0.2 1.3 0.5 27.9 0.8 0.1 29.3 8.2 0.4 0.4 7.6 0.8 0.2 99.4 4.1 0.3 1.4 0.4 1.1 0.1 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.2 3.1 0.2 166.3 0.2 0.1 0.0 0.2 1.4 0.0 0.0 107.3 0.3 0.7 0.3 0.1 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.8 4.6 52.8 0.1 0.5 0.1 0.6 1.5 0.1 0.0 11.6 0.9 2.0 0.0 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.3 5.4 0.8 0.1 3.0 0.1 0.3 5.0 3.5 238.2 0.1 2.6 0.2 4.1 0.5 0.8 0.5 0.2 0.4 307.8 0.3 0.3 6.9 260.6 0.4 0.3 2.6 3.9 0.3 572.6 0.6 14.8 0.4 0.5 1.3 0.6 0.4 0.6 1.4 0.2 0.5 0.1 0.4 1.4 0.5 0.0 1.8 0.3 162.7 1.8 2.1 0.0 0.0 0.7 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.3 192.8 28.3 0.0 0.7 0.0 1.1 0.3 0.8 19.8 0.4 0.3 1.1 0.2 1.1 2.6 0.5 4.5 0.2 0.0 0.5 1.4 0.0 0.3 18.4 0.0 0.6 38.0 0.0 0.0 13.0 7.2 0.0 1.6 0.6 1.0 0.0 0.2 0.0 787.8 0.4 2.0 1.4 5.0 0.3 0.7 1.0 0.0 1.3 0.8 0.2 1.1 0.0 1.3 0.3 2.7 0.1 37.6 1.3 SPOP "BTBD32, TEF2" ENSG00000121067 "Speckle type BTB/POZ protein" O43791 17 49598884-49678163 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 21: OE19 - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (8.83e-2)" "unprognostic (3.23e-1)" "unprognostic (2.15e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (1.89e-2)" "unprognostic (7.20e-2)" "unprognostic (1.17e-2)" "unprognostic (1.51e-2)" "unprognostic (1.24e-3)" "unprognostic (7.67e-2)" "unprognostic (2.81e-1)" "unprognostic (3.45e-2)" "unprognostic (1.10e-2)" "unprognostic (3.29e-1)" 32.3 26.8 33.4 28.7 37.6 13.6 30.2 49.8 39.8 45.7 35.9 92.2 27.4 50.1 35.8 56.9 42.2 29.8 41.0 36.1 37.3 29.5 37.1 33.1 38.9 33.1 34.0 40.9 25.1 30.9 22.7 32.5 34.6 64.8 39.2 38.2 32.8 81.7 57.2 26.5 34.0 77.8 31.8 32.8 35.0 17.0 38.4 43.6 35.2 52.4 42.8 46.7 30.6 42.8 33.7 30.9 40.9 18.3 49.0 51.8 28.0 44.1 47.6 57.6 62.8 71.1 36.8 56.4 84.2 41.3 38.5 29.2 49.3 29.1 68.8 111.4 57.6 70.6 38.9 47.8 54.6 45.9 50.3 39.0 41.4 42.9 46.2 43.1 60.9 39.6 73.3 54.2 42.4 33.3 79.2 44.0 11.4 80.9 46.3 48.8 64.5 79.9 32.9 21.0 65.2 26.7 29.7 14.1 37.2 22.5 54.2 45.8 55.4 65.9 41.0 49.9 39.5 52.3 51.7 50.6 37.6 41.0 32.9 145.3 71.2 93.0 61.3 68.7 59.8 76.4 66.0 68.9 91.8 80.2 98.2 78.9 107.9 74.9 88.8 67.9 63.9 92.4 33.4 37.6 49.8 39.8 36.1 37.3 33.1 34.0 34.6 31.8 38.4 42.8 54.5 48.1 41.6 80.6 59.2 42.8 36.2 26.7 34.7 72.7 44.5 38.7 51.6 35.8 30.4 29.5 43.8 23.3 47.3 25.9 29.4 36.5 24.4 30.3 38.8 57.5 51.5 53.2 50.5 28.2 23.3 55.9 18.8 28.4 31.0 39.2 66.8 47.3 38.5 75.7 50.1 46.2 30.5 62.2 59.4 8.9 56.2 49.0 39.2 45.9 67.7 100.2 33.0 54.3 49.3 25.6 30.5 73.4 61.4 30.6 40.1 29.6 32.4 58.7 72.3 37.1 59.2 36.6 45.8 28.2 43.9 36.1 46.7 50.1 33.3 22.8 SRSF6 "B52, SFRS6, SRP55" ENSG00000124193 "Serine and arginine rich splicing factor 6" Q13247 20 43457893-43466046 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029005, CAB034889" Supported Supported "Nuclear speckles" NA NA 50000 "Cluster 39: Non-specific - mRNA processing" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear speckles" "CAB034889: AB_785899, HPA029005: AB_10610424" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.25e-2)" "unprognostic (6.41e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "unprognostic (1.27e-3)" "unprognostic (6.03e-3)" "prognostic unfavorable (2.82e-4)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" "unprognostic (4.31e-1)" "unprognostic (1.18e-2)" 43.3 53.7 34.0 34.5 37.5 115.9 56.2 41.4 43.8 44.2 52.7 37.8 36.3 52.7 59.7 32.8 47.4 31.4 31.4 33.3 39.6 47.4 50.3 40.3 48.4 34.5 34.7 58.5 66.3 41.8 48.0 39.3 35.6 48.7 43.4 38.7 45.3 30.0 30.5 48.7 45.4 39.7 35.6 55.9 47.4 30.3 35.7 53.7 50.8 18.1 40.8 29.7 30.4 47.3 52.7 79.1 88.7 57.3 50.7 67.7 86.3 79.6 38.3 55.4 47.1 112.9 55.9 95.9 73.9 73.3 45.1 77.6 91.7 116.9 71.7 40.2 85.7 74.6 83.3 94.1 62.3 94.9 78.9 115.7 61.9 51.0 46.2 85.1 52.7 83.8 63.3 54.5 52.6 112.3 144.5 107.6 57.8 87.4 107.4 100.2 54.4 76.9 63.1 93.7 69.0 90.9 89.5 108.7 105.0 61.7 70.4 103.3 54.9 57.9 61.6 49.9 67.3 98.2 67.3 131.4 69.9 67.2 42.8 26.0 19.9 9.7 19.7 33.4 22.4 16.0 20.8 19.1 24.5 15.9 27.3 25.7 10.8 21.2 29.6 20.4 18.7 22.9 34.0 37.5 41.4 43.8 33.3 39.6 34.5 34.7 35.6 35.6 35.7 47.3 78.9 64.1 80.0 49.6 75.8 94.4 61.0 58.5 50.7 48.9 110.7 78.7 28.7 75.8 61.3 46.0 39.6 97.8 103.3 67.8 88.0 60.2 12.3 60.1 87.7 62.3 101.4 71.1 32.1 43.7 108.2 80.0 70.8 79.1 97.0 103.2 60.7 94.7 56.5 32.0 37.2 97.2 46.8 73.2 93.7 14.7 55.0 77.3 101.4 26.2 61.2 45.0 37.0 89.0 79.6 46.2 74.3 44.8 49.3 68.9 66.7 67.7 47.6 46.4 59.2 166.1 99.8 53.8 61.0 51.5 98.3 139.1 76.4 90.7 105.5 55.3 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375977-70439237 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Uncertain Vesicles "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favorable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavorable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 8.6 8.3 4.7 6.4 5.8 7.4 7.2 8.4 6.5 9.3 1.6 9.2 3.5 12.5 1.1 2.6 8.2 2.5 10.5 7.1 2.9 8.2 10.3 9.0 6.3 3.1 2.6 7.2 3.6 2.6 6.4 3.2 2.6 7.1 1.6 1.7 3.2 2.8 15.8 4.2 7.1 4.1 1.9 13.2 4.7 6.7 3.3 3.6 6.0 3.1 3.4 8.4 5.6 2.9 1.7 8.6 7.7 11.2 3.9 5.4 2.3 6.1 6.0 6.2 3.0 5.5 4.0 4.6 9.8 6.3 5.8 1.9 3.2 2.5 3.3 9.9 5.0 18.0 4.5 8.7 4.7 6.7 29.4 4.1 1.5 6.7 1.3 8.2 8.6 7.6 25.1 4.2 3.7 1.5 7.5 19.8 10.1 2.9 4.5 13.9 2.9 5.9 5.1 1.5 3.7 9.4 15.8 0.6 7.1 8.1 2.4 7.3 9.9 9.0 10.0 4.0 4.7 8.6 3.9 9.7 10.0 5.9 12.5 4.2 1.9 5.2 2.0 1.8 1.7 2.0 2.3 2.0 1.0 2.9 3.8 3.0 10.1 2.8 1.3 14.3 2.6 1.1 4.7 5.8 8.4 6.5 7.1 2.9 3.1 2.6 2.6 1.9 3.3 2.9 15.4 9.6 5.2 13.4 12.6 3.3 4.2 2.1 2.2 15.7 2.8 3.0 6.8 10.0 1.9 9.2 14.6 4.7 56.1 4.5 0.0 5.7 16.9 1.7 6.5 15.0 13.2 24.8 21.3 4.4 2.5 11.0 2.6 2.2 17.7 19.7 18.2 13.1 13.7 18.5 15.2 4.5 2.0 15.4 35.1 33.2 11.8 11.9 1.8 17.8 24.9 5.6 23.7 16.6 7.4 1.8 1.5 8.2 13.5 3.0 6.8 5.7 1.3 11.1 6.6 8.5 8.8 9.3 8.9 1.1 2.4 1.8 11.5 4.7 5.6 2.3 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 47.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 112.8;Oligodendrocyte precursor cells: 94.0;Oligodendrocytes: 108.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 54.4;RT4: 47.0;SK-MEL-30: 40.8;U-266/84: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060" "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favorable (4.99e-4)" "prognostic favorable (4.48e-4)" 17.5 47.4 17.1 4.6 26.9 2.3 8.5 16.4 20.1 5.4 7.9 5.0 1.0 9.9 0.9 2.7 10.4 8.1 4.2 16.0 24.7 2.8 9.8 14.6 9.1 24.7 22.6 10.1 3.9 0.4 12.8 17.7 23.1 6.7 2.6 31.0 7.1 0.5 12.4 6.1 6.9 3.5 20.6 20.0 5.6 10.8 23.6 5.0 27.9 3.5 4.4 20.8 5.9 41.6 0.3 27.0 2.5 54.4 22.0 11.8 8.0 5.9 18.0 5.6 5.0 0.5 19.6 0.7 0.2 10.2 2.5 1.0 3.6 6.4 7.0 0.2 3.2 0.6 1.1 1.0 17.6 0.4 7.8 6.9 0.8 2.1 0.8 10.1 13.7 7.4 0.8 30.2 18.3 1.8 1.9 3.1 0.2 9.6 0.0 3.5 17.0 11.0 2.9 47.0 3.8 3.8 0.2 0.1 40.8 5.4 0.2 1.1 4.5 0.1 2.7 0.1 0.4 30.0 42.5 0.5 4.2 5.6 27.7 0.6 0.8 0.1 0.6 3.0 0.8 1.1 0.3 0.4 0.5 0.7 0.3 0.3 0.6 0.6 2.4 0.2 0.1 0.3 17.1 26.9 16.4 20.1 16.0 24.7 24.7 22.6 23.1 20.6 23.6 41.6 8.5 86.6 112.8 37.5 29.1 5.6 27.6 20.5 1.2 56.6 3.1 2.3 1.9 40.0 33.9 3.7 58.4 0.4 48.3 0.2 3.9 12.0 12.3 9.0 27.8 8.1 6.7 0.4 46.9 16.6 1.1 21.7 6.1 8.5 34.8 35.2 29.6 21.1 35.6 72.3 60.2 0.1 12.2 45.4 18.1 12.0 8.1 24.9 32.0 45.9 20.1 56.0 12.3 94.0 108.4 6.2 0.1 1.9 19.5 6.8 0.0 3.7 10.7 45.2 0.0 21.3 5.0 8.4 16.1 0.2 3.8 0.3 28.9 6.3 0.1 8.3 SUPT5H "FLJ34157, SPT5, SPT5H" ENSG00000196235 "SPT5 homolog, DSIF elongation factor subunit" O00267 19 39436156-39476670 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029273, CAB034370" Supported Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "CAB034370: AB_2196394, HPA029273: AB_10603896" "unprognostic (3.96e-2)" "unprognostic (3.51e-1)" "unprognostic (1.32e-2)" "unprognostic (5.53e-3)" "unprognostic (4.19e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (7.00e-5)" "unprognostic (7.30e-2)" "unprognostic (4.35e-1)" "unprognostic (1.68e-2)" "unprognostic (1.94e-2)" "unprognostic (6.42e-2)" "unprognostic (1.37e-3)" "unprognostic (1.74e-1)" "unprognostic (2.68e-1)" "unprognostic (3.32e-1)" "unprognostic (2.38e-1)" 43.3 46.2 44.7 44.9 46.6 106.1 41.7 38.2 48.3 45.3 35.3 48.1 40.3 49.7 29.6 42.7 46.2 34.6 41.2 42.7 42.6 38.8 52.1 45.4 51.6 40.4 40.6 55.9 49.5 49.3 72.6 38.2 40.7 48.5 30.0 33.0 54.7 36.1 87.2 50.0 51.3 33.7 37.5 46.7 46.9 102.1 45.1 40.2 51.1 35.6 41.4 45.0 40.2 49.1 134.1 209.5 75.2 76.4 70.7 50.4 64.8 115.4 70.5 66.0 73.2 137.9 80.1 159.7 106.4 104.7 55.0 50.8 101.9 73.5 51.6 161.6 100.3 179.2 99.7 84.5 64.0 148.5 117.4 78.9 54.6 83.9 86.2 72.2 64.0 137.3 137.9 80.4 66.2 132.5 108.5 44.5 94.0 109.8 52.3 108.8 111.0 80.5 68.3 214.1 72.7 98.1 134.0 104.6 71.7 63.3 63.6 80.1 137.6 67.1 77.8 84.1 145.5 130.9 240.8 196.0 81.8 84.1 84.7 49.0 22.1 19.0 13.7 11.5 13.9 23.0 9.6 11.5 11.1 16.2 10.6 9.0 46.3 15.3 17.2 42.6 11.4 15.6 44.7 46.6 38.2 48.3 42.7 42.6 40.4 40.6 40.7 37.5 45.1 49.1 45.1 44.8 82.7 26.4 51.9 51.6 26.8 34.1 43.3 47.4 40.2 51.9 58.8 30.0 51.6 44.1 85.5 36.5 79.6 62.6 13.7 37.4 69.9 73.2 57.2 43.8 89.2 40.4 16.6 35.1 45.3 39.1 72.9 92.2 46.2 36.0 32.5 62.5 36.7 48.8 17.6 62.4 26.4 32.2 68.9 79.1 45.1 51.4 40.9 15.0 41.2 28.4 47.4 15.1 23.1 53.5 46.3 41.3 86.5 32.8 58.1 22.9 67.9 57.6 19.7 57.3 38.1 84.4 80.4 41.0 49.6 54.0 72.6 31.0 50.4 31.2 TAMALIN GRASP ENSG00000161835 "Trafficking regulator and scaffold protein tamalin" Q7Z6J2 12 52006946-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" No NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: AB_2684664" "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 31.9 6.3 9.8 4.1 14.9 23.8 26.9 3.2 21.5 17.6 0.4 9.4 2.2 22.0 1.6 7.1 22.2 9.6 24.2 10.5 3.7 12.2 4.2 46.8 3.8 5.0 4.9 14.9 5.7 2.8 6.2 8.9 4.8 13.0 1.9 0.1 6.5 3.1 10.6 10.7 9.8 6.0 4.1 18.2 8.6 2.6 7.6 3.7 16.3 8.4 2.3 12.5 17.1 7.1 0.0 0.0 4.4 0.2 1.9 3.6 1.0 0.2 1.1 0.0 1.1 0.0 0.0 0.0 10.0 0.0 0.4 0.1 1.3 0.0 0.4 0.2 1.3 0.3 0.0 6.2 7.4 0.3 3.3 7.2 0.0 0.3 0.0 0.0 37.4 1.0 1.6 0.0 0.9 0.2 3.1 10.5 4.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 1.1 1.6 0.0 0.2 7.5 2.7 0.0 0.3 27.4 0.0 2.5 0.2 0.0 0.2 0.0 0.1 0.6 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 9.8 14.9 3.2 21.5 10.5 3.7 5.0 4.9 4.8 4.1 7.6 7.1 243.8 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.2 114.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816830 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 11.3 10.1 10.4 12.4 12.2 10.0 10.1 12.7 6.5 9.3 8.3 6.1 7.1 13.3 7.3 7.7 7.4 19.3 10.6 12.4 16.6 10.3 8.0 12.2 12.2 10.5 8.6 9.4 18.2 8.2 7.3 12.4 6.9 7.7 17.7 8.5 6.9 29.9 6.3 7.2 7.7 10.5 11.1 11.1 10.0 10.4 11.2 11.7 24.1 10.3 8.2 5.5 15.8 12.2 11.9 10.3 15.1 16.7 26.0 23.5 12.9 14.3 10.8 13.1 3.1 17.2 27.4 12.3 12.4 6.0 7.6 13.0 18.2 11.5 17.1 17.0 13.4 10.3 6.3 19.0 33.3 16.3 20.6 12.8 14.3 37.3 11.2 16.1 37.7 28.2 21.7 11.7 5.9 28.4 10.9 13.9 14.9 7.6 16.0 19.3 49.4 11.3 6.3 21.6 18.5 14.5 25.1 30.6 19.2 26.6 19.6 10.1 7.9 10.3 16.4 13.0 19.4 32.9 44.9 20.6 26.8 12.0 26.1 37.2 60.2 12.7 59.3 11.5 39.7 15.8 15.4 45.6 31.0 12.5 14.9 42.8 13.8 64.4 74.6 16.1 22.9 10.1 12.4 10.1 12.7 10.6 12.4 12.2 10.5 12.4 10.5 10.4 15.8 9.1 6.4 16.2 17.3 18.5 4.5 8.1 14.2 3.4 16.1 8.5 8.3 36.6 8.6 8.0 3.7 18.8 14.3 39.7 3.4 41.1 18.1 12.2 10.8 7.6 8.9 10.2 6.5 35.1 16.5 17.5 10.0 6.1 7.8 7.0 10.8 5.3 7.0 18.8 15.2 43.9 5.1 12.2 27.6 8.3 4.0 5.3 20.4 14.2 17.8 31.0 17.8 8.2 23.1 53.6 12.0 6.2 4.9 9.3 6.2 7.3 26.4 12.5 29.6 6.6 8.8 9.2 24.2 17.9 6.6 4.4 9.3 11.1 11.0 5.2 7.0 TDG ENSG00000139372 "Thymine DNA glycosylase" Q13569 12 103965822-103988874 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052263 Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Plasma membrane" "HPA052263: AB_2681777" "unprognostic (3.15e-1)" "unprognostic (1.36e-1)" "unprognostic (9.89e-3)" "unprognostic (6.93e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (1.56e-2)" "prognostic unfavorable (6.90e-5)" "unprognostic (5.37e-2)" "unprognostic (1.82e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.90e-10)" "unprognostic (3.68e-1)" "unprognostic (2.90e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" 10.8 13.6 5.8 15.9 6.4 18.1 12.0 6.7 7.2 10.0 7.2 13.2 11.4 11.6 9.5 17.8 8.7 12.2 9.8 6.3 6.0 8.5 12.1 9.6 21.0 5.3 5.5 9.7 9.5 10.4 9.5 17.5 5.5 9.6 15.6 10.5 9.2 7.3 9.5 12.8 13.4 10.9 4.6 11.9 11.2 4.9 5.5 25.7 10.6 9.6 19.1 17.1 11.2 7.3 42.6 21.4 64.4 37.2 15.5 13.7 69.4 32.4 12.3 42.6 23.6 39.1 18.2 99.4 18.8 26.3 6.9 27.9 76.8 36.5 32.6 42.8 66.8 76.4 31.8 17.5 14.8 95.4 55.8 16.3 48.0 31.5 24.6 25.9 42.3 58.4 91.1 15.8 20.6 45.2 107.6 53.6 76.7 33.0 34.0 107.9 32.8 35.0 46.4 61.4 84.2 58.0 38.9 42.7 28.4 37.7 70.7 52.2 26.5 13.3 21.5 14.3 37.5 34.5 49.5 81.8 14.2 52.0 25.3 55.0 53.0 45.8 28.9 39.2 22.0 43.4 28.1 24.3 34.6 39.8 28.5 25.5 35.5 33.6 40.1 92.5 30.5 17.6 5.8 6.4 6.7 7.2 6.3 6.0 5.3 5.5 5.5 4.6 5.5 7.3 35.4 38.5 23.8 12.1 54.6 79.0 49.1 63.0 38.7 51.3 61.2 54.9 25.9 37.1 49.4 33.1 27.1 66.7 68.7 35.2 37.2 68.6 6.2 44.7 44.7 45.2 81.7 69.4 30.3 53.9 82.6 38.5 47.4 45.7 40.4 27.0 39.3 36.4 44.1 35.3 30.0 55.7 87.5 44.8 42.1 3.8 27.4 42.4 16.0 23.4 41.1 24.4 43.3 20.6 20.9 79.7 39.0 30.1 52.6 52.4 28.4 30.5 40.8 39.0 46.0 37.4 38.0 11.0 23.1 52.8 102.9 156.7 49.8 25.0 42.6 61.8 TENT4A "LAK-1, PAPD7, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Terminal nucleotidyltransferase 4A" Q5XG87 5 6713432-6757044 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 19.3;Breast glandular cells: 13.4;Breast myoepithelial cells: 13.2;dendritic cells: 12.3;Endometrial stromal cells: 15.4;Glandular and luminal cells: 14.0;Granulosa cells: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favorable (8.55e-4)" 13.1 8.1 8.4 9.5 8.6 27.6 11.0 16.6 10.1 12.5 5.7 10.0 8.7 11.1 6.4 10.7 11.5 10.0 8.5 8.7 8.1 9.6 20.5 12.8 13.0 6.5 6.5 15.6 12.0 10.0 11.1 9.1 7.0 11.1 7.2 12.5 8.2 8.8 9.3 15.7 12.4 12.2 6.0 13.7 9.6 10.1 7.9 14.6 10.2 12.1 10.4 10.1 11.8 8.9 31.7 20.9 25.4 31.6 17.7 15.6 37.0 21.0 25.7 25.1 28.2 21.9 17.3 23.1 16.1 25.5 28.5 22.9 20.7 16.4 23.1 26.1 14.0 12.0 72.5 12.4 11.0 18.0 17.3 10.7 13.8 28.7 18.4 18.6 15.0 16.9 16.3 29.8 20.8 17.6 24.4 25.3 13.6 9.7 16.6 21.8 21.2 6.0 10.5 17.5 25.1 19.3 50.7 24.1 14.5 13.4 14.5 9.9 13.6 30.6 32.7 27.2 29.8 28.6 12.6 20.4 19.6 16.4 19.2 0.0 0.2 0.2 0.6 0.1 0.6 0.5 0.4 0.4 0.3 0.4 0.5 0.5 0.1 0.1 0.2 1.1 0.6 0.2 8.4 8.6 16.6 10.1 8.7 8.1 6.5 6.5 7.0 6.0 7.9 8.9 19.3 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 13.4 13.2 0.0 0.0 0.0 5.5 0.0 5.3 12.3 0.0 1.9 4.9 0.0 10.7 15.4 4.8 0.0 0.0 0.0 4.4 4.0 4.0 0.0 14.0 0.0 14.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 4.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 5.6 4.8 10.7 0.0 0.0 TERF1 "PIN2, TRBF1, TRF, TRF1" ENSG00000147601 "Telomeric repeat binding factor 1" P54274 8 73008856-73048123 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048379 Approved "Nucleoli fibrillar center,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoli fibrillar center" "Nuclear bodies" "HPA048379: AB_2680378" "unprognostic (1.02e-2)" "unprognostic (1.66e-1)" "unprognostic (7.24e-2)" "unprognostic (2.42e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (6.53e-2)" "unprognostic (9.55e-2)" "unprognostic (1.52e-1)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (2.34e-3)" "unprognostic (1.04e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" 13.8 15.2 6.8 4.7 7.7 8.7 13.1 10.9 8.1 13.9 7.0 13.3 8.5 13.8 6.9 9.3 14.7 7.3 11.9 7.6 7.1 14.2 11.2 9.3 7.6 6.3 6.6 17.7 10.1 12.3 11.5 6.6 6.3 12.7 7.3 9.0 10.3 9.4 11.1 10.0 9.4 8.5 7.9 8.1 14.5 10.4 6.5 7.4 11.7 4.7 4.6 18.2 12.4 8.6 17.1 15.5 14.6 12.8 11.0 7.3 14.5 18.4 7.3 10.2 10.7 10.0 13.3 9.4 27.6 9.9 22.2 13.9 19.9 11.3 10.5 14.8 31.7 13.6 3.8 6.9 9.5 7.7 15.9 11.6 7.4 11.2 18.8 14.7 11.0 23.8 14.8 12.3 9.6 10.4 31.3 8.8 60.7 37.7 14.7 21.7 7.0 9.9 17.0 8.7 11.9 15.2 13.6 49.8 14.4 42.6 19.9 5.6 7.5 7.8 13.5 17.0 15.3 15.9 16.0 18.1 10.9 12.0 16.7 11.9 6.5 10.7 11.3 6.0 10.1 12.0 10.5 11.4 7.5 10.7 12.1 12.7 3.6 9.7 7.8 11.4 11.4 6.7 6.8 7.7 10.9 8.1 7.6 7.1 6.3 6.6 6.3 7.9 6.5 8.6 41.5 28.9 29.1 39.5 47.8 27.9 39.6 45.8 35.3 77.6 22.5 32.5 23.2 21.5 27.3 31.3 85.5 53.6 109.4 27.5 25.4 35.8 16.2 24.0 41.1 38.7 92.1 31.6 52.7 37.8 62.4 52.3 24.5 27.1 36.8 44.5 41.7 31.0 34.2 70.7 58.3 26.4 36.7 25.5 26.6 8.1 74.3 27.7 30.2 22.5 32.3 85.7 72.1 48.7 55.3 25.6 21.5 85.4 34.2 30.2 17.9 65.7 24.8 55.4 59.2 63.3 49.1 117.6 131.7 23.6 24.3 31.9 52.6 62.0 28.2 27.6 TGFBR1 "ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI" ENSG00000106799 "Transforming growth factor beta receptor 1" P36897 9 99104038-99154192 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 128.4;Late spermatids: 101.7;Microglial cells: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 253.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002441, CAB031481, HPA056473" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane" "CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144" "unprognostic (2.58e-3)" "unprognostic (1.20e-2)" "unprognostic (3.64e-3)" "unprognostic (2.80e-1)" "unprognostic (8.63e-2)" "unprognostic (3.36e-2)" "unprognostic (1.97e-2)" "unprognostic (1.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.01e-3)" "unprognostic (3.40e-2)" "unprognostic (3.19e-2)" "unprognostic (1.14e-2)" 15.9 9.9 9.8 18.2 9.3 33.7 15.4 13.2 8.9 19.4 11.8 18.8 11.7 20.6 8.8 15.0 8.5 21.7 8.2 6.8 11.3 22.6 14.8 16.3 13.8 18.4 14.5 13.0 8.3 8.5 7.6 48.8 20.0 17.1 13.4 4.7 8.3 16.8 8.7 6.2 9.3 33.0 18.0 16.5 18.4 18.3 17.5 11.2 11.2 13.2 13.6 22.5 8.4 27.9 13.7 19.5 115.5 36.1 26.2 19.3 17.4 44.1 47.8 40.7 44.9 19.9 9.3 29.7 13.4 34.6 32.1 30.4 39.6 34.1 54.0 77.1 12.3 43.9 20.7 17.8 43.2 27.2 102.8 40.2 35.4 62.8 29.5 25.2 7.4 10.9 62.4 12.1 55.4 20.3 4.0 31.0 24.7 12.2 11.5 11.0 253.1 12.5 9.9 3.8 31.1 36.2 34.3 150.2 46.4 47.3 28.1 36.6 13.6 29.8 25.5 129.3 27.3 12.1 13.4 20.0 62.5 45.9 26.2 16.2 2.4 9.5 7.8 1.6 6.7 1.6 3.3 5.8 2.0 1.2 3.2 6.2 4.9 4.3 2.0 1.4 2.4 2.2 9.8 9.3 13.2 8.9 6.8 11.3 18.4 14.5 20.0 18.0 17.5 27.9 13.5 6.4 8.8 18.9 18.9 23.6 7.4 19.9 44.3 8.0 18.9 11.7 7.6 4.3 12.8 60.7 0.0 23.0 37.3 5.0 0.0 18.8 128.4 6.4 22.7 17.6 9.6 7.4 14.2 31.2 6.7 36.0 9.2 9.3 29.9 19.5 6.4 12.7 49.4 0.0 8.6 7.3 8.2 32.4 52.5 101.7 9.6 39.7 35.6 116.2 24.3 3.1 35.0 45.8 21.1 33.8 4.2 13.5 11.9 18.4 3.6 13.8 5.0 2.0 32.9 21.8 20.9 11.0 12.7 25.6 16.2 19.4 25.4 7.6 8.3 11.5 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 215.5;lymphoid tissue: 126.0" "Cell type enhanced" "Detected in many" "dendritic cells: 87.5;Hofbauer cells: 62.6;Kupffer cells: 135.9;Langerhans cells: 59.9;Macrophages: 125.4;monocytes: 144.8;Plasma cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 403.3;eosinophil: 341.0;intermediate monocyte: 441.4;myeloid DC: 309.6;neutrophil: 498.1;non-classical monocyte: 454.6;plasmacytoid DC: 125.2" "Group enriched" "Detected in all" 6 "dendritic cells: 309.6;granulocytes: 498.1;monocytes: 454.6" "Cell line enhanced" "Detected in many" "Karpas-707: 135.9;U-266/70: 98.4;U-937: 62.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 30.7 10.6 10.8 72.8 13.1 215.5 12.7 13.6 14.4 7.2 12.3 14.7 10.1 5.7 3.9 8.0 10.2 23.6 6.6 11.2 16.6 9.2 19.1 45.8 47.9 22.2 14.3 3.3 5.4 2.7 4.9 18.8 19.1 5.4 10.1 0.9 11.1 3.9 3.4 4.5 28.2 15.5 15.4 126.0 12.2 22.4 17.8 16.0 11.0 4.5 29.9 26.9 6.4 24.6 9.1 0.3 3.4 0.5 11.4 15.6 1.5 1.9 20.0 28.7 40.2 1.3 2.4 12.8 1.2 6.6 15.9 1.3 5.2 1.2 4.6 1.7 1.2 18.0 0.4 2.3 22.3 23.0 27.8 7.9 0.3 14.8 0.1 1.5 11.1 1.0 24.7 135.9 2.1 6.1 0.9 20.1 11.8 0.3 1.8 4.1 12.8 23.2 8.6 0.3 0.2 5.0 0.1 0.8 26.2 2.1 0.3 20.2 6.9 1.7 0.2 5.6 0.3 98.4 6.1 0.8 32.3 62.1 0.5 41.7 403.3 341.0 71.9 441.4 66.1 41.5 53.1 60.2 309.6 21.8 45.6 48.2 498.1 61.9 454.6 125.2 56.4 380.7 10.8 13.1 13.6 14.4 11.2 16.6 22.2 14.3 19.1 15.4 17.8 24.6 2.2 3.2 20.0 0.3 42.6 3.2 1.1 2.7 0.6 0.4 1.0 0.6 0.7 2.8 8.7 0.0 0.0 0.8 87.5 0.3 0.0 0.9 2.3 4.5 1.8 6.8 10.7 6.1 6.2 8.3 1.3 1.8 1.1 6.4 13.3 7.1 3.6 1.3 62.6 0.0 0.7 0.2 36.7 135.9 59.9 5.2 0.6 125.4 17.8 6.5 144.8 0.1 54.6 0.5 14.7 8.7 0.0 0.4 57.3 3.0 0.0 0.4 3.2 0.2 0.0 21.9 2.1 1.8 2.9 0.1 1.1 2.5 21.2 3.0 0.8 5.0 TNFSF9 "4-1BB-L, 4-1BBL" ENSG00000125657 "TNF superfamily member 9" P41273 19 6531026-6535924 "Plasma proteins, Predicted intracellular proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 9.8;esophagus: 9.8;vagina: 9.5" "Cell type enhanced" "Detected in many" "B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 85.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059857 Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus" "HPA059857: AB_2684144" "unprognostic (2.21e-1)" "unprognostic (1.84e-1)" "unprognostic (1.26e-1)" "unprognostic (7.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-1)" "unprognostic (2.93e-2)" "unprognostic (2.41e-3)" "unprognostic (4.88e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (8.07e-3)" 1.8 0.6 3.5 1.0 3.0 3.7 0.8 3.7 7.6 9.8 2.3 1.2 0.3 0.3 0.3 9.8 1.1 1.0 0.6 3.9 3.3 0.9 0.4 4.9 1.1 3.6 2.9 0.5 0.3 0.5 0.3 0.9 3.4 0.3 1.8 0.3 1.5 0.1 0.7 1.4 1.2 0.4 3.1 2.2 0.6 3.3 3.1 0.5 0.4 0.3 0.7 0.7 9.5 6.3 10.7 13.4 0.2 4.8 2.5 6.0 0.4 1.5 4.8 3.6 17.1 0.3 18.0 11.3 6.8 3.0 0.0 19.2 5.4 2.3 0.9 0.0 2.6 1.8 18.4 4.4 0.4 0.3 85.8 1.0 10.1 20.1 5.5 2.6 0.6 1.6 10.9 0.2 1.3 1.5 0.9 1.8 1.8 0.7 9.5 1.2 0.0 2.8 22.9 0.4 0.0 0.0 29.8 1.7 5.0 0.6 1.2 16.4 6.2 0.0 9.6 26.0 0.0 26.9 10.2 20.9 10.2 5.9 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.5 3.0 3.7 7.6 3.9 3.3 3.6 2.9 3.4 3.1 3.1 6.3 11.3 0.0 4.5 0.0 57.5 2.7 0.3 4.3 6.2 0.2 4.0 3.8 8.1 0.0 1.6 0.0 0.0 0.1 51.6 4.3 0.0 0.3 0.1 5.7 3.9 6.8 14.2 0.0 2.2 0.2 0.0 12.6 23.0 9.2 8.9 0.6 1.8 0.0 4.5 0.0 2.5 3.4 2.0 1.9 15.9 0.0 0.0 22.5 3.6 0.0 1.6 0.8 0.0 1.5 2.9 0.8 4.9 0.0 17.2 0.9 0.2 0.1 0.9 0.2 0.0 2.5 7.5 0.1 0.4 12.7 1.3 0.1 31.5 0.9 5.7 0.3 USP7 HAUSP ENSG00000187555 "Ubiquitin specific peptidase 7" Q93009 16 8892097-8975328 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Developmental protein, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 282.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008108, HPA015641, CAB079904" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA 16000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700" "unprognostic (6.73e-2)" "unprognostic (1.59e-1)" "unprognostic (3.36e-3)" "unprognostic (1.94e-2)" "unprognostic (9.64e-2)" "unprognostic (8.09e-2)" "unprognostic (4.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.81e-1)" "unprognostic (2.49e-1)" "unprognostic (2.35e-1)" "unprognostic (9.93e-2)" "prognostic favorable (8.56e-5)" "unprognostic (1.35e-1)" "unprognostic (1.07e-1)" "unprognostic (7.31e-2)" "unprognostic (2.69e-1)" 22.3 16.1 17.6 27.0 19.8 54.6 20.5 20.5 20.7 20.1 15.1 33.1 21.8 21.5 10.1 29.6 19.0 19.9 23.8 21.4 18.1 19.5 25.1 19.3 39.9 16.9 20.1 19.8 26.7 34.8 13.9 23.7 17.5 20.7 32.5 21.7 18.7 18.7 45.2 25.4 25.9 25.7 18.7 24.2 25.5 58.8 18.8 51.1 22.8 41.0 44.9 26.3 17.7 20.8 39.9 73.5 62.2 46.9 34.9 42.9 42.9 53.6 44.7 48.1 40.4 66.6 46.7 94.6 33.8 61.0 27.7 48.8 95.2 61.9 79.6 63.1 38.1 78.4 49.5 132.9 49.0 87.6 48.8 37.3 37.7 52.6 61.0 37.0 69.7 139.8 77.7 101.5 49.6 75.4 130.8 16.9 43.9 49.8 41.4 114.5 69.7 86.2 33.4 77.9 58.8 35.5 59.4 55.3 28.7 62.3 55.0 39.4 60.4 52.1 54.1 80.3 40.4 49.1 134.3 145.1 48.5 49.6 43.5 5.2 2.1 2.8 4.5 2.2 5.7 4.0 4.1 5.3 2.2 4.9 4.9 4.3 3.4 2.8 6.1 6.5 5.1 1.1 17.6 19.8 20.5 20.7 21.4 18.1 16.9 20.1 17.5 18.7 18.8 20.8 40.4 35.3 54.5 22.2 38.0 46.5 23.1 17.9 22.8 51.1 29.7 28.8 74.3 21.5 36.4 29.5 25.0 21.9 51.4 39.8 5.9 22.5 282.4 38.5 50.9 35.8 42.2 46.5 31.4 33.4 14.5 34.4 31.1 57.6 26.6 47.8 25.0 37.5 19.8 43.7 34.9 49.3 10.2 29.2 31.0 112.2 25.4 43.8 19.6 21.5 36.3 29.2 24.7 24.1 30.2 35.6 39.0 34.6 46.8 34.1 31.3 13.7 37.8 44.2 6.6 58.4 39.4 33.8 39.4 41.3 50.0 21.1 40.4 47.6 54.8 35.0 VASH2 FLJ12505 ENSG00000143494 "Vasohibin 2" Q86V25 1 212950520-212992037 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 7.9" "Group enriched" "Detected in many" 6 "Early spermatids: 92.8;Late spermatids: 80.8" "Cancer enhanced" "Detected in many" "testis cancer: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 24.2;AN3-CA: 29.6;NTERA-2: 46.2;RH-30: 135.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045820 Approved Cytosol "Secreted to blood" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA045820: " "unprognostic (2.22e-1)" "unprognostic (1.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.57e-2)" "unprognostic (1.25e-2)" "unprognostic (4.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.50e-2)" "unprognostic (2.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.84e-5)" "unprognostic (1.95e-3)" "unprognostic (2.74e-1)" "unprognostic (6.85e-2)" "unprognostic (6.81e-4)" 1.7 0.1 0.9 3.3 0.8 0.9 2.0 0.2 1.1 1.7 0.0 0.5 0.7 1.9 0.4 4.0 0.7 2.6 1.1 0.6 0.4 0.4 0.2 1.1 2.3 1.6 0.9 0.6 0.2 0.8 2.6 0.8 1.6 2.7 0.6 0.5 0.9 0.8 0.5 0.5 0.9 1.8 0.2 1.2 0.8 7.9 2.1 4.3 0.3 0.8 2.1 1.4 0.5 0.7 0.3 1.7 24.2 29.6 0.2 0.1 4.0 0.1 0.0 1.0 1.3 0.1 0.6 0.1 0.4 0.1 0.6 0.1 9.9 0.0 1.2 20.3 3.7 2.0 1.4 1.5 0.1 0.2 0.4 3.8 0.0 1.3 0.0 0.6 0.3 11.4 0.1 5.9 2.0 0.5 13.1 1.5 46.2 0.0 3.6 7.6 135.5 1.3 0.2 1.9 5.6 8.6 3.1 0.2 0.3 12.4 4.5 0.9 0.0 1.0 2.7 0.6 1.3 3.4 6.2 0.9 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.8 0.2 1.1 0.6 0.4 1.6 0.9 1.6 0.2 2.1 0.7 0.9 0.0 1.1 0.0 0.6 1.5 0.8 0.2 5.7 3.0 4.1 6.0 1.2 0.0 0.0 0.0 2.1 0.1 12.6 0.2 0.0 0.7 92.8 0.9 1.4 1.1 1.2 0.8 5.4 0.2 0.3 10.9 2.0 1.0 0.0 11.2 0.0 0.1 0.2 1.7 4.3 0.2 2.0 0.3 3.2 80.8 0.3 1.5 0.0 0.0 0.7 0.4 0.0 0.5 0.6 0.1 0.0 0.7 1.0 1.5 0.0 0.4 0.9 2.0 0.0 8.4 4.0 3.2 1.1 0.4 1.6 0.0 0.5 0.1 0.3 0.4 VIPR2 "VPAC2, VPAC2R" ENSG00000106018 "Vasoactive intestinal peptide receptor 2" P41587 7 159028175-159144867 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 20.6;Excitatory neurons: 15.2;Muller glia cells: 38.9;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 45.1" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 17 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 17 "dendritic cells: 12.3" "Cell line enhanced" "Detected in some" "HeLa: 6.6;HMC-1: 9.0;MOLT-4: 12.9;U-266/70: 40.5" "Region enhanced" "Detected in many" "olfactory bulb: 27.1" "Low region specificity" "Detected in many" HPA062707 Approved Approved "Focal adhesion sites" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 46: Fibroblasts - ECM organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Focal adhesion sites" "HPA062707: AB_2684842" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (4.26e-2)" "unprognostic (2.04e-2)" "unprognostic (6.31e-2)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (8.58e-2)" "unprognostic (2.32e-2)" "unprognostic (1.02e-1)" "unprognostic (9.60e-2)" "unprognostic (1.74e-1)" "unprognostic (1.88e-1)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (8.89e-2)" 12.5 0.8 2.2 0.9 1.6 0.4 2.5 0.6 6.9 16.8 1.4 13.8 1.7 6.8 12.2 1.4 4.5 2.5 16.4 2.1 2.0 1.1 0.4 0.6 1.1 2.2 0.8 12.0 17.5 0.9 2.7 5.7 2.6 9.2 1.1 6.5 0.3 20.5 7.4 0.7 4.8 4.2 2.1 0.8 8.6 2.2 1.3 8.2 0.2 5.4 0.4 6.8 11.2 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.2 12.9 0.1 1.0 0.0 0.0 3.2 0.1 0.7 0.0 0.0 2.8 2.3 0.1 0.2 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 40.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.3 0.0 0.1 2.2 1.6 0.6 6.9 2.1 2.0 2.2 0.8 2.6 2.1 1.3 2.9 0.8 0.0 0.0 2.9 0.7 0.6 2.9 0.0 1.8 1.7 1.6 1.8 7.5 0.0 0.0 0.0 2.1 0.0 20.6 0.0 0.0 0.0 1.3 0.4 6.9 0.4 0.0 0.0 15.2 6.7 0.0 10.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.3 1.9 10.2 0.5 1.8 1.9 0.0 38.9 4.1 49.8 0.3 0.8 0.0 2.6 2.4 2.0 0.0 0.5 0.0 45.1 0.0 2.9 5.6 3.6 10.2 0.1 0.0 0.0 3.8 0.1 0.0 0.3 ZBTB18 "C2H2-171, RP58, TAZ-1, ZNF238" ENSG00000179456 "Zinc finger and BTB domain containing 18" Q99592 1 244048939-244057476 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 172.8;skeletal muscle: 85.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 51.8;Muller glia cells: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 217.5" "HPA024656, HPA074019" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Nuclear speckles" "HPA024656: , HPA074019: " "unprognostic (3.48e-3)" "unprognostic (9.17e-3)" "unprognostic (3.69e-3)" "prognostic favorable (1.34e-4)" "unprognostic (6.83e-2)" "unprognostic (4.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.15e-2)" "unprognostic (1.15e-2)" "unprognostic (8.43e-2)" "unprognostic (1.01e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-3)" "prognostic favorable (6.78e-6)" 9.8 6.3 36.2 14.9 45.4 28.2 9.0 172.8 57.5 7.4 20.3 9.2 13.2 7.2 18.5 5.8 8.6 7.4 12.2 66.1 13.5 11.9 19.0 10.0 18.2 18.0 18.1 7.2 24.6 6.2 4.9 9.4 24.7 10.1 10.8 42.2 10.6 11.5 85.5 8.3 14.6 6.1 19.0 20.2 11.4 22.3 18.9 41.9 8.4 37.5 15.7 10.0 5.4 29.8 23.7 8.2 31.2 1.2 4.0 4.1 21.7 13.0 9.6 20.5 12.4 6.3 18.7 17.9 1.2 25.2 6.6 2.4 20.1 6.4 25.5 6.4 17.7 3.0 3.1 3.0 6.3 3.8 9.1 3.5 5.3 12.3 7.7 24.7 22.5 19.3 2.3 7.5 24.5 0.3 31.4 15.2 16.1 7.3 3.6 9.1 21.2 5.1 13.1 8.0 45.8 44.6 5.4 0.2 14.8 13.0 0.4 27.2 33.7 10.5 12.9 6.5 28.0 3.2 0.4 7.0 10.6 11.6 21.6 0.1 0.2 1.3 0.1 0.3 0.1 0.6 0.2 0.2 0.3 0.9 0.5 0.3 2.3 0.1 0.6 0.9 0.2 0.1 36.2 45.4 172.8 57.5 66.1 13.5 18.0 18.1 24.7 19.0 18.9 29.8 18.5 9.6 18.5 37.2 16.2 11.2 3.3 5.0 8.0 6.1 32.6 6.1 22.2 8.6 10.0 18.4 12.5 1.5 8.2 10.5 0.0 4.5 3.8 18.2 3.3 15.3 19.3 0.0 51.8 5.1 2.0 3.8 10.7 11.0 6.3 5.1 12.8 44.3 6.1 6.7 19.8 16.1 18.3 25.4 26.7 5.0 2.1 16.1 3.6 15.0 13.9 52.1 2.1 21.6 20.8 8.5 7.9 4.9 2.2 5.2 6.6 12.0 17.4 27.6 13.1 10.9 6.2 9.8 7.7 8.7 19.7 1.0 7.2 1.7 14.8 4.2 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 6.4 7.0 6.4 8.5 7.0 19.5 15.4 7.1 9.0 6.8 4.7 6.8 7.7 6.2 9.4 9.9 8.2 7.3 4.9 6.4 9.2 6.4 19.0 8.7 13.2 7.3 8.7 9.7 8.4 13.7 4.8 8.8 8.5 7.4 6.5 5.7 10.4 6.0 5.4 18.8 6.4 4.8 8.4 11.5 8.6 5.7 9.3 16.2 10.2 7.7 12.8 8.0 4.8 9.7 13.6 12.9 19.6 18.1 15.9 17.8 23.4 10.3 13.5 11.7 14.5 9.0 11.7 19.5 18.8 10.4 15.7 20.7 31.9 15.7 15.3 22.0 21.6 20.3 20.3 12.7 11.6 21.2 22.7 12.7 19.9 11.2 17.6 17.1 20.9 18.7 13.5 23.2 14.6 15.6 19.2 14.1 24.3 20.9 15.3 21.9 14.9 32.0 12.5 22.2 35.6 15.2 20.9 21.3 25.3 14.9 11.5 29.6 19.6 9.5 6.9 14.3 18.5 12.7 13.1 24.7 12.6 29.4 11.9 11.5 4.2 5.6 2.9 6.4 5.0 2.4 3.8 3.9 6.2 2.2 4.6 3.4 0.9 4.0 4.2 6.7 3.5 3.6 6.4 7.0 7.1 9.0 6.4 9.2 7.3 8.7 8.5 8.4 9.3 9.7 15.7 16.0 7.0 3.9 7.9 12.7 7.8 5.1 12.5 4.5 11.5 13.1 5.2 8.6 11.9 1.8 0.0 7.7 21.7 5.3 1.9 5.5 0.1 12.9 8.7 8.5 8.4 10.3 3.4 6.7 8.7 7.9 7.1 10.3 0.0 16.0 7.9 16.6 7.6 3.3 4.6 7.0 6.1 12.8 10.3 0.4 4.4 8.2 3.6 3.7 14.6 7.0 14.4 5.0 4.6 6.9 5.7 2.6 5.4 9.5 6.8 4.0 15.3 1.6 6.6 6.9 4.1 5.0 10.0 12.7 13.1 9.3 8.7 11.2 6.0 11.9 ZC3HAV1 "ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2" ENSG00000105939 "Zinc finger CCCH-type containing, antiviral 1" Q7Z2W4 7 139043515-139132122 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 85.9" "Cell type enhanced" "Detected in many" "dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047818, HPA059096" Approved Supported "Golgi apparatus,Cytosol" NA NA 24000 "Cluster 49: Eosinophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Golgi apparatus" "HPA047818: AB_10962642, HPA059096: AB_2683903" "unprognostic (1.68e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-1)" "unprognostic (1.51e-2)" "unprognostic (3.92e-1)" "unprognostic (2.61e-2)" "prognostic unfavorable (8.77e-7)" "unprognostic (5.40e-2)" "unprognostic (3.08e-1)" "unprognostic (2.55e-2)" "unprognostic (3.72e-1)" "unprognostic (5.41e-2)" "unprognostic (3.31e-3)" "prognostic favorable (6.86e-4)" "unprognostic (6.47e-2)" "unprognostic (1.99e-1)" "unprognostic (7.84e-2)" 13.5 12.7 8.7 19.1 8.9 85.9 11.1 8.1 15.2 8.6 12.2 12.9 9.7 8.6 10.3 12.9 9.7 11.4 6.4 8.1 13.6 11.1 11.0 16.1 24.0 12.3 11.5 10.9 7.3 9.2 6.2 9.3 12.3 9.5 13.7 2.5 14.3 9.1 3.2 13.1 13.9 13.8 12.7 21.0 10.4 6.5 14.9 24.0 10.6 5.6 23.8 11.9 8.7 12.4 25.1 29.5 4.1 24.7 37.4 35.9 17.6 27.5 21.2 46.9 47.7 21.6 31.4 21.9 25.2 43.9 40.6 27.6 33.2 32.6 26.3 37.2 12.2 43.8 29.7 26.9 21.8 51.1 38.6 37.0 20.3 53.3 11.8 17.4 35.3 32.1 37.6 23.5 20.1 23.3 41.9 59.0 16.6 18.6 17.6 48.5 14.6 21.0 32.0 31.0 7.5 15.4 43.1 29.2 37.8 9.3 17.4 30.9 45.3 9.9 14.3 27.6 23.1 17.9 20.2 49.9 22.4 47.0 24.0 78.7 19.6 30.8 43.0 26.0 56.0 32.2 61.9 53.1 15.2 35.3 59.0 58.6 52.5 38.7 30.6 17.7 58.8 30.6 8.7 8.9 8.1 15.2 8.1 13.6 12.3 11.5 12.3 12.7 14.9 12.4 150.3 25.6 41.1 8.1 119.4 28.7 21.7 17.5 62.6 2.8 70.8 44.8 6.2 21.5 21.1 53.3 4.2 12.6 194.8 57.0 9.8 20.2 2.8 185.9 77.7 74.5 53.2 64.4 0.8 21.2 23.1 68.1 60.6 359.9 32.3 41.6 49.2 36.1 35.1 0.0 3.0 42.2 8.2 43.9 150.0 1.9 18.6 84.4 39.2 33.7 57.1 13.9 88.6 27.6 1.0 23.8 33.8 26.7 104.2 41.5 28.0 36.4 29.9 1.3 13.1 79.5 53.6 1.0 1.1 61.7 22.3 2.3 222.3 41.3 35.8 28.0 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type palmitoyltransferase 17" Q8IUH5 12 76764103-76853696 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 17.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 12: NES - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: AB_2732626" "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 15.6 14.1 18.6 12.1 20.4 23.7 16.1 23.1 25.9 15.8 11.8 13.7 7.5 21.7 12.3 8.0 12.8 10.5 12.5 19.8 18.9 11.0 9.8 10.6 14.8 18.2 18.6 20.1 10.2 12.7 11.0 16.4 18.9 14.1 10.1 31.0 8.1 12.8 11.8 10.2 10.3 14.6 19.2 14.4 8.5 12.8 19.4 14.9 11.8 14.2 11.4 11.7 11.7 27.8 8.2 9.5 30.1 15.4 17.6 18.5 14.6 16.2 13.4 10.5 9.2 7.8 5.8 11.2 9.5 15.9 10.5 7.5 12.1 10.1 16.2 9.5 12.6 16.4 13.1 12.0 11.9 16.5 13.9 17.6 10.3 10.0 14.7 35.2 12.2 15.2 18.0 5.2 13.8 7.6 12.0 21.9 22.1 3.6 11.3 16.1 10.7 12.3 12.0 12.3 11.7 20.1 17.8 6.4 10.7 25.7 14.4 16.3 16.9 14.3 11.0 8.8 9.3 8.1 8.5 11.9 5.4 7.6 15.0 6.2 2.3 5.7 3.6 2.4 2.9 2.5 2.9 2.6 2.8 3.9 3.0 2.5 5.9 2.0 2.5 17.1 1.3 1.5 18.6 20.4 23.1 25.9 19.8 18.9 18.2 18.6 18.9 19.2 19.4 27.8 33.4 32.1 18.3 75.7 20.1 7.1 10.4 9.8 12.5 54.6 9.9 10.7 21.3 12.8 15.5 12.9 39.6 20.3 74.1 5.0 0.0 8.0 11.3 11.8 23.8 24.8 19.2 12.0 102.2 4.7 10.2 21.2 7.1 10.1 41.2 20.7 20.3 10.6 8.8 28.6 95.1 7.5 8.2 12.3 19.4 13.7 20.2 14.9 5.4 54.4 14.9 26.1 18.6 88.4 115.8 6.8 4.5 21.1 13.5 10.2 8.4 5.5 18.0 38.1 0.0 32.3 22.0 17.7 22.6 9.5 5.5 5.6 18.1 19.6 6.2 5.5 ZNF672 FLJ22301 ENSG00000171161 "Zinc finger protein 672" Q499Z4 1 248838210-248849517 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055779, HPA062506" Approved Enhanced Nucleoplasm Yes Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA055779: AB_2682917, HPA062506: AB_2684786" "unprognostic (1.64e-2)" "unprognostic (3.45e-2)" "unprognostic (8.96e-2)" "unprognostic (2.92e-2)" "unprognostic (2.50e-1)" "unprognostic (9.54e-3)" "unprognostic (7.42e-3)" "unprognostic (1.08e-2)" "unprognostic (2.50e-1)" "unprognostic (2.40e-2)" "prognostic favorable (7.51e-4)" "unprognostic (9.03e-2)" "unprognostic (1.16e-2)" "unprognostic (1.99e-2)" "unprognostic (2.69e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.79e-5)" 13.4 14.8 13.4 11.7 14.8 13.5 13.1 17.9 14.1 13.3 14.6 16.1 11.3 14.3 7.7 19.1 14.9 7.8 30.2 12.8 13.4 22.3 26.1 17.0 14.8 17.2 14.8 11.1 18.0 16.2 17.1 9.3 14.8 24.0 8.4 10.7 17.6 8.2 49.5 17.9 16.8 8.1 14.0 19.8 16.9 16.0 14.9 15.8 20.2 35.7 14.0 16.8 13.7 15.8 19.4 21.5 17.2 19.5 9.4 6.6 33.0 17.8 9.7 12.7 13.6 11.8 19.7 22.0 18.1 11.7 9.6 18.8 9.4 13.3 8.0 32.5 5.3 33.7 20.0 16.0 12.0 14.6 24.4 7.4 10.7 16.6 11.5 10.2 11.7 15.2 41.5 17.6 8.8 13.8 26.8 14.5 20.0 22.3 36.5 49.1 16.3 17.4 12.9 15.6 25.5 22.2 16.0 24.0 15.9 10.2 13.8 30.1 10.0 17.5 10.5 11.6 37.3 52.8 22.2 13.2 16.0 25.1 14.5 9.2 16.3 11.9 8.8 15.9 7.2 11.9 6.3 8.8 24.3 15.0 6.7 6.3 9.2 12.7 15.4 13.6 7.8 14.0 13.4 14.8 17.9 14.1 12.8 13.4 17.2 14.8 14.8 14.0 14.9 15.8 10.7 3.2 15.2 5.9 22.3 13.0 28.2 10.1 6.8 22.0 12.8 9.8 20.2 14.3 8.1 16.5 12.5 32.0 22.0 19.5 21.5 18.3 7.8 9.5 5.7 12.0 18.0 17.0 2.2 10.7 19.9 10.0 10.2 8.9 28.0 12.5 7.5 17.2 16.8 10.1 4.0 17.6 8.2 16.4 16.9 14.6 5.6 20.6 12.4 1.9 17.8 19.5 20.6 2.5 5.2 14.6 19.7 5.7 9.6 21.1 26.5 15.8 9.0 30.5 6.6 17.5 11.7 32.4 23.4 5.5 14.6 71.3 13.5 10.6 16.9 22.5